data_1gyf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gyf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.842 0.353 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.435 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.5 146.96 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.509 ' O ' ' O ' ' A' ' 42' ' ' GLY . 53.0 m95 -132.52 -174.43 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.517 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 11.7 pt-20 -156.93 160.65 39.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.499 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 36.5 p90 -144.92 133.4 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 20.3 ttpp -114.58 123.5 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.082 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -55.23 -48.15 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 110.949 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.47 -177.39 3.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -124.65 38.64 4.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 p -105.14 165.23 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.58 -4.05 87.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.274 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.35 -23.7 9.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.598 0.237 . . . . 0.0 111.156 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -43.46 137.16 2.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.746 0.308 . . . . 0.0 111.523 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -64.42 137.09 57.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.1 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.27 136.1 53.34 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.626 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -141.8 -156.5 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.914 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.61 16.32 64.15 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.11 -0.828 . . . . 0.0 114.316 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.1 Cg_endo -70.4 54.6 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 119.976 1.888 . . . . 0.0 111.84 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m-85 -123.32 166.18 15.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 p -55.37 144.16 26.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.7 p -46.71 -30.28 2.3 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.221 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.67 83.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.536 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.464 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 6.6 tp60 -62.72 -26.22 68.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.66 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.8 mmm -72.29 -43.19 64.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.281 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -61.33 -33.86 74.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.258 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -62.88 -58.71 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.3 m-90 -57.66 -46.31 84.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.25 -44.64 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.0 m -75.35 -32.39 60.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 51' ' ' THR . 10.3 tm-20 -64.8 -39.57 93.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.13 2.11 9.27 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.92 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -55.68 -25.96 42.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 1.2 m-85 -121.95 78.67 41.28 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.07 -30.77 46.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.633 2.222 . . . . 0.0 112.355 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -105.18 4.87 31.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.6 162.33 33.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.248 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.45 164.83 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.267 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.95 83.47 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.317 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.5 m -76.03 144.93 40.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.77 159.33 35.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.604 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -95.69 133.3 39.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.719 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 6.2 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.797 0.332 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.27 135.13 57.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.0 p -52.82 -28.35 22.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -1.44 43.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -120.48 4.96 10.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.549 0.214 . . . . 0.0 111.489 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.6 mt -103.34 151.82 6.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.965 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -98.55 115.54 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 92.3 m-85 -98.59 30.39 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.3 29.05 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.0 mt -147.02 30.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.54 -52.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.878 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.761 0.315 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.416 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -100.33 140.49 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.917 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.498 ' O ' ' O ' ' A' ' 42' ' ' GLY . 50.0 m95 -134.11 -174.03 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 111.49 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -150.4 164.62 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.741 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 6.5 p90 -149.18 140.11 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.48 . . . . 0.0 111.653 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -130.66 118.48 21.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.001 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -54.3 -49.3 69.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.425 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.66 176.31 6.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.822 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -131.21 38.93 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -105.47 -174.56 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.02 68.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.871 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -122.46 -35.51 3.09 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.543 0.211 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.38 134.99 3.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.833 0.349 . . . . 0.0 111.473 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -58.56 -174.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.59 98.63 3.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.085 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 11.2 m-85 -114.05 -162.55 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.684 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.95 10.88 66.03 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 118.959 -0.912 . . . . 0.0 114.71 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.45 55.52 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 120.272 2.036 . . . . 0.0 111.964 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.8 m-85 -122.64 165.59 16.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -58.05 144.61 39.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.7 p -46.7 -31.42 2.92 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.174 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.79 96.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.445 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 2.7 tp60 -66.06 -25.94 67.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mmm -74.53 -44.69 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.413 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.88 -34.99 73.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.174 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 55' ' ' GLU . 99.3 m -63.13 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.445 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 4.5 m0 -54.96 -45.57 74.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.36 -47.0 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m -75.32 -31.84 60.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 tp10 -64.81 -29.45 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.1 3.22 23.15 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.949 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.408 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -58.93 -28.21 66.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 1.5 m-85 -120.91 80.26 33.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -27.81 17.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.658 2.239 . . . . 0.0 112.448 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 -7.73 19.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.294 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.13 160.09 31.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.387 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.32 164.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 111.181 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.12 84.9 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.284 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.7 m -84.51 148.21 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -165.03 148.42 8.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.788 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.7 mtmp? -84.29 130.1 34.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 9.9 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.865 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.779 0.323 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.88 127.28 31.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 p -52.52 -30.71 31.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -7.37 53.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 6.86 12.95 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.574 0.226 . . . . 0.0 111.399 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 80' ' ' ILE . 52.3 mt -104.38 153.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 0.0 111.053 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -102.12 115.67 31.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.754 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -96.7 35.53 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -137.35 28.05 2.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.886 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -146.51 30.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -133.53 -53.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.927 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.756 0.313 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.402 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 14.1 mtp -83.71 140.41 32.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.723 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.481 ' O ' ' O ' ' A' ' 42' ' ' GLY . 51.8 m95 -124.55 -174.26 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 65' ' ' ARG . 1.3 tt0 -153.04 145.23 23.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.425 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' TYR . 16.0 p90 -133.76 135.06 43.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.089 0.471 . . . . 0.0 111.983 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 5.8 ttpm? -119.8 129.31 54.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.941 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -59.53 -50.69 72.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.458 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -125.47 135.85 52.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.251 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -76.74 61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -111.85 168.28 9.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.14 -2.15 86.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.498 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.33 -28.1 6.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.653 0.264 . . . . 0.0 111.172 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.413 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -46.97 125.61 7.75 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 111.396 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.46 -177.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.94 125.78 17.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.209 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -135.93 -160.37 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.215 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.686 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.81 15.2 65.94 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-O 119.069 -0.851 . . . . 0.0 114.304 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.3 Cg_endo -70.63 54.6 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 119.996 1.898 . . . . 0.0 111.925 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.441 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.3 m-85 -125.43 165.46 18.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.025 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.7 p -55.11 144.36 24.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.984 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -46.38 -30.86 2.3 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.166 0.508 . . . . 0.0 110.257 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.65 88.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.475 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.428 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 19.1 tp60 -65.36 -26.3 67.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.1 mmm -76.06 -45.86 32.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.037 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -58.95 -30.37 67.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.919 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.4 m -67.8 -58.68 4.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.435 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.428 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 4.1 m0 -55.72 -43.44 76.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.693 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.91 -48.23 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.858 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -75.3 -28.47 59.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.028 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.9 mt-10 -64.74 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.15 -1.09 19.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.845 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -29.86 61.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.48 78.39 28.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.635 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.84 -28.8 42.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -105.09 5.18 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.66 159.82 24.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.213 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.46 164.85 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.849 0.357 . . . . 0.0 111.209 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.22 83.45 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.585 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -74.93 144.81 43.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.243 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -159.39 143.52 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.015 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 9.7 mtmt -84.09 130.47 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.98 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 7.0 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.801 0.334 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -59.77 126.45 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 t -52.04 -31.05 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -7.6 53.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.07 7.03 12.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.6 mt -104.36 153.33 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.014 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -99.43 114.9 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.761 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.47 38.44 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -143.6 30.73 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.1 mt -147.5 30.95 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.33 -49.98 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.883 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.783 0.325 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.434 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 4.4 mtp -88.32 144.56 26.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' GLY . 40.3 m95 -134.39 -173.68 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 65' ' ' ARG . 13.4 pt-20 -156.6 146.76 21.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.641 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 41' ' ' TYR . 34.0 p90 -128.94 144.23 51.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.139 0.495 . . . . 0.0 111.854 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 28.0 ttpt -125.84 115.58 20.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -54.37 -51.25 65.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.978 0.418 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 73.9 mm-40 -85.98 177.76 7.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.7 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -132.49 42.74 3.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.69 178.26 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.893 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.81 9.86 75.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.196 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.17 -28.1 3.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.549 0.214 . . . . 0.0 111.163 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -42.71 137.97 2.06 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.751 0.31 . . . . 0.0 111.612 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.96 -177.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.485 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.84 115.78 6.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.113 0.483 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -121.0 -158.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.056 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 82.75 17.61 67.61 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.293 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -70.32 54.01 1.35 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 119.91 1.855 . . . . 0.0 112.035 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.448 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.2 165.59 16.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -57.45 144.99 34.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.904 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t -47.03 -30.14 2.49 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.145 0.498 . . . . 0.0 110.135 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.51 86.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.426 ' O ' ' CE3' ' A' ' 52' ' ' TRP . 38.6 tp60 -68.85 -26.35 65.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 mmm -75.86 -47.88 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.411 ' OE1' ' CG ' ' A' ' 82' ' ' PHE . 36.4 tp60 -58.81 -31.83 68.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.166 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 55' ' ' GLU . 89.1 m -65.9 -54.5 25.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.426 ' CE3' ' O ' ' A' ' 48' ' ' GLN . 4.4 m0 -58.86 -43.29 90.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.488 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.07 -46.27 91.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.7 p -75.27 -28.53 59.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.887 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' THR . 20.8 mm-40 -64.81 -29.79 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.03 26.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.935 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -58.26 -33.32 69.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.327 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -113.61 83.23 6.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.32 -27.21 19.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.568 2.179 . . . . 0.0 112.483 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -105.19 -7.86 18.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.38 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.09 160.76 31.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.196 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 m -137.93 164.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 82.07 7.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.63 144.62 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.303 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -156.75 153.99 29.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.028 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -91.14 131.58 36.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 8.4 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.696 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 N--CA 1.46 0.054 0 CA-C-O 120.75 0.31 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.92 124.52 20.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.788 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -51.21 -34.1 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.255 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -72.64 -8.17 53.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.299 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 7.11 14.1 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.4 mt -105.05 153.75 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.918 0.389 . . . . 0.0 111.121 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.82 114.89 29.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.785 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' ' OE1' ' A' ' 50' ' ' GLN . 96.4 m-85 -96.69 29.84 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.085 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -130.07 23.61 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mt -144.88 30.05 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.735 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.1 -52.96 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.883 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.736 0.303 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.407 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 8.6 mtp -81.44 148.45 29.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.657 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.473 ' O ' ' O ' ' A' ' 42' ' ' GLY . 56.0 m95 -129.12 -174.16 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -152.43 156.6 39.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.654 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.1 p90 -143.62 146.74 33.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 111.788 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 38.5 ttpt -134.5 123.34 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.149 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 58.2 m95 -67.45 -59.99 2.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.318 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.4 134.65 34.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.455 ' ND2' ' CE2' ' A' ' 63' ' ' TYR . 8.7 t-20 -90.46 51.46 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -113.83 176.11 5.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.994 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.59 86.03 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.994 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -116.42 -30.74 5.8 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.564 0.221 . . . . 0.0 111.02 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.412 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -43.61 129.33 5.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.43 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.34 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.35 97.4 3.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.241 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 9.5 m-85 -111.33 -162.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.333 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.02 12.22 62.23 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 119.026 -0.874 . . . . 0.0 114.523 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 58.1 Cg_endo -71.5 54.87 1.97 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 120.21 2.005 . . . . 0.0 111.959 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -120.38 165.24 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -56.65 141.07 44.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.021 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -46.88 -30.97 2.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.179 0.514 . . . . 0.0 110.253 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.81 86.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.434 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.4 tp-100 -66.46 -25.57 66.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.678 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmm -74.34 -43.07 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.144 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 2.9 tp-100 -59.41 -37.34 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.996 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.3 m -62.19 -59.28 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m0 -55.53 -51.76 65.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.0 t -55.83 -50.51 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 t -75.27 -25.61 58.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.67 -26.02 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.71 2.79 37.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.766 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.52 -33.56 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -112.08 80.02 3.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.756 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.65 -28.65 37.33 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.462 2.108 . . . . 0.0 112.184 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.09 3.68 30.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.263 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.36 163.52 34.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.244 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 m -139.3 164.81 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 0.0 111.232 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -83.58 89.32 7.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.273 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -80.42 151.54 29.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.636 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 29' ' ' GLU . 8.5 ptm180 -165.43 146.33 7.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.505 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -84.44 139.86 31.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 5.2 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -63.36 127.14 29.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.2 p -51.96 -27.52 13.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -79.14 -1.72 37.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.544 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.89 8.11 7.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-O 120.553 0.216 . . . . 0.0 111.461 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.09 154.58 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.882 0.373 . . . . 0.0 111.192 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -108.25 116.26 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.542 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 50' ' ' GLN . 73.8 m-85 -95.92 28.07 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -124.08 30.47 6.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.66 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mt -144.92 29.27 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -140.54 -46.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.96 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.829 0.347 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 70.1 mmm -89.88 136.99 32.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' GLY . 35.3 m95 -127.29 -173.49 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.27 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 mt-10 -146.2 161.04 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.752 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.5 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 5.1 p90 -145.03 146.83 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.599 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.71 119.92 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -56.47 -51.51 68.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.25 176.95 6.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -120.98 38.82 3.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.57 160.25 15.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.28 -5.07 80.84 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.309 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -110.85 -23.91 10.73 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.573 0.225 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.71 149.96 0.27 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 75.2 mm-40 -55.23 152.6 7.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.92 89.93 3.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.317 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 15.8 m-85 -113.36 -164.39 0.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.287 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.04 8.89 64.34 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 119.003 -0.887 . . . . 0.0 114.731 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.5 Cg_endo -70.97 55.08 1.73 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.255 2.027 . . . . 0.0 112.096 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.7 m-85 -121.0 165.39 15.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.131 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -56.16 143.82 31.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.961 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.64 -30.49 2.35 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.24 -43.35 86.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.476 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.441 ' CG ' ' CH2' ' A' ' 52' ' ' TRP . 30.1 tp60 -65.98 -25.89 67.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.733 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.7 mmm -74.18 -51.22 16.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.527 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.12 -33.02 64.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 55' ' ' GLU . 33.0 m -64.54 -59.06 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.715 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CH2' ' CG ' ' A' ' 48' ' ' GLN . 5.0 m0 -56.18 -43.7 78.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.881 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.88 -51.01 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.029 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -75.4 -26.35 58.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.6 mm-40 -64.74 -29.46 70.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.21 0.3 23.8 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.856 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 1.5 m-85 -59.96 -31.75 70.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 110.826 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -117.27 75.81 8.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.1 -30.21 47.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.468 2.112 . . . . 0.0 112.262 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -105.28 5.03 31.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.24 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.18 160.55 29.53 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.145 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.15 164.57 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 0.0 111.241 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.18 88.43 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.036 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -85.11 150.12 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 111.629 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.24 151.6 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -84.38 139.78 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.751 -179.873 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.746 0.308 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -57.25 122.36 12.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -53.19 -28.76 28.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.46 49.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.301 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 7.13 11.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.5 mt -101.97 153.27 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -103.47 114.83 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.648 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.25 22.38 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.053 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.35 27.22 8.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.712 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mt -145.82 29.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.65 -56.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.846 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.788 0.327 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.409 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 26.3 mtp -83.22 144.02 30.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.726 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' A' ' 42' ' ' GLY . 51.3 m95 -126.86 -174.05 3.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.5 OUTLIER -152.07 155.79 38.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.722 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -140.97 143.38 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.041 0.448 . . . . 0.0 111.606 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -130.86 119.48 22.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.145 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -54.29 -46.89 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.95 173.42 7.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -120.79 39.24 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.688 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -108.13 176.25 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.49 -4.95 76.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.14 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.28 -24.1 10.43 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.558 0.218 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.33 159.2 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -57.22 -177.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.13 84.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.168 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 16.5 m-85 -114.81 -162.57 0.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.227 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.687 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.27 11.58 60.95 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.519 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -71.39 55.15 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.183 1.991 . . . . 0.0 111.997 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 4.0 m-85 -120.11 165.3 14.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -54.96 141.96 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 86.9 p -47.67 -30.31 3.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.18 0.514 . . . . 0.0 110.21 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.3 83.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.483 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.5 tp-100 -68.97 -25.85 64.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.585 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mmm -76.0 -45.1 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.869 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.96 -33.04 71.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.681 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -64.03 -56.04 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 5.5 m0 -58.04 -47.39 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.594 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.8 t -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.886 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -75.28 -33.74 61.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.679 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 51' ' ' THR . 11.3 mt-10 -64.93 -37.3 87.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.26 4.19 14.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.784 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -53.47 -32.24 49.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.34 . . . . 0.0 110.933 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 0.7 OUTLIER -114.0 78.73 4.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.733 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 -28.52 51.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.49 2.127 . . . . 0.0 112.201 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.18 5.24 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.246 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.16 162.92 27.11 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.154 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 m -138.49 164.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 111.281 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.25 84.45 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.357 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -77.59 144.6 37.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.019 0.438 . . . . 0.0 111.449 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -157.52 142.32 16.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 11.0 mtmt -83.91 139.0 32.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.999 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 2.6 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.819 0.343 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -59.43 124.74 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.2 p -52.45 -34.22 47.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -64.0 -15.6 59.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.203 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.1 7.83 18.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.387 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.04 153.6 6.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.122 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -104.51 127.63 52.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.611 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -108.82 26.47 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.313 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.94 31.34 2.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.88 0.371 . . . . 0.0 110.892 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mt -145.28 30.51 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.774 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -133.34 -49.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.954 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.926 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.872 0.368 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.436 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.0 139.9 38.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.673 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.45 ' O ' ' O ' ' A' ' 42' ' ' GLY . 58.2 m95 -123.42 -174.14 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 1.5 mt-10 -154.84 137.51 15.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.752 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' TYR . 15.6 p90 -122.32 148.91 44.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.216 0.531 . . . . 0.0 111.923 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 38' ' ' ALA . 6.1 ttmm -136.07 120.41 17.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.978 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 110.882 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -178.12 5.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.811 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -124.74 39.48 3.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.765 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -101.95 -166.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.91 -5.87 40.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.341 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.8 -19.26 8.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.525 0.202 . . . . 0.0 111.411 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.413 ' HB2' ' CG ' ' A' ' 31' ' ' LYS . . . -44.14 154.81 0.1 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.775 0.322 . . . . 0.0 111.526 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 3.5 pm0 -51.06 135.95 24.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.075 0.464 . . . . 0.0 111.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.99 78.64 1.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.043 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' TYR . 3.3 m-85 -106.66 -159.55 0.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.683 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.42 14.22 58.9 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 119.157 -0.802 . . . . 0.0 114.4 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 55.4 Cg_endo -71.19 55.13 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.041 1.921 . . . . 0.0 111.96 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CD1' ' CZ3' ' A' ' 52' ' ' TRP . 3.1 m-85 -123.0 165.62 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -62.35 149.62 41.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.99 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 t -45.86 -31.23 2.02 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.158 0.504 . . . . 0.0 110.165 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.42 72.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.28 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 22.4 tp60 -63.7 -25.74 68.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.613 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -45.97 62.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.284 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -33.81 72.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.124 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' GLU . 74.2 m -60.99 -62.41 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.432 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.1 m-90 -54.88 -44.13 73.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.921 0.391 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.06 -49.29 80.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 t -75.24 -28.35 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' THR . 14.6 tp10 -65.0 -43.78 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.31 -6.0 4.97 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.94 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.429 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -53.85 -35.89 62.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 0.7 OUTLIER -114.11 78.31 4.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.72 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -35.17 16.68 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.589 2.193 . . . . 0.0 112.39 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -104.9 4.95 32.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.275 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.71 160.25 36.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.333 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.93 164.87 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -78.84 86.9 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.306 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 6.8 m -82.83 146.24 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.64 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -161.73 144.49 11.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.047 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 1.5 mtmp? -84.0 133.19 34.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.893 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 3.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.228 -0.034 0 CA-C-O 120.786 0.327 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -54.52 126.59 24.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.181 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -52.45 -34.96 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -8.63 56.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.032 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -112.46 5.93 18.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.27 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.404 ' CD1' ' CB ' ' A' ' 64' ' ' CYS . 69.0 mt -105.11 154.29 6.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.867 0.365 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -107.0 117.06 33.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -96.68 27.94 3.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.028 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -133.41 31.04 3.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.767 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 mt -146.56 30.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -137.89 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.876 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.754 0.312 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 35.2 mmm -84.0 140.45 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.515 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 46' ' ' SER . 46.0 m95 -123.1 -175.67 3.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.012 0.434 . . . . 0.0 111.249 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -150.47 161.03 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.941 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.96 139.1 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.179 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -128.58 123.89 34.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -55.82 -47.77 76.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -98.49 176.59 5.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 63' ' ' TYR . 2.0 m-20 -119.86 39.54 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.838 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -106.2 176.53 5.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.48 -2.86 72.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.219 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.59 -25.57 9.07 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.561 0.22 . . . . 0.0 111.016 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.23 157.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.849 0.357 . . . . 0.0 111.435 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -55.24 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 86.44 1.15 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.456 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 10.1 m-85 -115.36 -174.16 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 102.68 -5.89 51.66 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.146 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 88.3 Cg_exo -41.53 -25.3 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.329 2.065 . . . . 0.0 113.139 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.425 ' CD2' ' CZ3' ' A' ' 52' ' ' TRP . 1.2 m-85 -42.53 165.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.308 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 p -64.32 147.06 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 36.5 p -47.31 -30.16 2.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.225 0.536 . . . . 0.0 110.204 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.96 80.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.644 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.428 ' O ' ' CE3' ' A' ' 52' ' ' TRP . 30.6 tp60 -68.32 -26.41 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.5 mmm -69.57 -52.3 27.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -60.77 -29.42 69.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.205 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 55' ' ' GLU . 52.9 m -59.92 -57.43 12.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.215 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.428 ' CE3' ' O ' ' A' ' 48' ' ' GLN . 2.4 m-90 -56.2 -43.0 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.767 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -65.36 -48.51 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -29.59 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 51' ' ' THR . 1.0 OUTLIER -64.98 -45.17 86.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.037 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.64 -24.32 0.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.14 162.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 60.08 65.59 2.29 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.93 -34.21 91.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.495 2.13 . . . . 0.0 112.138 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -105.32 -6.21 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.93 159.37 27.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.141 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.48 164.63 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.993 0.425 . . . . 0.0 111.231 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -78.19 86.99 4.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 2.7 m -83.47 153.57 24.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.421 . . . . 0.0 111.255 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.71 152.88 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.796 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.52 126.72 33.55 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.538 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 8.8 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.251 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.867 0.365 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -61.58 137.3 58.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.7 p -54.56 -26.61 33.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -81.95 -0.12 42.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.9 5.83 9.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.588 0.232 . . . . 0.0 111.484 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.6 mt -104.77 152.68 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -109.41 120.34 42.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CG ' ' HB3' ' A' ' 50' ' ' GLN . 37.0 m-85 -101.35 30.59 4.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -132.43 28.27 4.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.934 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mt -145.29 31.23 1.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.95 -49.74 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.892 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.8 mtp -84.28 147.66 27.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.508 ' O ' ' O ' ' A' ' 42' ' ' GLY . 47.0 m95 -132.72 -173.81 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 pt-20 -149.87 162.06 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.74 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -146.7 141.29 26.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 111.682 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -131.39 122.86 27.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.25 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -58.41 -51.9 67.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 0.0 110.945 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -78.58 161.57 26.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.1 38.68 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -104.91 -166.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.71 0.19 26.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.113 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.91 -29.78 7.52 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.525 0.202 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.69 157.26 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.874 0.368 . . . . 0.0 111.709 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 41' ' ' TYR . 1.6 mm-40 -59.79 -176.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.65 107.09 4.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.447 ' CZ ' ' CB ' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -124.27 -162.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.223 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.677 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.49 12.5 69.63 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 118.992 -0.893 . . . . 0.0 114.686 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.7 Cg_endo -70.22 54.91 1.41 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 120.27 2.035 . . . . 0.0 112.056 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.447 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -121.28 165.43 15.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.024 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.8 p -57.41 142.58 43.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -46.82 -30.44 2.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.081 0.467 . . . . 0.0 110.284 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.48 89.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.629 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.416 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 36.1 tp60 -68.56 -25.84 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.846 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmm -75.96 -44.37 40.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 37.3 tp60 -58.99 -38.85 80.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.314 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' GLU . 92.6 m -62.4 -57.31 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.582 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.8 m0 -53.89 -42.71 68.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.003 0.43 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.7 t -65.34 -50.48 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -28.98 60.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.1 tt0 -64.72 -26.52 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.055 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.76 2.83 28.72 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.927 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.8 -27.45 66.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.816 0.341 . . . . 0.0 111.027 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 1.5 m-85 -121.73 78.68 39.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.22 -36.81 99.11 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.551 2.167 . . . . 0.0 112.378 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.52 5.1 31.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.335 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.24 -173.61 46.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.141 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.4 m -158.85 164.7 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 0.0 111.215 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 84.9 2.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.188 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.4 m -84.19 147.79 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.78 153.55 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.034 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CE ' ' CZ2' ' A' ' 28' ' ' TRP . 10.2 mttt -85.95 138.79 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.633 179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.751 0.31 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.37 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.6 p -51.55 -31.51 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -7.48 52.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.388 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -117.61 7.79 12.7 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 80' ' ' ILE . 53.6 mt -105.0 152.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.87 0.367 . . . . 0.0 111.063 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -104.82 116.9 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 68.1 m-85 -96.88 30.86 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.4 26.86 4.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mt -147.0 30.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -137.58 -52.07 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.904 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.837 0.351 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.461 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.71 143.51 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.872 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' GLY . 57.2 m95 -135.95 -174.17 3.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.644 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -158.65 147.54 18.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.57 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.44 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 27.4 p90 -131.37 140.54 49.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.397 . . . . 0.0 111.544 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -123.76 123.13 39.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.2 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -58.11 -52.48 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.66 172.54 9.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.116 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.406 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 62.8 t-20 -118.02 40.33 3.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.73 -177.78 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.978 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.53 -9.55 61.39 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.154 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -112.87 -17.3 12.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.481 0.182 . . . . 0.0 111.347 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.06 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.833 0.349 . . . . 0.0 111.501 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -55.44 -177.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.86 85.86 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.36 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -118.72 -159.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.39 14.77 61.37 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.303 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.97 54.5 1.65 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 119.933 1.866 . . . . 0.0 112.011 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.453 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.9 m-85 -123.21 165.29 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.085 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -56.92 145.15 30.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.028 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 p -47.76 -30.16 3.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.168 0.509 . . . . 0.0 110.081 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.68 -41.51 92.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.374 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.433 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 5.3 tp60 -68.72 -26.07 65.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.775 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 15.1 mmm -76.35 -51.01 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.314 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -55.79 -32.03 63.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.027 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.8 m -65.38 -64.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.514 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.433 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.6 m0 -49.02 -42.74 39.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.5 t -62.64 -58.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.507 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.7 p -75.23 -24.75 57.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.756 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -64.66 -46.38 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 111.185 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.33 -31.18 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.416 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -57.59 156.83 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 110.82 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.401 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.4 OUTLIER 63.19 61.74 1.84 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 50.8 Cg_exo -53.78 -38.59 85.32 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.466 2.11 . . . . 0.0 112.297 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.37 5.13 31.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.35 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.65 160.75 36.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.288 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.08 164.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 111.242 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -77.93 82.0 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.7 m -73.81 146.6 44.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 29' ' ' GLU . 5.3 ttm180 -162.49 159.29 24.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -94.03 137.13 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 9.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.824 0.345 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -55.31 131.56 45.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -26.44 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.194 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 3.13 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.377 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -126.92 4.95 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.576 0.227 . . . . 0.0 111.376 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -105.0 153.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -107.29 114.84 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.78 10.02 40.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.9 32.27 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.4 mt -147.42 31.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.763 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -134.68 -47.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.908 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.912 0.386 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.439 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.19 140.99 24.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.811 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.481 ' O ' ' O ' ' A' ' 42' ' ' GLY . 31.1 m95 -131.17 -173.9 3.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.575 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 1.2 pt-20 -153.55 141.9 20.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.597 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' TYR . 12.8 p90 -123.39 141.75 51.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 111.783 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -130.07 121.73 26.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.96 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -54.55 -48.99 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -97.76 -174.82 2.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -129.68 38.48 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.667 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.24 173.55 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.989 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 -2.37 89.3 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.225 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -112.5 -26.99 8.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.552 0.215 . . . . 0.0 110.94 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.55 153.1 0.17 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.401 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' OE2' ' CE2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -56.26 -177.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 0.0 110.787 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.63 81.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.047 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 30' ' ' TYR . 1.9 m-85 -110.61 -157.07 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.07 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.26 14.81 61.54 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-O 119.098 -0.834 . . . . 0.0 114.392 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 54.6 Cg_endo -70.48 54.75 1.49 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-N 120.083 1.941 . . . . 0.0 111.955 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.441 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.6 m-85 -121.73 165.37 15.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 p -60.79 145.3 50.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.872 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.23 -30.36 1.97 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.135 0.493 . . . . 0.0 110.207 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.91 -44.17 90.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.526 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.455 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.8 tp-100 -66.27 -25.64 66.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.782 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 mmm -73.37 -42.85 61.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.425 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 1.1 mm-40 -60.75 -34.36 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.884 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 55' ' ' GLU . 44.3 m -61.95 -56.97 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.455 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.9 m0 -57.53 -49.16 77.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.763 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.56 -45.22 98.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.6 p -75.46 -29.19 59.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.9 mm-40 -64.71 -28.08 69.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.047 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.22 -24.21 3.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.461 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -56.59 159.68 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.5 OUTLIER 62.9 61.48 1.99 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.484 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 51.3 Cg_exo -55.2 -38.46 93.62 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.57 2.18 . . . . 0.0 112.509 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -105.19 5.12 31.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.74 159.02 35.24 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.026 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.92 164.72 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.92 85.44 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.8 m -84.86 146.71 27.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.233 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -163.87 147.05 9.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.084 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.3 mtmp? -84.05 126.44 33.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 7.2 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.705 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.755 0.312 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -56.34 122.96 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 t -51.7 -29.2 17.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -1.18 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.405 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.59 7.36 8.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.464 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.77 152.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.989 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -100.84 114.8 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.588 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 52.3 m-85 -97.1 31.78 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.005 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.19 35.09 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.977 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 mt -147.85 31.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CE1' ' HE2' ' A' ' 66' ' ' LYS . 94.6 m-85 -137.61 -49.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.897 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.814 0.34 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.2 mtp -88.9 135.1 33.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -123.03 -174.64 2.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.492 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 mt-10 -155.94 144.39 20.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.815 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 41' ' ' TYR . 47.1 p90 -128.52 135.96 50.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 111.695 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 4.1 ttpm? -118.16 116.77 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.055 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -56.57 -53.14 61.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.0 110.892 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.67 -174.0 4.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 66.4 t30 -134.2 38.69 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.732 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -107.59 162.38 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.27 -9.35 80.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.17 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -105.31 -25.27 12.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.604 0.24 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -43.58 132.98 4.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 111.415 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.81 -177.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.478 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.61 120.81 6.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.065 0.46 . . . . 0.0 111.573 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.573 ' O ' ' N ' ' A' ' 30' ' ' TYR . 8.2 m-85 -128.16 -173.03 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.907 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.692 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 98.48 2.22 57.7 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.338 -0.934 . . . . 0.0 115.158 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 83.7 Cg_exo -42.52 -25.68 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.284 2.042 . . . . 0.0 112.886 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CD2' ' HA2' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -43.28 165.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.365 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -61.89 146.94 48.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.087 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.0 p -47.83 -30.47 4.07 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.148 0.499 . . . . 0.0 110.22 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.64 -48.89 73.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.447 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 6.2 tp60 -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.395 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.8 mmm -75.46 -43.52 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.939 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -59.25 -28.56 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.09 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' GLU . 86.2 m -71.38 -58.07 3.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.541 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.447 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.8 m-90 -56.85 -43.2 80.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.76 -47.24 89.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.749 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.7 m -75.39 -29.57 59.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.02 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' THR . 3.3 tm-20 -64.74 -34.57 78.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.47 3.05 21.02 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.926 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.442 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -54.98 -30.32 58.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.993 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -113.8 81.63 5.96 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 -29.45 43.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -105.15 5.08 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.352 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.92 162.98 29.19 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.173 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.8 164.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.329 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -83.44 90.8 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.231 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -78.19 144.81 36.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.71 138.74 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.566 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -84.02 121.79 27.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 43' ' ' PRO . 2.8 mt . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.071 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.898 0.38 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.17 131.36 45.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.656 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.9 p -51.61 -26.91 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -78.95 -3.13 43.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.522 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.02 7.01 7.26 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 mt -104.69 152.97 6.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -111.29 117.59 33.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -96.67 30.54 2.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -128.44 30.21 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.778 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mt -147.05 30.17 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -137.64 -55.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.872 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.1 mmm -92.55 150.02 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.514 ' O ' ' O ' ' A' ' 42' ' ' GLY . 39.7 m95 -133.84 -173.96 3.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 13.2 pt-20 -151.76 156.77 40.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.558 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.8 p90 -139.48 146.56 40.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.21 0.528 . . . . 0.0 111.745 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.17 120.26 20.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.075 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -59.72 -55.49 33.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 110.999 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.51 160.38 21.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -107.43 39.28 1.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -103.45 161.89 13.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.004 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.75 0.15 88.6 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.111 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -112.39 -26.86 8.52 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 111.115 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.35 146.88 0.43 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.487 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 3.0 mp0 -56.52 -177.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.96 96.66 2.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.239 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.424 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-85 -113.65 -161.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.249 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.688 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.61 12.74 68.81 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 118.981 -0.899 . . . . 0.0 114.436 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.8 Cg_endo -70.61 54.63 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 120.136 1.968 . . . . 0.0 112.195 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.3 m-85 -121.46 165.23 15.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 p -57.74 144.44 38.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.995 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -30.47 2.54 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.134 0.493 . . . . 0.0 110.231 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.42 -43.27 86.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.433 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.425 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.8 tp60 -66.61 -25.91 66.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.4 mmm -76.12 -47.31 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.086 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -57.59 -31.9 66.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.143 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 55' ' ' GLU . 41.2 m -67.93 -57.31 6.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.607 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.425 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.8 m0 -57.72 -46.86 83.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.04 -47.85 91.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.767 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.1 t -75.19 -27.95 59.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.041 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 51' ' ' THR . 7.0 mm-40 -64.75 -38.5 91.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.3 4.0 11.32 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.855 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.85 -30.03 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -116.27 87.59 20.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.733 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.77 -33.73 33.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.4 2.066 . . . . 0.0 112.203 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -105.51 5.23 31.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.43 -176.21 44.78 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.102 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 m -156.34 164.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.36 . . . . 0.0 111.262 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.02 86.46 6.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.259 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.1 m -79.08 155.23 28.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.107 0.48 . . . . 0.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -166.5 155.56 11.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.515 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HE3' ' CH2' ' A' ' 28' ' ' TRP . 4.6 mtmp? -93.72 132.99 37.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.787 -179.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.883 0.373 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -58.63 125.38 23.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.2 t -51.96 -32.7 34.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -3.47 36.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.48 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.94 6.29 10.87 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 80' ' ' ILE . 41.1 mt -100.43 154.8 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 111.004 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -105.42 114.99 29.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -96.59 33.27 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -134.64 30.9 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.973 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 mt -146.09 30.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -138.44 -56.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.976 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.788 0.328 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.452 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -86.83 142.29 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.801 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 42' ' ' GLY . 58.5 m95 -132.89 -174.03 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.823 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -153.75 157.96 40.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.432 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 16.6 p90 -145.83 134.61 22.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 111.81 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.86 123.65 44.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.997 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -57.03 -50.05 73.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 110.922 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -86.81 176.64 7.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.67 39.29 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.64 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -106.27 165.8 10.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.025 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.58 -2.55 89.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.296 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.85 -26.7 8.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.75 146.0 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.583 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -55.53 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.6 122.13 5.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 30' ' ' TYR . 2.0 m-85 -132.63 -160.07 1.02 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.014 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.685 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.38 15.12 64.81 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.434 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.2 Cg_endo -70.65 54.61 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 120.112 1.956 . . . . 0.0 111.959 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.453 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.09 165.46 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.158 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.2 p -56.11 145.66 25.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.8 t -48.65 -29.97 4.94 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.16 0.505 . . . . 0.0 110.07 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.526 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' CE3' ' A' ' 52' ' ' TRP . 37.7 tp60 -73.8 -26.02 60.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.768 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmm -75.02 -47.23 30.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.059 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.418 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 33.8 tp60 -61.16 -34.54 75.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.039 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.5 m -61.38 -53.29 58.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.268 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.413 ' CE3' ' O ' ' A' ' 48' ' ' GLN . 3.5 m0 -58.13 -45.2 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.46 -45.76 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.88 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -28.36 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 51' ' ' THR . 5.2 mm-40 -64.89 -37.58 88.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.16 -23.23 1.74 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.643 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -57.84 160.73 4.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 52' ' ' TRP . 1.9 m-85 61.99 74.92 0.46 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.42 -38.92 7.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.231 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -105.22 5.18 31.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.156 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.77 159.02 34.78 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.019 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 m -130.95 164.3 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.32 88.56 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.097 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -85.25 150.12 25.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.091 0.472 . . . . 0.0 111.805 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.5 147.64 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.271 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -84.31 140.7 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 111.25 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 3.8 mt . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.763 0.316 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.83 123.07 14.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.9 p -53.58 -31.05 45.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.072 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -11.23 60.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 10.18 15.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.368 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.9 mt -105.0 153.58 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.04 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -109.57 116.23 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 53.8 m-85 -94.25 46.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -152.06 28.94 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.0 mt -147.6 30.79 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -134.47 -51.02 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.897 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.343 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.8 mtp -91.02 149.14 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.492 ' O ' ' O ' ' A' ' 42' ' ' GLY . 44.3 m95 -133.75 -173.82 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 11.1 pt-20 -151.99 154.41 35.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.234 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.3 p90 -138.94 143.91 38.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.15 0.5 . . . . 0.0 111.98 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -131.2 114.64 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.907 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.444 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 92.0 m95 -56.35 -53.01 62.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.899 0.38 . . . . 0.0 111.026 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.86 159.51 20.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.912 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -109.03 38.98 2.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.625 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -106.65 162.78 13.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.02 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.57 -4.64 85.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -111.03 -22.88 11.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.526 0.203 . . . . 0.0 111.084 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 111.452 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 23.1 mm-40 -56.3 -175.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.45 90.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.97 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 5.0 m-85 -119.92 -160.26 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.302 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 89.37 12.63 62.79 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.645 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.4 Cg_endo -71.01 55.56 1.81 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 120.195 1.998 . . . . 0.0 111.92 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.444 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 6.0 m-85 -121.02 165.23 15.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.4 p -59.94 147.68 37.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.4 p -47.32 -32.11 4.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.168 0.509 . . . . 0.0 110.04 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.23 99.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.388 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.467 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 12.0 tp60 -70.01 -25.93 63.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.451 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -46.51 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.983 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -60.45 -33.59 72.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.216 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.9 m -65.21 -57.7 7.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 2.8 m0 -57.73 -45.4 85.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.0 -44.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.786 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.1 t -75.28 -30.29 60.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.967 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.6 mm-40 -64.82 -32.36 74.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.51 3.09 22.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.887 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.25 -33.22 67.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.777 0.322 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.444 ' CD1' ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -112.32 77.55 2.25 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.682 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.62 -29.21 30.36 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.61 2.206 . . . . 0.0 112.3 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -105.07 -0.6 26.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 161.65 37.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.333 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.54 164.89 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 0.0 111.262 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.64 84.07 5.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.067 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -82.9 145.56 29.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.414 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.4 153.69 29.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.044 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -90.21 135.75 33.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.545 179.821 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.809 0.338 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -57.27 127.26 31.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.3 p -52.62 -33.94 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 -7.36 51.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.349 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -113.79 6.26 16.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.651 0.262 . . . . 0.0 111.429 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 80' ' ' ILE . 45.8 mt -105.09 153.92 6.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.353 . . . . 0.0 110.996 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -104.8 115.7 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.82 33.69 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.4 33.07 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.942 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mt -145.91 30.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.7 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.83 -57.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.999 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 p30 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.889 0.376 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.48 110.49 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.435 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.5 146.96 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.509 ' O ' ' O ' ' A' ' 42' ' ' GLY . 53.0 m95 -132.52 -174.43 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.517 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 11.7 pt-20 -156.93 160.65 39.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.499 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 36.5 p90 -144.92 133.4 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 20.3 ttpp -114.58 123.5 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.082 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -55.23 -48.15 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 110.949 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.47 -177.39 3.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -124.65 38.64 4.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 p -105.14 165.23 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.58 -4.05 87.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.274 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.35 -23.7 9.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.598 0.237 . . . . 0.0 111.156 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -43.46 137.16 2.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.746 0.308 . . . . 0.0 111.523 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -64.42 137.09 57.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.1 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.27 136.1 53.34 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.626 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -141.8 -156.5 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.914 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.61 16.32 64.15 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.11 -0.828 . . . . 0.0 114.316 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.1 Cg_endo -70.4 54.6 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 119.976 1.888 . . . . 0.0 111.84 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.491 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m-85 -123.32 166.18 15.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 p -55.37 144.16 26.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.7 p -46.71 -30.28 2.3 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.221 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.67 83.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.536 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.464 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 6.6 tp60 -62.72 -26.22 68.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.66 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.8 mmm -72.29 -43.19 64.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.281 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -61.33 -33.86 74.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.258 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -62.88 -58.71 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.3 m-90 -57.66 -46.31 84.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -64.25 -44.64 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.0 m -75.35 -32.39 60.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 51' ' ' THR . 10.3 tm-20 -64.8 -39.57 93.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.13 2.11 9.27 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.92 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.424 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -55.68 -25.96 42.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 1.2 m-85 -121.95 78.67 41.28 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.07 -30.77 46.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.633 2.222 . . . . 0.0 112.355 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -105.18 4.87 31.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.6 162.33 33.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.248 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.45 164.83 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.267 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CD2' ' CD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -77.95 83.47 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.317 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.5 m -76.03 144.93 40.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HG3' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -158.77 159.33 35.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.604 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -95.69 133.3 39.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.719 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 6.2 mt -64.88 -66.33 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.59 126.36 26.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.806 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.43 139.13 50.43 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.531 -1.445 . . . . 0.0 112.293 0.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.28 135.59 16.97 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.478 2.119 . . . . 0.0 112.322 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.02 -101.76 0.37 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.657 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.38 -149.54 8.16 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.475 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 48.9 69.16 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.3 0.571 . . . . 0.0 110.783 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 19.0 m-85 -54.56 163.47 0.91 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.137 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.15 129.8 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.796 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.27 135.13 57.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.0 p -52.82 -28.35 22.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -1.44 43.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -120.48 4.96 10.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.549 0.214 . . . . 0.0 111.489 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.6 mt -103.34 151.82 6.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.965 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -98.55 115.54 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 92.3 m-85 -98.59 30.39 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.3 29.05 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.0 mt -147.02 30.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.54 -52.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.878 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.802 0.334 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.25 135.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.073 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.416 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -100.33 140.49 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.917 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.498 ' O ' ' O ' ' A' ' 42' ' ' GLY . 50.0 m95 -134.11 -174.03 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 111.49 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -150.4 164.62 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.741 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 6.5 p90 -149.18 140.11 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.48 . . . . 0.0 111.653 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -130.66 118.48 21.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.001 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -54.3 -49.3 69.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.425 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.66 176.31 6.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.822 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -131.21 38.93 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -105.47 -174.56 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.02 68.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.871 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -122.46 -35.51 3.09 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.543 0.211 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.38 134.99 3.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.833 0.349 . . . . 0.0 111.473 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -58.56 -174.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.59 98.63 3.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.085 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 11.2 m-85 -114.05 -162.55 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.684 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.95 10.88 66.03 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 118.959 -0.912 . . . . 0.0 114.71 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.45 55.52 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 120.272 2.036 . . . . 0.0 111.964 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.8 m-85 -122.64 165.59 16.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -58.05 144.61 39.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.7 p -46.7 -31.42 2.92 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.174 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.79 96.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.445 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 2.7 tp60 -66.06 -25.94 67.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.2 mmm -74.53 -44.69 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.413 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.88 -34.99 73.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.174 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 55' ' ' GLU . 99.3 m -63.13 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.445 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 4.5 m0 -54.96 -45.57 74.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.36 -47.0 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.218 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m -75.32 -31.84 60.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 tp10 -64.81 -29.45 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.1 3.22 23.15 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.949 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.408 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -58.93 -28.21 66.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 1.5 m-85 -120.91 80.26 33.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -27.81 17.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.658 2.239 . . . . 0.0 112.448 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 -7.73 19.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.294 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.13 160.09 31.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.387 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.32 164.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 111.181 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.12 84.9 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.284 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.7 m -84.51 148.21 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -165.03 148.42 8.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.788 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.7 mtmp? -84.29 130.1 34.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 9.9 mt -58.37 -66.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.865 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -118.5 136.61 24.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.61 148.69 84.12 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.409 -1.496 . . . . 0.0 112.382 0.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.47 154.31 27.65 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.563 2.175 . . . . 0.0 112.433 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.96 70.0 0.31 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.652 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.36 175.56 32.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.47 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 8.9 mt-30 -115.03 66.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.072 0.463 . . . . 0.0 110.975 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.436 ' CG ' ' O ' ' A' ' 73' ' ' GLN . 50.0 p90 45.09 -172.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.674 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 179.63 113.39 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.788 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.88 127.28 31.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 p -52.52 -30.71 31.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -7.37 53.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 6.86 12.95 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.574 0.226 . . . . 0.0 111.399 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 80' ' ' ILE . 52.3 mt -104.38 153.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 0.0 111.053 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -102.12 115.67 31.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.754 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -96.7 35.53 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -137.35 28.05 2.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.886 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -146.51 30.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -133.53 -53.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.927 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 56.3 t0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.861 0.362 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 t -64.05 105.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.195 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.402 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 14.1 mtp -83.71 140.41 32.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.723 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.481 ' O ' ' O ' ' A' ' 42' ' ' GLY . 51.8 m95 -124.55 -174.26 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 65' ' ' ARG . 1.3 tt0 -153.04 145.23 23.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.425 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' TYR . 16.0 p90 -133.76 135.06 43.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.089 0.471 . . . . 0.0 111.983 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 5.8 ttpm? -119.8 129.31 54.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.941 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -59.53 -50.69 72.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.458 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -125.47 135.85 52.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.251 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -76.74 61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -111.85 168.28 9.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.14 -2.15 86.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.498 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.33 -28.1 6.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.653 0.264 . . . . 0.0 111.172 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.413 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -46.97 125.61 7.75 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 111.396 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -60.46 -177.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.94 125.78 17.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.209 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -135.93 -160.37 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.215 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.686 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.81 15.2 65.94 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-O 119.069 -0.851 . . . . 0.0 114.304 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.3 Cg_endo -70.63 54.6 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 119.996 1.898 . . . . 0.0 111.925 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.441 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.3 m-85 -125.43 165.46 18.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.025 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.7 p -55.11 144.36 24.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.984 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -46.38 -30.86 2.3 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.166 0.508 . . . . 0.0 110.257 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.65 88.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.475 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.428 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 19.1 tp60 -65.36 -26.3 67.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.1 mmm -76.06 -45.86 32.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.037 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -58.95 -30.37 67.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.919 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.4 m -67.8 -58.68 4.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.435 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.428 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 4.1 m0 -55.72 -43.44 76.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.693 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.0 t -63.91 -48.23 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.858 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -75.3 -28.47 59.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.028 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.9 mt-10 -64.74 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.15 -1.09 19.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.845 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -29.86 61.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.48 78.39 28.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.635 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.84 -28.8 42.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -105.09 5.18 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.66 159.82 24.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.213 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.46 164.85 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.849 0.357 . . . . 0.0 111.209 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.22 83.45 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.585 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -74.93 144.81 43.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.243 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -159.39 143.52 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.015 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 9.7 mtmt -84.09 130.47 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.98 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 7.0 mt -59.55 -59.22 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -120.14 132.22 24.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.73 141.58 67.58 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.867 -1.305 . . . . 0.0 112.09 0.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.38 111.46 3.04 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.581 2.187 . . . . 0.0 112.314 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.38 23.39 2.21 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.835 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 56.16 -160.18 7.53 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.693 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 64.74 65.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.421 0.629 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.449 ' CD2' ' CB ' ' A' ' 65' ' ' ARG . 89.1 m-85 -55.64 -178.09 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.084 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -157.86 129.87 7.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -59.77 126.45 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 t -52.04 -31.05 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -7.6 53.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.07 7.03 12.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.6 mt -104.36 153.33 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.014 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -99.43 114.9 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.761 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.47 38.44 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -143.6 30.73 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.1 mt -147.5 30.95 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.33 -49.98 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.883 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.812 0.339 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 t -62.05 120.39 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.434 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 4.4 mtp -88.32 144.56 26.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' GLY . 40.3 m95 -134.39 -173.68 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 65' ' ' ARG . 13.4 pt-20 -156.6 146.76 21.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.641 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 41' ' ' TYR . 34.0 p90 -128.94 144.23 51.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.139 0.495 . . . . 0.0 111.854 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 28.0 ttpt -125.84 115.58 20.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -54.37 -51.25 65.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.978 0.418 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 73.9 mm-40 -85.98 177.76 7.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.7 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -132.49 42.74 3.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.69 178.26 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.893 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.81 9.86 75.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.196 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.17 -28.1 3.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.549 0.214 . . . . 0.0 111.163 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -42.71 137.97 2.06 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.751 0.31 . . . . 0.0 111.612 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.96 -177.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.485 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.84 115.78 6.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.113 0.483 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -121.0 -158.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.056 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 82.75 17.61 67.61 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.293 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -70.32 54.01 1.35 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 119.91 1.855 . . . . 0.0 112.035 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.448 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.2 165.59 16.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -57.45 144.99 34.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.904 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t -47.03 -30.14 2.49 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.145 0.498 . . . . 0.0 110.135 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.51 86.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.426 ' O ' ' CE3' ' A' ' 52' ' ' TRP . 38.6 tp60 -68.85 -26.35 65.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 mmm -75.86 -47.88 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.411 ' OE1' ' CG ' ' A' ' 82' ' ' PHE . 36.4 tp60 -58.81 -31.83 68.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.166 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 55' ' ' GLU . 89.1 m -65.9 -54.5 25.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.426 ' CE3' ' O ' ' A' ' 48' ' ' GLN . 4.4 m0 -58.86 -43.29 90.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.488 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.07 -46.27 91.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.7 p -75.27 -28.53 59.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.887 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' THR . 20.8 mm-40 -64.81 -29.79 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.03 26.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.935 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -58.26 -33.32 69.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.327 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -113.61 83.23 6.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.32 -27.21 19.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.568 2.179 . . . . 0.0 112.483 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -105.19 -7.86 18.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.38 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.09 160.76 31.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.196 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 m -137.93 164.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 82.07 7.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.3 m -75.63 144.62 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.303 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -156.75 153.99 29.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.028 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -91.14 131.58 36.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 8.4 mt -66.12 -67.78 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.696 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -122.54 136.59 26.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.55 148.15 79.88 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.174 -0.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.33 102.73 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.555 2.17 . . . . 0.0 112.26 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.11 39.92 0.21 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.706 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -133.58 156.87 22.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.469 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -114.11 70.37 0.73 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 10.0 m-85 56.48 166.71 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.137 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.423 ' CG ' ' O ' ' A' ' 74' ' ' PHE . 5.2 m-85 -174.05 114.97 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.621 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.92 124.52 20.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.788 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -51.21 -34.1 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.255 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -72.64 -8.17 53.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.299 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 7.11 14.1 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.4 mt -105.05 153.75 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.918 0.389 . . . . 0.0 111.121 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -101.82 114.89 29.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.785 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' ' OE1' ' A' ' 50' ' ' GLN . 96.4 m-85 -96.69 29.84 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.085 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -130.07 23.61 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mt -144.88 30.05 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.735 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.1 -52.96 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.883 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.818 0.342 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.47 97.36 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.252 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.407 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 8.6 mtp -81.44 148.45 29.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.657 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.473 ' O ' ' O ' ' A' ' 42' ' ' GLY . 56.0 m95 -129.12 -174.16 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -152.43 156.6 39.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.654 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.1 p90 -143.62 146.74 33.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 111.788 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 38.5 ttpt -134.5 123.34 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.149 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 58.2 m95 -67.45 -59.99 2.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.318 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.4 134.65 34.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.455 ' ND2' ' CE2' ' A' ' 63' ' ' TYR . 8.7 t-20 -90.46 51.46 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -113.83 176.11 5.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.994 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.59 86.03 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.994 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -116.42 -30.74 5.8 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.564 0.221 . . . . 0.0 111.02 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.412 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -43.61 129.33 5.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.43 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.34 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.35 97.4 3.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.241 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 9.5 m-85 -111.33 -162.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.333 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.02 12.22 62.23 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 119.026 -0.874 . . . . 0.0 114.523 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 58.1 Cg_endo -71.5 54.87 1.97 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 120.21 2.005 . . . . 0.0 111.959 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -120.38 165.24 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -56.65 141.07 44.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.021 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -46.88 -30.97 2.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.179 0.514 . . . . 0.0 110.253 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.81 86.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.434 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.4 tp-100 -66.46 -25.57 66.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.678 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.9 mmm -74.34 -43.07 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.144 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 2.9 tp-100 -59.41 -37.34 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.996 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.3 m -62.19 -59.28 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m0 -55.53 -51.76 65.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.0 t -55.83 -50.51 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 t -75.27 -25.61 58.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.67 -26.02 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.71 2.79 37.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.766 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.52 -33.56 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -112.08 80.02 3.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.756 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.65 -28.65 37.33 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.462 2.108 . . . . 0.0 112.184 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.09 3.68 30.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.263 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.36 163.52 34.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.244 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 m -139.3 164.81 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 0.0 111.232 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -83.58 89.32 7.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.273 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -80.42 151.54 29.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.636 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.432 ' HD2' ' CE1' ' A' ' 74' ' ' PHE . 8.5 ptm180 -165.43 146.33 7.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.505 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -84.44 139.86 31.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 5.2 mt -71.26 -19.85 62.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -120.99 104.35 41.62 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.918 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.01 160.53 91.59 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 123.512 -1.453 . . . . 0.0 112.355 0.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.07 113.77 3.69 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.613 2.209 . . . . 0.0 112.382 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.07 81.75 0.7 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.617 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.72 176.78 44.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.553 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 46.83 64.26 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.424 0.63 . . . . 0.0 110.862 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.432 ' CE1' ' HD2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -74.95 142.03 43.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.899 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -167.64 137.11 2.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -63.36 127.14 29.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.2 p -51.96 -27.52 13.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -79.14 -1.72 37.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.544 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.89 8.11 7.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-O 120.553 0.216 . . . . 0.0 111.461 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 57.0 mt -105.09 154.58 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.882 0.373 . . . . 0.0 111.192 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -108.25 116.26 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.542 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 50' ' ' GLN . 73.8 m-85 -95.92 28.07 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -124.08 30.47 6.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.66 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.8 mt -144.92 29.27 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -140.54 -46.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.96 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.72 0.295 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 t -55.06 123.61 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.251 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 70.1 mmm -89.88 136.99 32.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' GLY . 35.3 m95 -127.29 -173.49 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.27 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 mt-10 -146.2 161.04 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.752 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.5 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 5.1 p90 -145.03 146.83 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.599 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.71 119.92 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -56.47 -51.51 68.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.25 176.95 6.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -120.98 38.82 3.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.57 160.25 15.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.28 -5.07 80.84 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.309 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -110.85 -23.91 10.73 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.573 0.225 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.71 149.96 0.27 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 75.2 mm-40 -55.23 152.6 7.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.92 89.93 3.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.317 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 15.8 m-85 -113.36 -164.39 0.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.287 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.04 8.89 64.34 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 119.003 -0.887 . . . . 0.0 114.731 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.5 Cg_endo -70.97 55.08 1.73 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.255 2.027 . . . . 0.0 112.096 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.7 m-85 -121.0 165.39 15.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.131 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -56.16 143.82 31.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.961 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.64 -30.49 2.35 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.24 -43.35 86.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.476 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.441 ' CG ' ' CH2' ' A' ' 52' ' ' TRP . 30.1 tp60 -65.98 -25.89 67.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.733 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.7 mmm -74.18 -51.22 16.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.527 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.12 -33.02 64.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 55' ' ' GLU . 33.0 m -64.54 -59.06 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.715 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CH2' ' CG ' ' A' ' 48' ' ' GLN . 5.0 m0 -56.18 -43.7 78.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.881 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.88 -51.01 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.029 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -75.4 -26.35 58.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.6 mm-40 -64.74 -29.46 70.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.21 0.3 23.8 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.856 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 1.5 m-85 -59.96 -31.75 70.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 110.826 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 57' ' ' TYR . 0.8 OUTLIER -117.27 75.81 8.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.1 -30.21 47.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.468 2.112 . . . . 0.0 112.262 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -105.28 5.03 31.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.24 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.18 160.55 29.53 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.145 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.15 164.57 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 0.0 111.241 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 74' ' ' PHE . 0.3 OUTLIER -79.18 88.43 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.036 179.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -85.11 150.12 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 111.629 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.24 151.6 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -84.38 139.78 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.29 -65.67 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.751 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -118.45 131.52 24.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.868 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.44 133.9 33.25 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.224 0.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -55.62 124.22 15.75 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.396 2.064 . . . . 0.0 112.297 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.27 42.93 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.777 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.72 137.23 15.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.314 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -112.22 65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.188 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.407 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 7.2 m-85 48.61 104.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.623 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -128.47 104.93 7.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -57.25 122.36 12.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 p -53.19 -28.76 28.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.46 49.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.301 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 7.13 11.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.5 mt -101.97 153.27 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -103.47 114.83 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.648 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.25 22.38 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.053 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.35 27.22 8.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.712 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mt -145.82 29.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.65 -56.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.846 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.872 0.368 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 t -65.18 104.86 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.252 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.409 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 26.3 mtp -83.22 144.02 30.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.726 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' A' ' 42' ' ' GLY . 51.3 m95 -126.86 -174.05 3.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.5 OUTLIER -152.07 155.79 38.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.722 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -140.97 143.38 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.041 0.448 . . . . 0.0 111.606 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -130.86 119.48 22.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.145 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -54.29 -46.89 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.95 173.42 7.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -120.79 39.24 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.688 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -108.13 176.25 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.49 -4.95 76.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.14 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.28 -24.1 10.43 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.558 0.218 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.33 159.2 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -57.22 -177.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.13 84.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.168 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 16.5 m-85 -114.81 -162.57 0.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.227 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.687 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.27 11.58 60.95 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.519 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -71.39 55.15 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.183 1.991 . . . . 0.0 111.997 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 4.0 m-85 -120.11 165.3 14.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -54.96 141.96 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 86.9 p -47.67 -30.31 3.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.18 0.514 . . . . 0.0 110.21 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.3 83.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.483 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.5 tp-100 -68.97 -25.85 64.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.585 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.6 mmm -76.0 -45.1 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.869 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.96 -33.04 71.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.681 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -64.03 -56.04 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 5.5 m0 -58.04 -47.39 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.594 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.8 t -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.886 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -75.28 -33.74 61.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.679 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 51' ' ' THR . 11.3 mt-10 -64.93 -37.3 87.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.26 4.19 14.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.784 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -53.47 -32.24 49.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.34 . . . . 0.0 110.933 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 0.7 OUTLIER -114.0 78.73 4.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.733 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 -28.52 51.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.49 2.127 . . . . 0.0 112.201 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.18 5.24 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.246 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.16 162.92 27.11 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.154 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 m -138.49 164.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 111.281 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.473 ' CE2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -79.25 84.45 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.357 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -77.59 144.6 37.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.019 0.438 . . . . 0.0 111.449 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -157.52 142.32 16.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 11.0 mtmt -83.91 139.0 32.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.999 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.409 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 2.6 mt -70.75 -68.51 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -122.48 130.48 24.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.08 138.56 51.91 Favored 'Cis proline' 0 C--N 1.348 0.5 0 C-N-CA 123.507 -1.455 . . . . 0.0 112.35 -0.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.68 104.96 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.51 2.14 . . . . 0.0 112.337 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.43 77.85 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.601 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.42 159.17 32.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.446 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -109.29 71.19 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.049 0.452 . . . . 0.0 111.065 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.473 ' CG ' ' CE2' ' A' ' 63' ' ' TYR . 9.7 m-85 59.22 155.16 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.989 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.37 107.62 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.897 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -59.43 124.74 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.2 p -52.45 -34.22 47.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -64.0 -15.6 59.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.203 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.1 7.83 18.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.387 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.04 153.6 6.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.122 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -104.51 127.63 52.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.611 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -108.82 26.47 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.313 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.94 31.34 2.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.88 0.371 . . . . 0.0 110.892 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mt -145.28 30.51 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.774 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -133.34 -49.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.954 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.926 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.847 0.356 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 t -60.12 117.14 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.436 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.0 139.9 38.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.673 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.45 ' O ' ' O ' ' A' ' 42' ' ' GLY . 58.2 m95 -123.42 -174.14 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 1.5 mt-10 -154.84 137.51 15.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.752 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' TYR . 15.6 p90 -122.32 148.91 44.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.216 0.531 . . . . 0.0 111.923 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 38' ' ' ALA . 6.1 ttmm -136.07 120.41 17.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.978 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 110.882 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -178.12 5.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.811 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -124.74 39.48 3.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.765 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -101.95 -166.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.91 -5.87 40.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.341 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.8 -19.26 8.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.525 0.202 . . . . 0.0 111.411 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.413 ' HB2' ' CG ' ' A' ' 31' ' ' LYS . . . -44.14 154.81 0.1 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.775 0.322 . . . . 0.0 111.526 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.421 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 3.5 pm0 -51.06 135.95 24.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.075 0.464 . . . . 0.0 111.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.99 78.64 1.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.043 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' TYR . 3.3 m-85 -106.66 -159.55 0.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.683 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.42 14.22 58.9 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 119.157 -0.802 . . . . 0.0 114.4 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 55.4 Cg_endo -71.19 55.13 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.041 1.921 . . . . 0.0 111.96 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CD1' ' CZ3' ' A' ' 52' ' ' TRP . 3.1 m-85 -123.0 165.62 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -62.35 149.62 41.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.99 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 t -45.86 -31.23 2.02 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.158 0.504 . . . . 0.0 110.165 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.42 72.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.28 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 22.4 tp60 -63.7 -25.74 68.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.613 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -45.97 62.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.284 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -33.81 72.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.124 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' GLU . 74.2 m -60.99 -62.41 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.432 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.1 m-90 -54.88 -44.13 73.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.921 0.391 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.06 -49.29 80.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 t -75.24 -28.35 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' THR . 14.6 tp10 -65.0 -43.78 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.31 -6.0 4.97 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.94 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.429 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -53.85 -35.89 62.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 0.7 OUTLIER -114.11 78.31 4.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.72 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -35.17 16.68 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.589 2.193 . . . . 0.0 112.39 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -104.9 4.95 32.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.275 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.71 160.25 36.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.333 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.93 164.87 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -78.84 86.9 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.306 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 6.8 m -82.83 146.24 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.64 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -161.73 144.49 11.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.047 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 1.5 mtmp? -84.0 133.19 34.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.893 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 3.1 mt -64.19 -63.8 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -115.84 133.27 22.87 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.865 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.65 142.35 63.93 Favored 'Cis proline' 0 C--N 1.348 0.516 0 C-N-CA 123.425 -1.49 . . . . 0.0 112.285 0.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.11 150.23 42.49 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.445 2.096 . . . . 0.0 112.236 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.81 69.77 0.24 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.616 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.99 178.85 28.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.325 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -118.45 64.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.176 0.512 . . . . 0.0 111.085 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 49.49 -178.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.392 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -174.62 108.28 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.471 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -54.52 126.59 24.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.181 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -52.45 -34.96 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -8.63 56.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.032 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -112.46 5.93 18.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.27 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.404 ' CD1' ' CB ' ' A' ' 64' ' ' CYS . 69.0 mt -105.11 154.29 6.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.867 0.365 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -107.0 117.06 33.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -96.68 27.94 3.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.028 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -133.41 31.04 3.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.767 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 mt -146.56 30.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -137.89 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.876 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.913 0.387 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t -62.66 100.86 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 35.2 mmm -84.0 140.45 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.515 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' A' ' 46' ' ' SER . 46.0 m95 -123.1 -175.67 3.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.012 0.434 . . . . 0.0 111.249 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -150.47 161.03 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.941 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.96 139.1 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.179 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -128.58 123.89 34.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -55.82 -47.77 76.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -98.49 176.59 5.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 63' ' ' TYR . 2.0 m-20 -119.86 39.54 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.838 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -106.2 176.53 5.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.48 -2.86 72.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.219 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.59 -25.57 9.07 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.561 0.22 . . . . 0.0 111.016 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.23 157.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.849 0.357 . . . . 0.0 111.435 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -55.24 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 86.44 1.15 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.456 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 10.1 m-85 -115.36 -174.16 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 102.68 -5.89 51.66 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.146 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 88.3 Cg_exo -41.53 -25.3 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.329 2.065 . . . . 0.0 113.139 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.425 ' CD2' ' CZ3' ' A' ' 52' ' ' TRP . 1.2 m-85 -42.53 165.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.308 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 p -64.32 147.06 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 36.5 p -47.31 -30.16 2.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.225 0.536 . . . . 0.0 110.204 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.96 80.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.644 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.428 ' O ' ' CE3' ' A' ' 52' ' ' TRP . 30.6 tp60 -68.32 -26.41 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.5 mmm -69.57 -52.3 27.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.431 ' HG3' ' N ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -60.77 -29.42 69.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.205 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 55' ' ' GLU . 52.9 m -59.92 -57.43 12.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.215 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.428 ' CE3' ' O ' ' A' ' 48' ' ' GLN . 2.4 m-90 -56.2 -43.0 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.767 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -65.36 -48.51 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -29.59 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 51' ' ' THR . 1.0 OUTLIER -64.98 -45.17 86.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.037 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.64 -24.32 0.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.14 162.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 60.08 65.59 2.29 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.93 -34.21 91.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.495 2.13 . . . . 0.0 112.138 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -105.32 -6.21 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.93 159.37 27.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.141 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.48 164.63 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.993 0.425 . . . . 0.0 111.231 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -78.19 86.99 4.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 2.7 m -83.47 153.57 24.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.421 . . . . 0.0 111.255 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.45 ' CG ' ' HA ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -175.71 152.88 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.796 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.52 126.72 33.55 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.538 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 8.8 mt -50.67 -34.26 25.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.251 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -125.29 109.07 26.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.029 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.61 143.72 78.0 Favored 'Cis proline' 0 C--N 1.349 0.588 0 C-N-CA 123.677 -1.384 . . . . 0.0 112.254 0.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.69 111.51 2.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.488 2.125 . . . . 0.0 112.483 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.1 100.3 1.23 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.451 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' CD2' ' A' ' 74' ' ' PHE . . . -166.88 -131.52 1.28 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.981 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -63.73 76.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.014 0.435 . . . . 0.0 111.173 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.45 ' HA ' ' CG ' ' A' ' 65' ' ' ARG . 83.3 m-85 -54.28 146.5 15.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.754 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -152.75 134.85 14.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.993 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -61.58 137.3 58.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 54.7 p -54.56 -26.61 33.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -81.95 -0.12 42.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.9 5.83 9.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.588 0.232 . . . . 0.0 111.484 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.6 mt -104.77 152.68 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -109.41 120.34 42.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CG ' ' HB3' ' A' ' 50' ' ' GLN . 37.0 m-85 -101.35 30.59 4.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -132.43 28.27 4.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.934 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mt -145.29 31.23 1.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.95 -49.74 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.892 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.836 0.351 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.1 104.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.8 mtp -84.28 147.66 27.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.508 ' O ' ' O ' ' A' ' 42' ' ' GLY . 47.0 m95 -132.72 -173.81 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 pt-20 -149.87 162.06 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.74 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -146.7 141.29 26.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 111.682 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -131.39 122.86 27.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.25 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -58.41 -51.9 67.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 0.0 110.945 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -78.58 161.57 26.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.1 38.68 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -104.91 -166.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.71 0.19 26.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.113 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.91 -29.78 7.52 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.525 0.202 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -39.69 157.26 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.874 0.368 . . . . 0.0 111.709 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 41' ' ' TYR . 1.6 mm-40 -59.79 -176.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.65 107.09 4.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.447 ' CZ ' ' CB ' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -124.27 -162.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.223 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.677 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.49 12.5 69.63 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 118.992 -0.893 . . . . 0.0 114.686 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.7 Cg_endo -70.22 54.91 1.41 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 120.27 2.035 . . . . 0.0 112.056 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.447 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -121.28 165.43 15.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.024 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.8 p -57.41 142.58 43.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -46.82 -30.44 2.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.081 0.467 . . . . 0.0 110.284 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.48 89.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.629 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.416 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 36.1 tp60 -68.56 -25.84 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.846 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.3 mmm -75.96 -44.37 40.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 37.3 tp60 -58.99 -38.85 80.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.314 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' GLU . 92.6 m -62.4 -57.31 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.582 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.8 m0 -53.89 -42.71 68.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.003 0.43 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.7 t -65.34 -50.48 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -28.98 60.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.1 tt0 -64.72 -26.52 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.055 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.76 2.83 28.72 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.927 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.8 -27.45 66.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.816 0.341 . . . . 0.0 111.027 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 52' ' ' TRP . 1.5 m-85 -121.73 78.68 39.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.22 -36.81 99.11 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.551 2.167 . . . . 0.0 112.378 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.52 5.1 31.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.335 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.24 -173.61 46.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.141 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.4 m -158.85 164.7 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 0.0 111.215 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 84.9 2.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.188 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.4 m -84.19 147.79 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.78 153.55 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.034 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CE ' ' CZ2' ' A' ' 28' ' ' TRP . 10.2 mttt -85.95 138.79 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.8 -69.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.633 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -124.85 134.25 25.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.797 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.14 144.75 73.78 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.507 -1.455 . . . . 0.0 112.265 0.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.87 135.46 19.36 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.482 2.122 . . . . 0.0 112.268 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.49 -32.25 0.15 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.74 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.78 135.4 48.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.55 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -95.12 69.46 3.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.981 0.419 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 59.83 154.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.117 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -168.27 118.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.873 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.37 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.6 p -51.55 -31.51 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -7.48 52.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.388 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -117.61 7.79 12.7 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 80' ' ' ILE . 53.6 mt -105.0 152.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.87 0.367 . . . . 0.0 111.063 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -104.82 116.9 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 68.1 m-85 -96.88 30.86 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.4 26.86 4.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 mt -147.0 30.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -137.58 -52.07 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.904 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.906 0.384 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.82 126.07 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.104 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.461 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.71 143.51 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.872 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.475 ' O ' ' O ' ' A' ' 42' ' ' GLY . 57.2 m95 -135.95 -174.17 3.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.644 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -158.65 147.54 18.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.57 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.44 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 27.4 p90 -131.37 140.54 49.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.397 . . . . 0.0 111.544 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -123.76 123.13 39.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.2 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -58.11 -52.48 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.66 172.54 9.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.116 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.406 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 62.8 t-20 -118.02 40.33 3.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.73 -177.78 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.978 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.53 -9.55 61.39 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.154 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -112.87 -17.3 12.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.481 0.182 . . . . 0.0 111.347 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.06 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.833 0.349 . . . . 0.0 111.501 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -55.44 -177.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.86 85.86 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.36 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -118.72 -159.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.39 14.77 61.37 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.303 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.97 54.5 1.65 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 119.933 1.866 . . . . 0.0 112.011 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.453 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.9 m-85 -123.21 165.29 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.085 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -56.92 145.15 30.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.028 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 p -47.76 -30.16 3.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.168 0.509 . . . . 0.0 110.081 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.68 -41.51 92.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.374 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.433 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 5.3 tp60 -68.72 -26.07 65.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.775 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 15.1 mmm -76.35 -51.01 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.314 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -55.79 -32.03 63.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.027 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.8 m -65.38 -64.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.514 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.433 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.6 m0 -49.02 -42.74 39.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.5 t -62.64 -58.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.507 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.7 p -75.23 -24.75 57.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.756 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -64.66 -46.38 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 111.185 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.33 -31.18 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.416 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -57.59 156.83 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 110.82 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.401 ' N ' ' HD3' ' A' ' 59' ' ' PRO . 0.4 OUTLIER 63.19 61.74 1.84 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 50.8 Cg_exo -53.78 -38.59 85.32 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.466 2.11 . . . . 0.0 112.297 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.37 5.13 31.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.35 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.65 160.75 36.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.288 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.08 164.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 111.242 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -77.93 82.0 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.7 m -73.81 146.6 44.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 29' ' ' GLU . 5.3 ttm180 -162.49 159.29 24.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -94.03 137.13 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 9.1 mt -72.09 -64.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -109.95 127.59 26.83 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.779 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.13 172.05 59.49 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.214 0.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.92 162.13 41.1 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.573 2.182 . . . . 0.0 112.278 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.02 43.9 94.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.471 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.02 156.39 41.08 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.626 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -67.27 75.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.408 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 33.0 p90 -54.54 151.88 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.055 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 74' ' ' PHE . 5.2 m-85 -173.11 152.57 2.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.629 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -55.31 131.56 45.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.74 -26.44 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.194 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 3.13 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.377 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -126.92 4.95 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.576 0.227 . . . . 0.0 111.376 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -105.0 153.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -107.29 114.84 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.78 10.02 40.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.9 32.27 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.4 mt -147.42 31.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.763 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -134.68 -47.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.908 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.9 t0 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.787 0.327 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.7 t -63.67 158.67 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.089 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.439 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.19 140.99 24.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.811 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.481 ' O ' ' O ' ' A' ' 42' ' ' GLY . 31.1 m95 -131.17 -173.9 3.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.575 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 1.2 pt-20 -153.55 141.9 20.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.597 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' TYR . 12.8 p90 -123.39 141.75 51.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 111.783 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -130.07 121.73 26.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.96 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -54.55 -48.99 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -97.76 -174.82 2.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -129.68 38.48 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.667 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.24 173.55 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.989 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 -2.37 89.3 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.225 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -112.5 -26.99 8.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.552 0.215 . . . . 0.0 110.94 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.55 153.1 0.17 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.401 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' OE2' ' CE2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -56.26 -177.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 0.0 110.787 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.63 81.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.047 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 30' ' ' TYR . 1.9 m-85 -110.61 -157.07 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.07 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.26 14.81 61.54 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-O 119.098 -0.834 . . . . 0.0 114.392 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 54.6 Cg_endo -70.48 54.75 1.49 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-N 120.083 1.941 . . . . 0.0 111.955 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.441 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.6 m-85 -121.73 165.37 15.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 p -60.79 145.3 50.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.872 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.23 -30.36 1.97 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.135 0.493 . . . . 0.0 110.207 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.91 -44.17 90.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.526 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.455 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.8 tp-100 -66.27 -25.64 66.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.782 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 mmm -73.37 -42.85 61.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.425 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 1.1 mm-40 -60.75 -34.36 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.884 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 55' ' ' GLU . 44.3 m -61.95 -56.97 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.455 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.9 m0 -57.53 -49.16 77.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.763 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.56 -45.22 98.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.133 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.6 p -75.46 -29.19 59.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.9 mm-40 -64.71 -28.08 69.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.047 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.22 -24.21 3.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.461 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -56.59 159.68 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.5 OUTLIER 62.9 61.48 1.99 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.484 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 51.3 Cg_exo -55.2 -38.46 93.62 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.57 2.18 . . . . 0.0 112.509 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -105.19 5.12 31.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.74 159.02 35.24 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.026 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.92 164.72 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CE2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -76.92 85.44 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.8 m -84.86 146.71 27.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.233 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -163.87 147.05 9.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.084 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.3 mtmp? -84.05 126.44 33.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 7.2 mt -57.51 -61.37 2.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.705 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -119.94 136.53 24.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.81 148.82 83.8 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.511 -1.454 . . . . 0.0 112.306 0.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.92 133.17 13.54 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.521 2.148 . . . . 0.0 112.33 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.1 67.88 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.634 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.87 174.19 33.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.421 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -119.99 66.78 0.82 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.125 0.488 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CG ' ' CE2' ' A' ' 63' ' ' TYR . 34.5 m-85 52.78 175.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.36 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.426 ' CG ' ' O ' ' A' ' 74' ' ' PHE . 14.1 m-85 -169.06 110.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.657 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -56.34 122.96 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 t -51.7 -29.2 17.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -1.18 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.405 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.59 7.36 8.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.464 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 51.2 mt -101.77 152.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.989 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -100.84 114.8 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.588 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 52.3 m-85 -97.1 31.78 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.005 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -136.19 35.09 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.977 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.8 mt -147.85 31.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CE1' ' HE2' ' A' ' 66' ' ' LYS . 94.6 m-85 -137.61 -49.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.897 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.1 t -57.79 114.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.2 mtp -88.9 135.1 33.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -123.03 -174.64 2.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.492 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 mt-10 -155.94 144.39 20.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.815 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 41' ' ' TYR . 47.1 p90 -128.52 135.96 50.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 111.695 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 38' ' ' ALA . 4.1 ttpm? -118.16 116.77 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.055 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -56.57 -53.14 61.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.0 110.892 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.67 -174.0 4.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 66.4 t30 -134.2 38.69 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.732 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -107.59 162.38 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.27 -9.35 80.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.17 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -105.31 -25.27 12.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.604 0.24 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.432 ' CB ' ' HD2' ' A' ' 31' ' ' LYS . . . -43.58 132.98 4.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 111.415 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -55.81 -177.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.478 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.61 120.81 6.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.065 0.46 . . . . 0.0 111.573 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.573 ' O ' ' N ' ' A' ' 30' ' ' TYR . 8.2 m-85 -128.16 -173.03 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.907 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.692 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 98.48 2.22 57.7 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.338 -0.934 . . . . 0.0 115.158 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 83.7 Cg_exo -42.52 -25.68 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.284 2.042 . . . . 0.0 112.886 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CD2' ' HA2' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -43.28 165.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.365 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -61.89 146.94 48.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.087 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.0 p -47.83 -30.47 4.07 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.148 0.499 . . . . 0.0 110.22 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.64 -48.89 73.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.447 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 6.2 tp60 -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.395 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 37.8 mmm -75.46 -43.52 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.939 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -59.25 -28.56 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.09 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' GLU . 86.2 m -71.38 -58.07 3.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.541 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.447 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.8 m-90 -56.85 -43.2 80.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.76 -47.24 89.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.749 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.7 m -75.39 -29.57 59.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.02 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' THR . 3.3 tm-20 -64.74 -34.57 78.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.47 3.05 21.02 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.926 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.442 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -54.98 -30.32 58.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.993 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -113.8 81.63 5.96 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 -29.45 43.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -105.15 5.08 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.352 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.92 162.98 29.19 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.173 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.8 164.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.329 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -83.44 90.8 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.231 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -78.19 144.81 36.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' HD2' ' HB3' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -154.71 138.74 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.566 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -84.02 121.79 27.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 43' ' ' PRO . 2.8 mt -53.21 -31.02 41.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.071 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -124.4 108.8 29.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.09 151.0 96.22 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.656 -1.393 . . . . 0.0 112.31 -0.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.15 112.91 3.54 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.602 2.201 . . . . 0.0 112.514 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.46 94.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.84 -136.38 2.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.081 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.52 74.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 111.27 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.41 ' HB3' ' HD2' ' A' ' 65' ' ' ARG . 5.4 p90 -54.64 166.56 0.45 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.69 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -168.16 141.15 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.136 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.17 131.36 45.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.656 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.9 p -51.61 -26.91 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -78.95 -3.13 43.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.522 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.02 7.01 7.26 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.5 mt -104.69 152.97 6.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -111.29 117.59 33.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -96.67 30.54 2.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -128.44 30.21 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.778 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.5 mt -147.05 30.17 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -137.64 -55.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.872 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.863 0.363 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 t -64.5 113.77 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.1 mmm -92.55 150.02 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.514 ' O ' ' O ' ' A' ' 42' ' ' GLY . 39.7 m95 -133.84 -173.96 3.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 13.2 pt-20 -151.76 156.77 40.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.558 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.8 p90 -139.48 146.56 40.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.21 0.528 . . . . 0.0 111.745 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.17 120.26 20.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.075 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -59.72 -55.49 33.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 110.999 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.51 160.38 21.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -107.43 39.28 1.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -103.45 161.89 13.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.004 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.75 0.15 88.6 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.111 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -112.39 -26.86 8.52 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 111.115 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.35 146.88 0.43 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.487 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 3.0 mp0 -56.52 -177.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.96 96.66 2.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.239 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.424 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-85 -113.65 -161.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.249 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.688 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.61 12.74 68.81 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 118.981 -0.899 . . . . 0.0 114.436 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.8 Cg_endo -70.61 54.63 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 120.136 1.968 . . . . 0.0 112.195 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.3 m-85 -121.46 165.23 15.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 p -57.74 144.44 38.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.995 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -30.47 2.54 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.134 0.493 . . . . 0.0 110.231 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.42 -43.27 86.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.433 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.425 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.8 tp60 -66.61 -25.91 66.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.4 mmm -76.12 -47.31 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.086 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -57.59 -31.9 66.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.143 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 55' ' ' GLU . 41.2 m -67.93 -57.31 6.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.607 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.425 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.8 m0 -57.72 -46.86 83.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.04 -47.85 91.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.767 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.1 t -75.19 -27.95 59.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.041 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 51' ' ' THR . 7.0 mm-40 -64.75 -38.5 91.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.3 4.0 11.32 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.855 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.85 -30.03 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -116.27 87.59 20.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.733 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.77 -33.73 33.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.4 2.066 . . . . 0.0 112.203 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -105.51 5.23 31.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.43 -176.21 44.78 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.102 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 m -156.34 164.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.36 . . . . 0.0 111.262 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.02 86.46 6.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.259 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.1 m -79.08 155.23 28.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.107 0.48 . . . . 0.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -166.5 155.56 11.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.515 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' HE3' ' CH2' ' A' ' 28' ' ' TRP . 4.6 mtmp? -93.72 132.99 37.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mt -65.87 -68.17 0.39 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.787 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -122.76 131.47 24.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.772 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.58 153.81 79.82 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.366 -0.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.83 163.31 31.47 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.597 2.198 . . . . 0.0 112.358 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.58 49.26 0.29 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.637 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -129.99 136.77 9.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.324 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.496 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 64.1 mt-30 -93.0 66.99 4.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.496 ' CG ' ' O ' ' A' ' 73' ' ' GLN . 10.3 p90 51.83 160.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.836 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -165.0 111.7 0.98 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.756 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -58.63 125.38 23.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.2 t -51.96 -32.7 34.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -3.47 36.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.48 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.94 6.29 10.87 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 80' ' ' ILE . 41.1 mt -100.43 154.8 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 111.004 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -105.42 114.99 29.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -96.59 33.27 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -134.64 30.9 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.973 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.2 mt -146.09 30.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -138.44 -56.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.976 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -64.44 115.32 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.18 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.452 ' HB3' ' CD1' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -86.83 142.29 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.801 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.479 ' O ' ' O ' ' A' ' 42' ' ' GLY . 58.5 m95 -132.89 -174.03 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.823 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -153.75 157.96 40.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.432 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 16.6 p90 -145.83 134.61 22.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 111.81 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.86 123.65 44.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.997 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -57.03 -50.05 73.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 110.922 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -86.81 176.64 7.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.67 39.29 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.64 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -106.27 165.8 10.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.025 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.58 -2.55 89.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.296 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.85 -26.7 8.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -43.75 146.0 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.583 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -55.53 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.6 122.13 5.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 30' ' ' TYR . 2.0 m-85 -132.63 -160.07 1.02 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.014 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.685 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.38 15.12 64.81 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.434 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.2 Cg_endo -70.65 54.61 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 120.112 1.956 . . . . 0.0 111.959 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.453 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.09 165.46 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.158 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.2 p -56.11 145.66 25.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.8 t -48.65 -29.97 4.94 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.16 0.505 . . . . 0.0 110.07 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.526 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' CE3' ' A' ' 52' ' ' TRP . 37.7 tp60 -73.8 -26.02 60.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.768 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmm -75.02 -47.23 30.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.059 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.418 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 33.8 tp60 -61.16 -34.54 75.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.039 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.5 m -61.38 -53.29 58.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.268 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.413 ' CE3' ' O ' ' A' ' 48' ' ' GLN . 3.5 m0 -58.13 -45.2 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.46 -45.76 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.88 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -28.36 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 51' ' ' THR . 5.2 mm-40 -64.89 -37.58 88.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.16 -23.23 1.74 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.643 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -57.84 160.73 4.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 52' ' ' TRP . 1.9 m-85 61.99 74.92 0.46 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.42 -38.92 7.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.231 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -105.22 5.18 31.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.156 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.77 159.02 34.78 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.019 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 m -130.95 164.3 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.32 88.56 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.097 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -85.25 150.12 25.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.091 0.472 . . . . 0.0 111.805 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.5 147.64 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.271 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -84.31 140.7 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 111.25 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 27' ' ' MET . 3.8 mt -74.42 -67.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -119.99 125.41 27.36 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.798 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.05 142.1 73.75 Favored 'Cis proline' 0 C--N 1.348 0.516 0 C-N-CA 123.56 -1.433 . . . . 0.0 112.255 -0.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.32 169.34 21.01 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.487 2.125 . . . . 0.0 112.354 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.2 27.95 2.53 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.747 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.56 134.96 21.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.357 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.14 66.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.006 0.432 . . . . 0.0 111.01 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 51.44 103.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.313 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.6 99.17 5.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.73 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.83 123.07 14.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.9 p -53.58 -31.05 45.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.072 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -11.23 60.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 10.18 15.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.368 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 93.9 mt -105.0 153.58 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.04 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -109.57 116.23 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 53.8 m-85 -94.25 46.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -152.06 28.94 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.0 mt -147.6 30.79 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -134.47 -51.02 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.897 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.725 0.298 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.68 113.52 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 5.8 mtp -91.02 149.14 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.492 ' O ' ' O ' ' A' ' 42' ' ' GLY . 44.3 m95 -133.75 -173.82 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 11.1 pt-20 -151.99 154.41 35.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.234 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.3 p90 -138.94 143.91 38.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.15 0.5 . . . . 0.0 111.98 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -131.2 114.64 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.907 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.444 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 92.0 m95 -56.35 -53.01 62.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.899 0.38 . . . . 0.0 111.026 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.86 159.51 20.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.912 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -109.03 38.98 2.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.625 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -106.65 162.78 13.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.02 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.57 -4.64 85.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -111.03 -22.88 11.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.526 0.203 . . . . 0.0 111.084 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 111.452 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 23.1 mm-40 -56.3 -175.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.45 90.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.97 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 5.0 m-85 -119.92 -160.26 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.302 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 89.37 12.63 62.79 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.645 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.4 Cg_endo -71.01 55.56 1.81 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 120.195 1.998 . . . . 0.0 111.92 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.444 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 6.0 m-85 -121.02 165.23 15.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.4 p -59.94 147.68 37.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.4 p -47.32 -32.11 4.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.168 0.509 . . . . 0.0 110.04 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.23 99.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.388 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.467 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 12.0 tp60 -70.01 -25.93 63.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.451 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -46.51 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.983 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -60.45 -33.59 72.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.216 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.9 m -65.21 -57.7 7.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 2.8 m0 -57.73 -45.4 85.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.0 -44.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.786 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.1 t -75.28 -30.29 60.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.967 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.6 mm-40 -64.82 -32.36 74.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.51 3.09 22.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.887 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.25 -33.22 67.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.777 0.322 . . . . 0.0 110.854 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.444 ' CD1' ' CH2' ' A' ' 32' ' ' TRP . 0.8 OUTLIER -112.32 77.55 2.25 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.682 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.62 -29.21 30.36 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.61 2.206 . . . . 0.0 112.3 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -105.07 -0.6 26.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 161.65 37.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.333 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.54 164.89 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 0.0 111.262 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.64 84.07 5.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.067 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -82.9 145.56 29.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.414 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.4 153.69 29.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.044 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -90.21 135.75 33.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mt -71.3 -67.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.545 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -121.1 134.14 24.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.715 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.98 149.39 92.02 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.497 -1.46 . . . . 0.0 112.361 0.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.51 138.36 35.28 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.473 2.116 . . . . 0.0 112.371 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.18 78.7 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.582 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.42 136.22 4.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.324 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -97.25 67.76 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.105 0.478 . . . . 0.0 111.113 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 59.27 154.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.093 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -160.93 105.33 1.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -57.27 127.26 31.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.3 p -52.62 -33.94 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 -7.36 51.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.349 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -113.79 6.26 16.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.651 0.262 . . . . 0.0 111.429 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 80' ' ' ILE . 45.8 mt -105.09 153.92 6.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.353 . . . . 0.0 110.996 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -104.8 115.7 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.82 33.69 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.4 33.07 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.942 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mt -145.91 30.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.7 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.83 -57.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.999 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.842 0.353 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.561 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.5 146.96 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.828 ' O ' HD21 ' A' ' 67' ' ' LEU . 53.0 m95 -132.52 -174.43 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.517 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.624 ' OE1' HD13 ' A' ' 40' ' ' LEU . 11.7 pt-20 -156.93 160.65 39.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.499 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.432 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 36.5 p90 -144.92 133.4 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.674 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 20.3 ttpp -114.58 123.5 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.082 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -55.23 -48.15 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 110.949 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.47 -177.39 3.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -124.65 38.64 4.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 p -105.14 165.23 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.58 -4.05 87.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.274 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.35 -23.7 9.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.598 0.237 . . . . 0.0 111.156 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.46 137.16 2.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.746 0.308 . . . . 0.0 111.523 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -64.42 137.09 57.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.1 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.624 HD13 ' OE1' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -114.27 136.1 53.34 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.626 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' H ' HD23 ' A' ' 40' ' ' LEU . 11.4 m-85 -141.8 -156.5 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.914 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.61 16.32 64.15 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.11 -0.828 . . . . 0.0 114.316 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.1 Cg_endo -70.4 54.6 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 119.976 1.888 . . . . 0.0 111.84 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.494 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m-85 -123.32 166.18 15.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 p -55.37 144.16 26.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.7 p -46.71 -30.28 2.3 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.221 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.67 83.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.536 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.464 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 6.6 tp60 -62.72 -26.22 68.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.66 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.645 ' O ' HG23 ' A' ' 53' ' ' VAL . 36.8 mmm -72.29 -43.19 64.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.281 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.424 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -61.33 -33.86 74.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.258 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -62.88 -58.71 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.3 m-90 -57.66 -46.31 84.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 49' ' ' MET . 60.0 t -64.25 -44.64 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.0 m -75.35 -32.39 60.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 51' ' ' THR . 10.3 tm-20 -64.8 -39.57 93.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.13 2.11 9.27 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.92 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.428 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -55.68 -25.96 42.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.538 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.2 m-85 -121.95 78.67 41.28 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.07 -30.77 46.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.633 2.222 . . . . 0.0 112.355 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -105.18 4.87 31.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.6 162.33 33.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.248 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.45 164.83 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.267 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.95 83.47 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.317 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.484 ' CB ' HD12 ' A' ' 80' ' ' ILE . 1.5 m -76.03 144.93 40.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.77 159.33 35.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.604 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HE2' ' CZ2' ' A' ' 28' ' ' TRP . 15.4 mtmt -95.69 133.3 39.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.719 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.828 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.2 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.797 0.332 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.27 135.13 57.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.0 p -52.82 -28.35 22.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -1.44 43.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -120.48 4.96 10.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.549 0.214 . . . . 0.0 111.489 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.484 HD12 ' CB ' ' A' ' 64' ' ' CYS . 34.6 mt -103.34 151.82 6.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.965 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -98.55 115.54 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 92.3 m-85 -98.59 30.39 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.751 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -134.3 29.05 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.0 mt -147.02 30.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.54 -52.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.878 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.761 0.315 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.584 ' CG ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -100.33 140.49 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.917 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.785 ' O ' HD21 ' A' ' 67' ' ' LEU . 50.0 m95 -134.11 -174.03 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 111.49 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.769 ' CD ' HD11 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -150.4 164.62 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.741 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 6.5 p90 -149.18 140.11 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.48 . . . . 0.0 111.653 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.727 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 5.2 ttmt -130.66 118.48 21.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.001 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -54.3 -49.3 69.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.425 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -94.66 176.31 6.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.822 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -131.21 38.93 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -105.47 -174.56 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.02 68.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.871 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -122.46 -35.51 3.09 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.543 0.211 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.38 134.99 3.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.833 0.349 . . . . 0.0 111.473 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -58.56 -174.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.769 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -141.59 98.63 3.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.085 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 11.2 m-85 -114.05 -162.55 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.684 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.95 10.88 66.03 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 118.959 -0.912 . . . . 0.0 114.71 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.45 55.52 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 120.272 2.036 . . . . 0.0 111.964 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.8 m-85 -122.64 165.59 16.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -58.05 144.61 39.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.7 p -46.7 -31.42 2.92 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.174 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.79 96.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.447 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 2.7 tp60 -66.06 -25.94 67.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.595 ' O ' HG23 ' A' ' 53' ' ' VAL . 34.2 mmm -74.53 -44.69 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.413 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -34.99 73.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.174 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 55' ' ' GLU . 99.3 m -63.13 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.5 m0 -54.96 -45.57 74.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG22 ' HD2' ' A' ' 58' ' ' PHE . 83.9 t -65.36 -47.0 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.218 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m -75.32 -31.84 60.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 tp10 -64.81 -29.45 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.1 3.22 23.15 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.949 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -58.93 -28.21 66.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.644 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 -120.91 80.26 33.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -27.81 17.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.658 2.239 . . . . 0.0 112.448 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 -7.73 19.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.294 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.13 160.09 31.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.387 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.32 164.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 111.181 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.12 84.9 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.284 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.7 m -84.51 148.21 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -165.03 148.42 8.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.788 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.7 mtmp? -84.29 130.1 34.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 28' ' ' TRP . 9.9 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.865 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.779 0.323 . . . . 0.0 110.788 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.88 127.28 31.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 p -52.52 -30.71 31.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -7.37 53.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 6.86 12.95 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.574 0.226 . . . . 0.0 111.399 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 75' ' ' TYR . 52.3 mt -104.38 153.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 0.0 111.053 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -102.12 115.67 31.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.754 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HE2' HG11 ' A' ' 53' ' ' VAL . 22.3 m-85 -96.7 35.53 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.7 m-20 -137.35 28.05 2.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.2 mt -146.51 30.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -133.53 -53.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.927 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.756 0.313 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.543 ' CB ' HD12 ' A' ' 67' ' ' LEU . 14.1 mtp -83.71 140.41 32.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.723 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.827 ' O ' HD21 ' A' ' 67' ' ' LEU . 51.8 m95 -124.55 -174.26 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 1.3 tt0 -153.04 145.23 23.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.425 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' TYR . 16.0 p90 -133.76 135.06 43.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.089 0.471 . . . . 0.0 111.983 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.791 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 5.8 ttpm? -119.8 129.31 54.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.941 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -59.53 -50.69 72.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.458 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -125.47 135.85 52.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.251 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -76.74 61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -111.85 168.28 9.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.14 -2.15 86.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.498 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.33 -28.1 6.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.653 0.264 . . . . 0.0 111.172 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -46.97 125.61 7.75 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 111.396 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 2.6 mm-40 -60.46 -177.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.94 125.78 17.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.209 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -135.93 -160.37 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.215 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.686 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.81 15.2 65.94 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-O 119.069 -0.851 . . . . 0.0 114.304 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.3 Cg_endo -70.63 54.6 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 119.996 1.898 . . . . 0.0 111.925 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.3 m-85 -125.43 165.46 18.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.025 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.7 p -55.11 144.36 24.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.984 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -46.38 -30.86 2.3 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.166 0.508 . . . . 0.0 110.257 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.65 88.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.475 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 19.1 tp60 -65.36 -26.3 67.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.627 ' O ' HG23 ' A' ' 53' ' ' VAL . 27.1 mmm -76.06 -45.86 32.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.037 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -58.95 -30.37 67.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.919 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.4 m -67.8 -58.68 4.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.435 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.448 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 4.1 m0 -55.72 -43.44 76.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.693 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 49' ' ' MET . 72.0 t -63.91 -48.23 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.858 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -75.3 -28.47 59.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.028 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.9 mt-10 -64.74 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.15 -1.09 19.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.845 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -29.86 61.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.48 78.39 28.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.635 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.84 -28.8 42.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -105.09 5.18 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.66 159.82 24.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.213 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.46 164.85 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.849 0.357 . . . . 0.0 111.209 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.22 83.45 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.585 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -74.93 144.81 43.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.243 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -159.39 143.52 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.015 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.438 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 9.7 mtmt -84.09 130.47 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.98 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 28' ' ' TRP . 7.0 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.801 0.334 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -59.77 126.45 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 t -52.04 -31.05 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -7.6 53.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.07 7.03 12.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.449 HD12 ' CB ' ' A' ' 64' ' ' CYS . 41.6 mt -104.36 153.33 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.014 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 12.4 t0 -99.43 114.9 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.47 38.44 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.756 ' O ' HD23 ' A' ' 84' ' ' LEU . 5.5 t70 -143.6 30.73 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -147.5 30.95 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.33 -49.98 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.883 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.783 0.325 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.672 ' CB ' HD12 ' A' ' 67' ' ' LEU . 4.4 mtp -88.32 144.56 26.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.796 ' O ' HD21 ' A' ' 67' ' ' LEU . 40.3 m95 -134.39 -173.68 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 13.4 pt-20 -156.6 146.76 21.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.641 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 41' ' ' TYR . 34.0 p90 -128.94 144.23 51.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.139 0.495 . . . . 0.0 111.854 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 28.0 ttpt -125.84 115.58 20.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -54.37 -51.25 65.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.978 0.418 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.98 177.76 7.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.7 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -132.49 42.74 3.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.69 178.26 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.893 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.81 9.86 75.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.196 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.17 -28.1 3.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.549 0.214 . . . . 0.0 111.163 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -42.71 137.97 2.06 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.751 0.31 . . . . 0.0 111.612 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.96 -177.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.485 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.84 115.78 6.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.113 0.483 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -121.0 -158.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.056 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 82.75 17.61 67.61 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.293 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -70.32 54.01 1.35 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 119.91 1.855 . . . . 0.0 112.035 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.449 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.2 165.59 16.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -57.45 144.99 34.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.904 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t -47.03 -30.14 2.49 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.145 0.498 . . . . 0.0 110.135 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.51 86.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 38.6 tp60 -68.85 -26.35 65.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.66 ' O ' HG23 ' A' ' 53' ' ' VAL . 26.8 mmm -75.86 -47.88 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.411 ' OE1' ' CG ' ' A' ' 82' ' ' PHE . 36.4 tp60 -58.81 -31.83 68.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.166 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 55' ' ' GLU . 89.1 m -65.9 -54.5 25.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.4 m0 -58.86 -43.29 90.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.488 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 49' ' ' MET . 61.9 t -65.07 -46.27 91.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.404 ' HB3' ' NE2' ' A' ' 50' ' ' GLN . 17.7 p -75.27 -28.53 59.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.887 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' THR . 20.8 mm-40 -64.81 -29.79 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.03 26.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.935 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -58.26 -33.32 69.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.327 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.53 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -113.61 83.23 6.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.32 -27.21 19.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.568 2.179 . . . . 0.0 112.483 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -105.19 -7.86 18.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.38 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.09 160.76 31.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.196 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 m -137.93 164.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 82.07 7.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -75.63 144.62 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.303 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -156.75 153.99 29.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.028 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -91.14 131.58 36.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.4 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.696 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.683 ' HB3' HD11 ' A' ' 80' ' ' ILE . 5.2 m-85 . . . . . 0 N--CA 1.46 0.054 0 CA-C-O 120.75 0.31 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -59.92 124.52 20.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.788 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -51.21 -34.1 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.255 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -72.64 -8.17 53.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.299 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 7.11 14.1 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 75' ' ' TYR . 40.4 mt -105.05 153.75 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.918 0.389 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 80' ' ' ILE . 10.4 t0 -101.82 114.89 29.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.785 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' ' OE1' ' A' ' 50' ' ' GLN . 96.4 m-85 -96.69 29.84 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.085 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.85 ' O ' HD23 ' A' ' 84' ' ' LEU . 32.0 m-20 -130.07 23.61 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -144.88 30.05 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.1 -52.96 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 86' ' ' THR . 5.2 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.736 0.303 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.568 ' CB ' HD12 ' A' ' 67' ' ' LEU . 8.6 mtp -81.44 148.45 29.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.657 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.83 ' O ' HD21 ' A' ' 67' ' ' LEU . 56.0 m95 -129.12 -174.16 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -152.43 156.6 39.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.654 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.1 p90 -143.62 146.74 33.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 111.788 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.758 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 38.5 ttpt -134.5 123.34 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.149 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 58.2 m95 -67.45 -59.99 2.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.318 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -85.4 134.65 34.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -90.46 51.46 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -113.83 176.11 5.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.994 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.59 86.03 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.994 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -116.42 -30.74 5.8 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.564 0.221 . . . . 0.0 111.02 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.758 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.61 129.33 5.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.43 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.34 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.499 HD11 ' HD3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -138.35 97.4 3.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.241 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.436 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 9.5 m-85 -111.33 -162.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.333 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.02 12.22 62.23 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 119.026 -0.874 . . . . 0.0 114.523 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 58.1 Cg_endo -71.5 54.87 1.97 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 120.21 2.005 . . . . 0.0 111.959 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -120.38 165.24 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -56.65 141.07 44.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.021 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -46.88 -30.97 2.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.179 0.514 . . . . 0.0 110.253 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.81 86.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.434 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 32.3 tp60 -66.46 -25.57 66.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.678 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.9 mmm -74.34 -43.07 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.144 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 2.9 tp-100 -59.41 -37.34 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.996 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.3 m -62.19 -59.28 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m0 -55.53 -51.76 65.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 49' ' ' MET . 84.0 t -55.83 -50.51 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 t -75.27 -25.61 58.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.67 -26.02 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.71 2.79 37.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.766 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.52 -33.56 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -112.08 80.02 3.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.756 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.65 -28.65 37.33 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.462 2.108 . . . . 0.0 112.184 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.09 3.68 30.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.263 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.36 163.52 34.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.244 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.7 m -139.3 164.81 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.58 89.32 7.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.273 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -80.42 151.54 29.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.636 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.499 ' HD3' HD11 ' A' ' 40' ' ' LEU . 8.5 ptm180 -165.43 146.33 7.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.505 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -84.44 139.86 31.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 28' ' ' TRP . 5.2 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -63.36 127.14 29.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 62' ' ' VAL . 12.2 p -51.96 -27.52 13.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -79.14 -1.72 37.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.544 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.89 8.11 7.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-O 120.553 0.216 . . . . 0.0 111.461 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 81' ' ' ASP . 57.0 mt -105.09 154.58 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.882 0.373 . . . . 0.0 111.192 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.433 ' N ' HG22 ' A' ' 80' ' ' ILE . 32.7 t0 -108.25 116.26 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.542 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CB ' ' HB2' ' A' ' 50' ' ' GLN . 73.8 m-85 -95.92 28.07 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.648 ' O ' HD23 ' A' ' 84' ' ' LEU . 7.9 t70 -124.08 30.47 6.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -144.92 29.27 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -140.54 -46.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.96 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.829 0.347 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.581 ' CB ' HD12 ' A' ' 67' ' ' LEU . 70.1 mmm -89.88 136.99 32.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.713 ' O ' HD21 ' A' ' 67' ' ' LEU . 35.3 m95 -127.29 -173.49 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.27 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 mt-10 -146.2 161.04 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.752 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.5 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 5.1 p90 -145.03 146.83 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.599 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.727 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -135.71 119.92 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -56.47 -51.51 68.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.25 176.95 6.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -120.98 38.82 3.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.57 160.25 15.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.28 -5.07 80.84 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.309 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -110.85 -23.91 10.73 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.573 0.225 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.71 149.96 0.27 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 75.2 mm-40 -55.23 152.6 7.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -123.92 89.93 3.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.317 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 15.8 m-85 -113.36 -164.39 0.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.287 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.04 8.89 64.34 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 119.003 -0.887 . . . . 0.0 114.731 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.5 Cg_endo -70.97 55.08 1.73 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.255 2.027 . . . . 0.0 112.096 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.7 m-85 -121.0 165.39 15.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.131 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -56.16 143.82 31.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.961 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.64 -30.49 2.35 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.24 -43.35 86.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.476 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 30.1 tp60 -65.98 -25.89 67.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.733 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.644 ' O ' HG23 ' A' ' 53' ' ' VAL . 34.7 mmm -74.18 -51.22 16.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.527 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.12 -33.02 64.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 55' ' ' GLU . 33.0 m -64.54 -59.06 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.715 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.0 m0 -56.18 -43.7 78.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.881 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 49' ' ' MET . 58.5 t -61.88 -51.01 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.029 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -75.4 -26.35 58.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.6 mm-40 -64.74 -29.46 70.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.21 0.3 23.8 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.856 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.439 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 1.5 m-85 -59.96 -31.75 70.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 110.826 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.589 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -117.27 75.81 8.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.1 -30.21 47.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.468 2.112 . . . . 0.0 112.262 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -105.28 5.03 31.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.24 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.18 160.55 29.53 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.145 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.1 m -135.15 164.57 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 0.0 111.241 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.18 88.43 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.036 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -85.11 150.12 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 111.629 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.24 151.6 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -84.38 139.78 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.8 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.751 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.765 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.746 0.308 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -57.25 122.36 12.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.423 ' HB3' HG23 ' A' ' 62' ' ' VAL . 8.3 p -53.19 -28.76 28.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.46 49.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.301 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 7.13 11.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 75' ' ' TYR . 58.5 mt -101.97 153.27 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 17.0 t0 -103.47 114.83 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.25 22.38 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.053 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.783 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -119.35 27.22 8.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.712 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.0 mt -145.82 29.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.65 -56.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.846 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.423 ' OXT' HG23 ' A' ' 86' ' ' THR . 1.9 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.788 0.327 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.529 ' CB ' HD12 ' A' ' 67' ' ' LEU . 26.3 mtp -83.22 144.02 30.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.726 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.806 ' O ' HD21 ' A' ' 67' ' ' LEU . 51.3 m95 -126.86 -174.05 3.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' CD ' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -152.07 155.79 38.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.722 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -140.97 143.38 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.041 0.448 . . . . 0.0 111.606 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.671 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 7.5 ttpt -130.86 119.48 22.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.145 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -54.29 -46.89 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.95 173.42 7.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 63' ' ' TYR . 2.8 p30 -120.79 39.24 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.688 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -108.13 176.25 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.49 -4.95 76.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.14 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.28 -24.1 10.43 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.558 0.218 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.33 159.2 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -57.22 -177.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.13 84.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.168 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 16.5 m-85 -114.81 -162.57 0.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.227 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.687 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.27 11.58 60.95 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.519 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -71.39 55.15 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.183 1.991 . . . . 0.0 111.997 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 4.0 m-85 -120.11 165.3 14.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -54.96 141.96 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 86.9 p -47.67 -30.31 3.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.18 0.514 . . . . 0.0 110.21 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.3 83.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.483 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 32.1 tp60 -68.97 -25.85 64.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.585 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 40.6 mmm -76.0 -45.1 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.869 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.96 -33.04 71.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.681 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -64.03 -56.04 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.466 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 5.5 m0 -58.04 -47.39 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.594 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 58' ' ' PHE . 79.8 t -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.886 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -75.28 -33.74 61.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.679 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 51' ' ' THR . 11.3 mt-10 -64.93 -37.3 87.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.26 4.19 14.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.784 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -53.47 -32.24 49.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.34 . . . . 0.0 110.933 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -114.0 78.73 4.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.733 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 -28.52 51.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.49 2.127 . . . . 0.0 112.201 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.18 5.24 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.246 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.16 162.92 27.11 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.154 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 m -138.49 164.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 111.281 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -79.25 84.45 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.357 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -77.59 144.6 37.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.019 0.438 . . . . 0.0 111.449 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -157.52 142.32 16.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 11.0 mtmt -83.91 139.0 32.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.999 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.806 HD21 ' O ' ' A' ' 28' ' ' TRP . 2.6 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.82 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.819 0.343 . . . . 0.0 110.897 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -59.43 124.74 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.2 p -52.45 -34.22 47.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -64.0 -15.6 59.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.203 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.1 7.83 18.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.387 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 75' ' ' TYR . 54.3 mt -105.04 153.6 6.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.535 ' OD2' HD11 ' A' ' 84' ' ' LEU . 8.3 t0 -104.51 127.63 52.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.611 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -108.82 26.47 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.313 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.803 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -139.94 31.34 2.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.88 0.371 . . . . 0.0 110.892 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.803 HD23 ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -145.28 30.51 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.774 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -133.34 -49.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.954 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.926 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG12 ' NE1' ' A' ' 28' ' ' TRP . 32.7 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.872 0.368 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.472 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.0 139.9 38.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.673 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.811 ' O ' HD21 ' A' ' 67' ' ' LEU . 58.2 m95 -123.42 -174.14 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.57 ' CD ' HD22 ' A' ' 67' ' ' LEU . 1.5 mt-10 -154.84 137.51 15.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.752 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 41' ' ' TYR . 15.6 p90 -122.32 148.91 44.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.216 0.531 . . . . 0.0 111.923 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.523 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 6.1 ttmm -136.07 120.41 17.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.978 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 110.882 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -178.12 5.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.811 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -124.74 39.48 3.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.765 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -101.95 -166.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.91 -5.87 40.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.341 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.8 -19.26 8.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.525 0.202 . . . . 0.0 111.411 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -44.14 154.81 0.1 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.775 0.322 . . . . 0.0 111.526 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 3.5 pm0 -51.06 135.95 24.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.075 0.464 . . . . 0.0 111.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -121.99 78.64 1.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.043 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' TYR . 3.3 m-85 -106.66 -159.55 0.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.683 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.42 14.22 58.9 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 119.157 -0.802 . . . . 0.0 114.4 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 55.4 Cg_endo -71.19 55.13 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.041 1.921 . . . . 0.0 111.96 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CD1' ' CZ3' ' A' ' 52' ' ' TRP . 3.1 m-85 -123.0 165.62 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -62.35 149.62 41.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.99 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 t -45.86 -31.23 2.02 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.158 0.504 . . . . 0.0 110.165 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.42 72.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.28 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 22.4 tp60 -63.7 -25.74 68.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.613 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.661 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.04 -45.97 62.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.284 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -33.81 72.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.124 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' GLU . 74.2 m -60.99 -62.41 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.432 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 3.1 m-90 -54.88 -44.13 73.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.921 0.391 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.706 HG22 ' HD2' ' A' ' 58' ' ' PHE . 62.1 t -65.06 -49.29 80.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 t -75.24 -28.35 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' THR . 14.6 tp10 -65.0 -43.78 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.31 -6.0 4.97 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.94 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -53.85 -35.89 62.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.706 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -114.11 78.31 4.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.72 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -35.17 16.68 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.589 2.193 . . . . 0.0 112.39 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -104.9 4.95 32.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.275 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.71 160.25 36.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.333 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.93 164.87 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -78.84 86.9 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.306 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.525 ' CB ' HD12 ' A' ' 80' ' ' ILE . 6.8 m -82.83 146.24 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.64 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -161.73 144.49 11.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.047 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 1.5 mtmp? -84.0 133.19 34.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.893 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.811 HD21 ' O ' ' A' ' 28' ' ' TRP . 3.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.487 ' HB3' HD11 ' A' ' 80' ' ' ILE . 2.5 m-85 . . . . . 0 C--O 1.228 -0.034 0 CA-C-O 120.786 0.327 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -54.52 126.59 24.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.181 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -52.45 -34.96 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -8.63 56.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.032 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -112.46 5.93 18.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.27 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' A' ' 64' ' ' CYS . 69.0 mt -105.11 154.29 6.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.867 0.365 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 80' ' ' ILE . 6.9 t0 -107.0 117.06 33.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -96.68 27.94 3.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.028 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.677 ' O ' HD23 ' A' ' 84' ' ' LEU . 15.4 t70 -133.41 31.04 3.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.767 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.9 mt -146.56 30.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -137.89 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.876 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.754 0.312 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.492 ' HB2' HD12 ' A' ' 67' ' ' LEU . 35.2 mmm -84.0 140.45 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.768 ' O ' HD21 ' A' ' 67' ' ' LEU . 46.0 m95 -123.1 -175.67 3.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.012 0.434 . . . . 0.0 111.249 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HG2' HD23 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -150.47 161.03 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.941 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.96 139.1 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.179 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.695 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 25.9 ttmt -128.58 123.89 34.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -55.82 -47.77 76.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB3' HG23 ' A' ' 35' ' ' THR . 4.7 mt-10 -98.49 176.59 5.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.86 39.54 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.838 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.6 p -106.2 176.53 5.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.48 -2.86 72.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.219 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.59 -25.57 9.07 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.561 0.22 . . . . 0.0 111.016 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.23 157.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.849 0.357 . . . . 0.0 111.435 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -55.24 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 86.44 1.15 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.492 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 10.1 m-85 -115.36 -174.16 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 102.68 -5.89 51.66 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.146 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 88.3 Cg_exo -41.53 -25.3 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.329 2.065 . . . . 0.0 113.139 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.425 ' CD2' ' CZ3' ' A' ' 52' ' ' TRP . 1.2 m-85 -42.53 165.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.308 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 p -64.32 147.06 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 36.5 p -47.31 -30.16 2.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.225 0.536 . . . . 0.0 110.204 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.96 80.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.644 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.6 tp60 -68.32 -26.41 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . 26.5 mmm -69.57 -52.3 27.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -60.77 -29.42 69.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.205 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' GLU . 52.9 m -59.92 -57.43 12.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.215 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.434 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m-90 -56.2 -43.0 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.767 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG22 ' CD2' ' A' ' 58' ' ' PHE . 47.8 t -65.36 -48.51 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -29.59 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' THR . 1.0 OUTLIER -64.98 -45.17 86.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.037 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.64 -24.32 0.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.14 162.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 60.08 65.59 2.29 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.93 -34.21 91.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.495 2.13 . . . . 0.0 112.138 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -105.32 -6.21 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.93 159.37 27.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.141 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.407 HG11 ' CD1' ' A' ' 58' ' ' PHE . 12.0 m -133.48 164.63 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.993 0.425 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.19 86.99 4.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.519 ' CB ' HD12 ' A' ' 80' ' ' ILE . 2.7 m -83.47 153.57 24.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.421 . . . . 0.0 111.255 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.71 152.88 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.796 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.52 126.72 33.55 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.538 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.768 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.8 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.251 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.867 0.365 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -61.58 137.3 58.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 62' ' ' VAL . 54.7 p -54.56 -26.61 33.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -81.95 -0.12 42.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.9 5.83 9.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.588 0.232 . . . . 0.0 111.484 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 64' ' ' CYS . 46.6 mt -104.77 152.68 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.451 ' OD2' HD11 ' A' ' 84' ' ' LEU . 33.6 t0 -109.41 120.34 42.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 50' ' ' GLN . 37.0 m-85 -101.35 30.59 4.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.809 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.6 t0 -132.43 28.27 4.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -145.29 31.23 1.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.95 -49.74 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.892 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.619 ' CB ' HD12 ' A' ' 67' ' ' LEU . 11.8 mtp -84.28 147.66 27.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.821 ' O ' HD21 ' A' ' 67' ' ' LEU . 47.0 m95 -132.72 -173.81 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 pt-20 -149.87 162.06 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.74 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -146.7 141.29 26.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 111.682 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.625 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 4.0 ttmt -131.39 122.86 27.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.25 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -58.41 -51.9 67.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 0.0 110.945 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HB3' HG23 ' A' ' 35' ' ' THR . 5.0 mt-10 -78.58 161.57 26.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -112.1 38.68 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.4 p -104.91 -166.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.71 0.19 26.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.113 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.91 -29.78 7.52 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.525 0.202 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -39.69 157.26 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.874 0.368 . . . . 0.0 111.709 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 1.6 mm-40 -59.79 -176.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -146.65 107.09 4.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -124.27 -162.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.223 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.677 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.49 12.5 69.63 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 118.992 -0.893 . . . . 0.0 114.686 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.7 Cg_endo -70.22 54.91 1.41 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 120.27 2.035 . . . . 0.0 112.056 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.447 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -121.28 165.43 15.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.024 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.8 p -57.41 142.58 43.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -46.82 -30.44 2.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.081 0.467 . . . . 0.0 110.284 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.48 89.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.629 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.438 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 36.1 tp60 -68.56 -25.84 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.846 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.3 mmm -75.96 -44.37 40.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.603 HE21 ' CB ' ' A' ' 82' ' ' PHE . 6.0 tp-100 -58.99 -38.85 80.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.314 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' GLU . 92.6 m -62.4 -57.31 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.582 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.8 m0 -53.89 -42.71 68.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.003 0.43 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.595 HG22 ' HD2' ' A' ' 58' ' ' PHE . 73.7 t -65.34 -50.48 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -28.98 60.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.1 tt0 -64.72 -26.52 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.055 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.76 2.83 28.72 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.927 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.419 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.8 -27.45 66.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.816 0.341 . . . . 0.0 111.027 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.595 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 -121.73 78.68 39.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.22 -36.81 99.11 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.551 2.167 . . . . 0.0 112.378 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.52 5.1 31.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.335 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 86.24 -173.61 46.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.141 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 61' ' ' GLY . 6.4 m -158.85 164.7 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 0.0 111.215 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 84.9 2.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.188 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.4 m -84.19 147.79 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.78 153.55 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.034 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CE ' ' CZ2' ' A' ' 28' ' ' TRP . 10.2 mttt -85.95 138.79 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.3 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.633 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.542 ' HB3' HD11 ' A' ' 80' ' ' ILE . 3.0 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.751 0.31 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.37 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.6 p -51.55 -31.51 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -7.48 52.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.388 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -117.61 7.79 12.7 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 75' ' ' TYR . 53.6 mt -105.0 152.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.87 0.367 . . . . 0.0 111.063 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' HG22 ' A' ' 80' ' ' ILE . 27.4 t0 -104.82 116.9 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CB ' HE21 ' A' ' 50' ' ' GLN . 68.1 m-85 -96.88 30.86 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.784 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.3 m-20 -132.4 26.86 4.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.784 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.3 mt -147.0 30.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -137.58 -52.07 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.904 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.837 0.351 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.622 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.71 143.51 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.872 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.816 ' O ' HD21 ' A' ' 67' ' ' LEU . 57.2 m95 -135.95 -174.17 3.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.644 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HG2' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.65 147.54 18.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.57 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.44 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 27.4 p90 -131.37 140.54 49.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.397 . . . . 0.0 111.544 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.705 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 16.0 ttpt -123.76 123.13 39.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.2 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -58.11 -52.48 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.66 172.54 9.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.116 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.406 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 62.8 t-20 -118.02 40.33 3.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.73 -177.78 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.978 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.53 -9.55 61.39 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.154 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -112.87 -17.3 12.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.481 0.182 . . . . 0.0 111.347 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.705 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.06 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.833 0.349 . . . . 0.0 111.501 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -55.44 -177.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.86 85.86 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.36 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 6.6 m-85 -118.72 -159.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.39 14.77 61.37 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.303 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.97 54.5 1.65 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 119.933 1.866 . . . . 0.0 112.011 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.452 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.9 m-85 -123.21 165.29 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.085 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -56.92 145.15 30.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.028 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 p -47.76 -30.16 3.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.168 0.509 . . . . 0.0 110.081 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.68 -41.51 92.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.374 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.461 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 5.3 tp60 -68.72 -26.07 65.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.775 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.431 ' O ' HG23 ' A' ' 53' ' ' VAL . 15.1 mmm -76.35 -51.01 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.314 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -55.79 -32.03 63.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.027 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.8 m -65.38 -64.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.514 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.461 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.6 m0 -49.02 -42.74 39.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.494 HG22 ' HD2' ' A' ' 58' ' ' PHE . 81.5 t -62.64 -58.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.507 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.7 p -75.23 -24.75 57.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.756 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -64.66 -46.38 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 111.185 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.33 -31.18 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.416 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -57.59 156.83 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 110.82 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.494 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 63.19 61.74 1.84 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 50.8 Cg_exo -53.78 -38.59 85.32 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.466 2.11 . . . . 0.0 112.297 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.37 5.13 31.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.35 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.65 160.75 36.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.288 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.08 164.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 111.242 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -77.93 82.0 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.471 ' CB ' HD12 ' A' ' 80' ' ' ILE . 1.7 m -73.81 146.6 44.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 29' ' ' GLU . 5.3 ttm180 -162.49 159.29 24.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -94.03 137.13 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 28' ' ' TRP . 9.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.824 0.345 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -55.31 131.56 45.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.458 ' OG ' HG21 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -52.74 -26.44 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.194 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 3.13 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.377 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -126.92 4.95 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.576 0.227 . . . . 0.0 111.376 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 64' ' ' CYS . 43.0 mt -105.0 153.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 13.2 t0 -107.29 114.84 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.78 10.02 40.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.76 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -108.9 32.27 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -147.42 31.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.763 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -134.68 -47.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.908 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 27' ' ' MET . 23.7 t . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.912 0.386 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.559 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.19 140.99 24.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.811 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.748 ' O ' HD21 ' A' ' 67' ' ' LEU . 31.1 m95 -131.17 -173.9 3.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.575 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.728 ' OE2' HD23 ' A' ' 67' ' ' LEU . 1.2 pt-20 -153.55 141.9 20.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.597 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' TYR . 12.8 p90 -123.39 141.75 51.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 111.783 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.645 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 16.1 ttpt -130.07 121.73 26.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.96 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -54.55 -48.99 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -97.76 -174.82 2.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -129.68 38.48 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.667 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.24 173.55 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.989 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 -2.37 89.3 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.225 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -112.5 -26.99 8.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.552 0.215 . . . . 0.0 110.94 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.645 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -44.55 153.1 0.17 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.401 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' OE2' ' CE2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -56.26 -177.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 0.0 110.787 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.63 81.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.047 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 30' ' ' TYR . 1.9 m-85 -110.61 -157.07 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.07 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.26 14.81 61.54 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-O 119.098 -0.834 . . . . 0.0 114.392 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 54.6 Cg_endo -70.48 54.75 1.49 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-N 120.083 1.941 . . . . 0.0 111.955 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.6 m-85 -121.73 165.37 15.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 p -60.79 145.3 50.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.872 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.23 -30.36 1.97 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.135 0.493 . . . . 0.0 110.207 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.91 -44.17 90.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.526 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 34.3 tp60 -66.27 -25.64 66.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.782 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 mmm -73.37 -42.85 61.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 1.1 mm-40 -60.75 -34.36 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.884 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 55' ' ' GLU . 44.3 m -61.95 -56.97 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.9 m0 -57.53 -49.16 77.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.763 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.683 HG22 ' HD2' ' A' ' 58' ' ' PHE . 94.7 t -63.56 -45.22 98.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.133 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.6 p -75.46 -29.19 59.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.9 mm-40 -64.71 -28.08 69.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.047 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.22 -24.21 3.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.461 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -56.59 159.68 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.683 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.5 OUTLIER 62.9 61.48 1.99 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.484 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.431 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 51.3 Cg_exo -55.2 -38.46 93.62 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.57 2.18 . . . . 0.0 112.509 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -105.19 5.12 31.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.74 159.02 35.24 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.026 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.92 164.72 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.92 85.44 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.8 m -84.86 146.71 27.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.233 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -163.87 147.05 9.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.084 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.3 mtmp? -84.05 126.44 33.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.748 HD21 ' O ' ' A' ' 28' ' ' TRP . 7.2 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.705 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.548 ' HB3' HD11 ' A' ' 80' ' ' ILE . 14.1 m-85 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.755 0.312 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -56.34 122.96 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 t -51.7 -29.2 17.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -1.18 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.405 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.59 7.36 8.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.464 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 75' ' ' TYR . 51.2 mt -101.77 152.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 80' ' ' ILE . 32.5 t0 -100.84 114.8 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 52.3 m-85 -97.1 31.78 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.005 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.724 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -136.19 35.09 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.977 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.8 mt -147.85 31.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CE1' ' HE2' ' A' ' 66' ' ' LYS . 94.6 m-85 -137.61 -49.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.897 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 85' ' ' TYR . 20.1 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.814 0.34 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.2 mtp -88.9 135.1 33.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.719 ' O ' HD21 ' A' ' 67' ' ' LEU . 45.0 m95 -123.03 -174.64 2.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.492 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.566 ' CD ' HD22 ' A' ' 67' ' ' LEU . 2.8 mt-10 -155.94 144.39 20.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.815 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 41' ' ' TYR . 47.1 p90 -128.52 135.96 50.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 111.695 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.823 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 4.1 ttpm? -118.16 116.77 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.055 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -56.57 -53.14 61.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.0 110.892 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.67 -174.0 4.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 66.4 t30 -134.2 38.69 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.732 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -107.59 162.38 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.27 -9.35 80.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.17 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -105.31 -25.27 12.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.604 0.24 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.823 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.58 132.98 4.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 111.415 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.6 tt0 -55.81 -177.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.478 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -151.61 120.81 6.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.065 0.46 . . . . 0.0 111.573 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.573 ' O ' ' N ' ' A' ' 30' ' ' TYR . 8.2 m-85 -128.16 -173.03 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.907 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.692 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 98.48 2.22 57.7 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.338 -0.934 . . . . 0.0 115.158 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.844 ' HA ' HD11 ' A' ' 67' ' ' LEU . 83.7 Cg_exo -42.52 -25.68 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.284 2.042 . . . . 0.0 112.886 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' CD2' ' HA2' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -43.28 165.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.365 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -61.89 146.94 48.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.087 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.0 p -47.83 -30.47 4.07 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.148 0.499 . . . . 0.0 110.22 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.64 -48.89 73.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.2 tp60 -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.395 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.516 ' O ' HG23 ' A' ' 53' ' ' VAL . 37.8 mmm -75.46 -43.52 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.939 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.482 ' NE2' ' HB2' ' A' ' 82' ' ' PHE . 3.4 tp-100 -59.25 -28.56 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.09 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' GLU . 86.2 m -71.38 -58.07 3.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.541 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 3.8 m-90 -56.85 -43.2 80.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 49' ' ' MET . 96.8 t -64.76 -47.24 89.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.7 m -75.39 -29.57 59.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.02 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' THR . 3.3 tm-20 -64.74 -34.57 78.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.47 3.05 21.02 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.926 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -54.98 -30.32 58.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.993 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -113.8 81.63 5.96 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 -29.45 43.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -105.15 5.08 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.352 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.92 162.98 29.19 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.173 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.6 m -138.8 164.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.329 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -83.44 90.8 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.231 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -78.19 144.81 36.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.71 138.74 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.566 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -84.02 121.79 27.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' A' ' 43' ' ' PRO . 2.8 mt . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.071 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.898 0.38 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.17 131.36 45.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.656 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.44 ' HB3' HG23 ' A' ' 62' ' ' VAL . 10.9 p -51.61 -26.91 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -78.95 -3.13 43.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.522 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.02 7.01 7.26 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 64' ' ' CYS . 43.5 mt -104.69 152.97 6.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 80' ' ' ILE . 28.8 t0 -111.29 117.59 33.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' HB2' ' NE2' ' A' ' 50' ' ' GLN . 70.9 m-85 -96.67 30.54 2.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.78 ' O ' HD23 ' A' ' 84' ' ' LEU . 8.0 t70 -128.44 30.21 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.778 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.78 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.5 mt -147.05 30.17 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.478 ' HB3' HG21 ' A' ' 26' ' ' VAL . 63.6 m-85 -137.64 -55.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.872 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.613 ' CB ' HD12 ' A' ' 67' ' ' LEU . 12.1 mmm -92.55 150.02 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.797 ' O ' HD21 ' A' ' 67' ' ' LEU . 39.7 m95 -133.84 -173.96 3.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.5 ' CD ' HD11 ' A' ' 40' ' ' LEU . 13.2 pt-20 -151.76 156.77 40.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.558 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.8 p90 -139.48 146.56 40.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.21 0.528 . . . . 0.0 111.745 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -133.17 120.26 20.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.075 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -59.72 -55.49 33.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 110.999 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.51 160.38 21.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -107.43 39.28 1.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -103.45 161.89 13.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.004 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.75 0.15 88.6 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.111 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -112.39 -26.86 8.52 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 111.115 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.518 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -43.35 146.88 0.43 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.487 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 3.0 mp0 -56.52 -177.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.5 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -145.96 96.66 2.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.239 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.454 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-85 -113.65 -161.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.249 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.688 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.61 12.74 68.81 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 118.981 -0.899 . . . . 0.0 114.436 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.8 Cg_endo -70.61 54.63 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 120.136 1.968 . . . . 0.0 112.195 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.3 m-85 -121.46 165.23 15.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 p -57.74 144.44 38.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.995 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -30.47 2.54 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.134 0.493 . . . . 0.0 110.231 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.42 -43.27 86.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.433 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.8 tp60 -66.61 -25.91 66.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.4 mmm -76.12 -47.31 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.086 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -57.59 -31.9 66.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.143 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 55' ' ' GLU . 41.2 m -67.93 -57.31 6.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.607 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.8 m0 -57.72 -46.86 83.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 49' ' ' MET . 98.3 t -61.04 -47.85 91.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.767 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.1 t -75.19 -27.95 59.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.041 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 51' ' ' THR . 7.0 mm-40 -64.75 -38.5 91.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.3 4.0 11.32 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.855 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.85 -30.03 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -116.27 87.59 20.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.733 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.77 -33.73 33.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.4 2.066 . . . . 0.0 112.203 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -105.51 5.23 31.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 88.43 -176.21 44.78 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.102 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 61' ' ' GLY . 5.5 m -156.34 164.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.36 . . . . 0.0 111.262 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.02 86.46 6.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.259 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.1 m -79.08 155.23 28.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.107 0.48 . . . . 0.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -166.5 155.56 11.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.515 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HE3' ' CH2' ' A' ' 28' ' ' TRP . 4.6 mtmp? -93.72 132.99 37.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.3 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.787 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.883 0.373 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -58.63 125.38 23.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.2 t -51.96 -32.7 34.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -3.47 36.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.48 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.94 6.29 10.87 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 81' ' ' ASP . 41.1 mt -100.43 154.8 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 111.004 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 80' ' ' ILE . 14.3 t0 -105.42 114.99 29.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -96.59 33.27 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.649 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.2 t0 -134.64 30.9 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.973 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -146.09 30.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -138.44 -56.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.976 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 85' ' ' TYR . 16.2 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.788 0.328 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.604 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -86.83 142.29 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.801 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.825 ' O ' HD21 ' A' ' 67' ' ' LEU . 58.5 m95 -132.89 -174.03 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.823 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.651 ' OE1' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -153.75 157.96 40.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.432 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 16.6 p90 -145.83 134.61 22.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 111.81 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.663 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -119.86 123.65 44.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.997 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -57.03 -50.05 73.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 110.922 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' HG23 ' A' ' 35' ' ' THR . 13.2 mt-10 -86.81 176.64 7.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.67 39.29 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.64 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 33' ' ' GLU . 2.0 p -106.27 165.8 10.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.025 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.58 -2.55 89.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.296 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.85 -26.7 8.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.75 146.0 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.583 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -55.53 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.651 HD23 ' OE1' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -154.6 122.13 5.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' TYR . 2.0 m-85 -132.63 -160.07 1.02 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.014 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.685 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.38 15.12 64.81 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.434 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.2 Cg_endo -70.65 54.61 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 120.112 1.956 . . . . 0.0 111.959 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.09 165.46 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.158 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.2 p -56.11 145.66 25.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.8 t -48.65 -29.97 4.94 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.16 0.505 . . . . 0.0 110.07 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.526 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 37.7 tp60 -73.8 -26.02 60.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.768 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmm -75.02 -47.23 30.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.059 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.418 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 33.8 tp60 -61.16 -34.54 75.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.039 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.5 m -61.38 -53.29 58.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.268 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.429 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 3.5 m0 -58.13 -45.2 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.535 HG22 ' CD2' ' A' ' 58' ' ' PHE . 95.4 t -65.46 -45.76 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.88 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -28.36 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 51' ' ' THR . 5.2 mm-40 -64.89 -37.58 88.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.16 -23.23 1.74 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.643 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -57.84 160.73 4.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 53' ' ' VAL . 1.9 m-85 61.99 74.92 0.46 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.42 -38.92 7.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.231 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -105.22 5.18 31.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.156 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.77 159.02 34.78 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.019 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 58' ' ' PHE . 5.3 m -130.95 164.3 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -79.32 88.56 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.097 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -85.25 150.12 25.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.091 0.472 . . . . 0.0 111.805 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.5 147.64 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.271 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -84.31 140.7 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 111.25 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.825 HD21 ' O ' ' A' ' 28' ' ' TRP . 3.8 mt . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.759 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.763 0.316 . . . . 0.0 110.73 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.83 123.07 14.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.423 ' HA ' HD12 ' A' ' 80' ' ' ILE . 83.9 p -53.58 -31.05 45.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.072 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -11.23 60.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 10.18 15.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.368 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.759 HD11 ' HB3' ' A' ' 75' ' ' TYR . 93.9 mt -105.0 153.58 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.04 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.406 ' N ' HG22 ' A' ' 80' ' ' ILE . 16.2 t0 -109.57 116.23 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 53.8 m-85 -94.25 46.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.757 ' O ' HD23 ' A' ' 84' ' ' LEU . 4.3 t0 -152.06 28.94 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.0 mt -147.6 30.79 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.557 ' HB3' HG21 ' A' ' 26' ' ' VAL . 62.7 m-85 -134.47 -51.02 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 86' ' ' THR . 8.3 t . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.343 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.644 ' CB ' HD12 ' A' ' 67' ' ' LEU . 5.8 mtp -91.02 149.14 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.785 ' O ' HD21 ' A' ' 67' ' ' LEU . 44.3 m95 -133.75 -173.82 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 11.1 pt-20 -151.99 154.41 35.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.234 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.3 p90 -138.94 143.91 38.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.15 0.5 . . . . 0.0 111.98 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 34.2 ttpt -131.2 114.64 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.907 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.444 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 92.0 m95 -56.35 -53.01 62.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.899 0.38 . . . . 0.0 111.026 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.6 OUTLIER -84.86 159.51 20.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.912 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -109.03 38.98 2.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.625 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.6 p -106.65 162.78 13.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.02 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.57 -4.64 85.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -111.03 -22.88 11.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.526 0.203 . . . . 0.0 111.084 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.767 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 111.452 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 23.1 mm-40 -56.3 -175.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -156.45 90.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.97 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 5.0 m-85 -119.92 -160.26 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.302 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 89.37 12.63 62.79 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.645 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.4 Cg_endo -71.01 55.56 1.81 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 120.195 1.998 . . . . 0.0 111.92 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 6.0 m-85 -121.02 165.23 15.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.4 p -59.94 147.68 37.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.4 p -47.32 -32.11 4.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.168 0.509 . . . . 0.0 110.04 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.23 99.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.388 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.467 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 12.0 tp60 -70.01 -25.93 63.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.451 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.676 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -76.11 -46.51 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.983 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -60.45 -33.59 72.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.216 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.9 m -65.21 -57.7 7.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 2.8 m0 -57.73 -45.4 85.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 49' ' ' MET . 59.3 t -65.0 -44.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.786 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.1 t -75.28 -30.29 60.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.967 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.6 mm-40 -64.82 -32.36 74.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.51 3.09 22.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.887 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -57.25 -33.22 67.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.777 0.322 . . . . 0.0 110.854 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -112.32 77.55 2.25 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.682 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.62 -29.21 30.36 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.61 2.206 . . . . 0.0 112.3 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -105.07 -0.6 26.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 161.65 37.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.333 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.54 164.89 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 0.0 111.262 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.64 84.07 5.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.067 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -82.9 145.56 29.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.414 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.4 153.69 29.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.044 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -90.21 135.75 33.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 28' ' ' TRP . 5.3 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.545 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HB3' HD11 ' A' ' 80' ' ' ILE . 9.7 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.809 0.338 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -57.27 127.26 31.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.3 p -52.62 -33.94 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 -7.36 51.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.349 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -113.79 6.26 16.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.651 0.262 . . . . 0.0 111.429 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.625 HD13 ' CZ3' ' A' ' 28' ' ' TRP . 45.8 mt -105.09 153.92 6.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.353 . . . . 0.0 110.996 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 80' ' ' ILE . 17.2 t0 -104.8 115.7 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.82 33.69 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.604 ' O ' HD23 ' A' ' 84' ' ' LEU . 9.4 t70 -139.4 33.07 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 83' ' ' ASP . 7.4 mt -145.91 30.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.7 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.83 -57.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.999 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 p30 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.889 0.376 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.48 110.49 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.561 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.5 146.96 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.828 ' O ' HD21 ' A' ' 67' ' ' LEU . 53.0 m95 -132.52 -174.43 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.517 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.624 ' OE1' HD13 ' A' ' 40' ' ' LEU . 11.7 pt-20 -156.93 160.65 39.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.499 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 36.5 p90 -144.92 133.4 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.674 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 20.3 ttpp -114.58 123.5 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.082 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -55.23 -48.15 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 110.949 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.47 -177.39 3.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -124.65 38.64 4.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 p -105.14 165.23 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.58 -4.05 87.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.274 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.35 -23.7 9.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.598 0.237 . . . . 0.0 111.156 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.46 137.16 2.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.746 0.308 . . . . 0.0 111.523 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -64.42 137.09 57.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.1 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.624 HD13 ' OE1' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -114.27 136.1 53.34 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.626 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' H ' HD23 ' A' ' 40' ' ' LEU . 11.4 m-85 -141.8 -156.5 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.914 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.61 16.32 64.15 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.11 -0.828 . . . . 0.0 114.316 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.1 Cg_endo -70.4 54.6 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 119.976 1.888 . . . . 0.0 111.84 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.494 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m-85 -123.32 166.18 15.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 p -55.37 144.16 26.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.7 p -46.71 -30.28 2.3 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.221 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.67 83.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.536 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.464 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 6.6 tp60 -62.72 -26.22 68.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.66 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.645 ' O ' HG23 ' A' ' 53' ' ' VAL . 36.8 mmm -72.29 -43.19 64.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.281 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.424 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -61.33 -33.86 74.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.258 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -62.88 -58.71 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.3 m-90 -57.66 -46.31 84.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 49' ' ' MET . 60.0 t -64.25 -44.64 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.0 m -75.35 -32.39 60.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 51' ' ' THR . 10.3 tm-20 -64.8 -39.57 93.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.13 2.11 9.27 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.92 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.428 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -55.68 -25.96 42.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.538 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.2 m-85 -121.95 78.67 41.28 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.07 -30.77 46.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.633 2.222 . . . . 0.0 112.355 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -105.18 4.87 31.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.6 162.33 33.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.248 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.45 164.83 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.267 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CD2' ' CD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -77.95 83.47 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.317 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.484 ' CB ' HD12 ' A' ' 80' ' ' ILE . 1.5 m -76.03 144.93 40.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -158.77 159.33 35.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.604 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HE2' ' CZ2' ' A' ' 28' ' ' TRP . 15.4 mtmt -95.69 133.3 39.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.719 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.828 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.2 mt -64.88 -66.33 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.59 126.36 26.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.806 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.43 139.13 50.43 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.531 -1.445 . . . . 0.0 112.293 0.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.28 135.59 16.97 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.478 2.119 . . . . 0.0 112.322 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.02 -101.76 0.37 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.657 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.38 -149.54 8.16 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.475 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 48.9 69.16 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.3 0.571 . . . . 0.0 110.783 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 19.0 m-85 -54.56 163.47 0.91 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.137 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.15 129.8 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.796 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.27 135.13 57.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.0 p -52.82 -28.35 22.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -1.44 43.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -120.48 4.96 10.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.549 0.214 . . . . 0.0 111.489 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.484 HD12 ' CB ' ' A' ' 64' ' ' CYS . 34.6 mt -103.34 151.82 6.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.965 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -98.55 115.54 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 92.3 m-85 -98.59 30.39 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.751 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -134.3 29.05 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.0 mt -147.02 30.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.54 -52.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.878 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.802 0.334 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.25 135.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.073 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.584 ' CG ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -100.33 140.49 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.917 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.785 ' O ' HD21 ' A' ' 67' ' ' LEU . 50.0 m95 -134.11 -174.03 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 111.49 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.769 ' CD ' HD11 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -150.4 164.62 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.741 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 6.5 p90 -149.18 140.11 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.48 . . . . 0.0 111.653 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.727 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 5.2 ttmt -130.66 118.48 21.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.001 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -54.3 -49.3 69.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.425 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -94.66 176.31 6.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.822 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -131.21 38.93 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -105.47 -174.56 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.02 68.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.871 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -122.46 -35.51 3.09 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.543 0.211 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.38 134.99 3.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.833 0.349 . . . . 0.0 111.473 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -58.56 -174.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.769 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -141.59 98.63 3.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.085 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 11.2 m-85 -114.05 -162.55 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.684 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.95 10.88 66.03 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 118.959 -0.912 . . . . 0.0 114.71 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.45 55.52 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 120.272 2.036 . . . . 0.0 111.964 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.8 m-85 -122.64 165.59 16.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -58.05 144.61 39.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.7 p -46.7 -31.42 2.92 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.174 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.79 96.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.447 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 2.7 tp60 -66.06 -25.94 67.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.595 ' O ' HG23 ' A' ' 53' ' ' VAL . 34.2 mmm -74.53 -44.69 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.413 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -34.99 73.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.174 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 55' ' ' GLU . 99.3 m -63.13 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.5 m0 -54.96 -45.57 74.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG22 ' HD2' ' A' ' 58' ' ' PHE . 83.9 t -65.36 -47.0 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.218 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m -75.32 -31.84 60.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 tp10 -64.81 -29.45 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.1 3.22 23.15 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.949 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -58.93 -28.21 66.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.644 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 -120.91 80.26 33.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -27.81 17.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.658 2.239 . . . . 0.0 112.448 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 -7.73 19.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.294 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.13 160.09 31.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.387 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.32 164.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 111.181 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.12 84.9 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.284 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.7 m -84.51 148.21 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -165.03 148.42 8.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.788 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.7 mtmp? -84.29 130.1 34.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 28' ' ' TRP . 9.9 mt -58.37 -66.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.865 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -118.5 136.61 24.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.61 148.69 84.12 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.409 -1.496 . . . . 0.0 112.382 0.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.47 154.31 27.65 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.563 2.175 . . . . 0.0 112.433 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.96 70.0 0.31 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.652 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.407 ' HA3' ' NH2' ' A' ' 65' ' ' ARG . . . -154.36 175.56 32.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.47 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 8.9 mt-30 -115.03 66.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.072 0.463 . . . . 0.0 110.975 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.436 ' CG ' ' O ' ' A' ' 73' ' ' GLN . 50.0 p90 45.09 -172.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.674 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER 179.63 113.39 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.788 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.88 127.28 31.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 p -52.52 -30.71 31.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -7.37 53.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 6.86 12.95 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.574 0.226 . . . . 0.0 111.399 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 75' ' ' TYR . 52.3 mt -104.38 153.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 0.0 111.053 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -102.12 115.67 31.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.754 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HE2' HG11 ' A' ' 53' ' ' VAL . 22.3 m-85 -96.7 35.53 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.7 m-20 -137.35 28.05 2.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.2 mt -146.51 30.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -133.53 -53.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.927 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.565 ' OD1' HG22 ' A' ' 45' ' ' THR . 56.3 t0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.861 0.362 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 t -64.05 105.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.195 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.543 ' CB ' HD12 ' A' ' 67' ' ' LEU . 14.1 mtp -83.71 140.41 32.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.723 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.827 ' O ' HD21 ' A' ' 67' ' ' LEU . 51.8 m95 -124.55 -174.26 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 1.3 tt0 -153.04 145.23 23.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.425 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' TYR . 16.0 p90 -133.76 135.06 43.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.089 0.471 . . . . 0.0 111.983 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.791 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 5.8 ttpm? -119.8 129.31 54.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.941 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -59.53 -50.69 72.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.458 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -125.47 135.85 52.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.251 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -76.74 61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -111.85 168.28 9.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.14 -2.15 86.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.498 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.33 -28.1 6.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.653 0.264 . . . . 0.0 111.172 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -46.97 125.61 7.75 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 111.396 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 2.6 mm-40 -60.46 -177.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD21 ' HE2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -141.94 125.78 17.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.209 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -135.93 -160.37 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.215 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.686 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.81 15.2 65.94 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-O 119.069 -0.851 . . . . 0.0 114.304 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.3 Cg_endo -70.63 54.6 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 119.996 1.898 . . . . 0.0 111.925 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.3 m-85 -125.43 165.46 18.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.025 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.565 HG22 ' OD1' ' A' ' 25' ' ' ASP . 14.7 p -55.11 144.36 24.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.984 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -46.38 -30.86 2.3 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.166 0.508 . . . . 0.0 110.257 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.65 88.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.475 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 19.1 tp60 -65.36 -26.3 67.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.627 ' O ' HG23 ' A' ' 53' ' ' VAL . 27.1 mmm -76.06 -45.86 32.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.037 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -58.95 -30.37 67.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.919 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.4 m -67.8 -58.68 4.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.435 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.448 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 4.1 m0 -55.72 -43.44 76.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.693 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 49' ' ' MET . 72.0 t -63.91 -48.23 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.858 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -75.3 -28.47 59.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.028 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.9 mt-10 -64.74 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.15 -1.09 19.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.845 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -29.86 61.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.48 78.39 28.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.635 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.84 -28.8 42.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -105.09 5.18 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.66 159.82 24.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.213 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.46 164.85 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.849 0.357 . . . . 0.0 111.209 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.22 83.45 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.585 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -74.93 144.81 43.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.243 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -159.39 143.52 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.015 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.438 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 9.7 mtmt -84.09 130.47 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.98 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 28' ' ' TRP . 7.0 mt -59.55 -59.22 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -120.14 132.22 24.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.73 141.58 67.58 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.867 -1.305 . . . . 0.0 112.09 0.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.38 111.46 3.04 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.581 2.187 . . . . 0.0 112.314 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.38 23.39 2.21 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.835 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 56.16 -160.18 7.53 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.693 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 64.74 65.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.421 0.629 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.696 ' HE2' HD21 ' A' ' 40' ' ' LEU . 89.1 m-85 -55.64 -178.09 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.084 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -157.86 129.87 7.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -59.77 126.45 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 t -52.04 -31.05 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -7.6 53.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.07 7.03 12.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.449 HD12 ' CB ' ' A' ' 64' ' ' CYS . 41.6 mt -104.36 153.33 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.014 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 12.4 t0 -99.43 114.9 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.47 38.44 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.756 ' O ' HD23 ' A' ' 84' ' ' LEU . 5.5 t70 -143.6 30.73 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -147.5 30.95 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.33 -49.98 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.883 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.812 0.339 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 t -62.05 120.39 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.672 ' CB ' HD12 ' A' ' 67' ' ' LEU . 4.4 mtp -88.32 144.56 26.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.796 ' O ' HD21 ' A' ' 67' ' ' LEU . 40.3 m95 -134.39 -173.68 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 13.4 pt-20 -156.6 146.76 21.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.641 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 41' ' ' TYR . 34.0 p90 -128.94 144.23 51.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.139 0.495 . . . . 0.0 111.854 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 28.0 ttpt -125.84 115.58 20.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -54.37 -51.25 65.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.978 0.418 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.98 177.76 7.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.7 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -132.49 42.74 3.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.69 178.26 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.893 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.81 9.86 75.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.196 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.17 -28.1 3.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.549 0.214 . . . . 0.0 111.163 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -42.71 137.97 2.06 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.751 0.31 . . . . 0.0 111.612 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.96 -177.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.485 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.84 115.78 6.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.113 0.483 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -121.0 -158.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.056 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 82.75 17.61 67.61 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.293 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -70.32 54.01 1.35 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 119.91 1.855 . . . . 0.0 112.035 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.449 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.2 165.59 16.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -57.45 144.99 34.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.904 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t -47.03 -30.14 2.49 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.145 0.498 . . . . 0.0 110.135 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.51 86.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 38.6 tp60 -68.85 -26.35 65.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.66 ' O ' HG23 ' A' ' 53' ' ' VAL . 26.8 mmm -75.86 -47.88 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.411 ' OE1' ' CG ' ' A' ' 82' ' ' PHE . 36.4 tp60 -58.81 -31.83 68.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.166 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 55' ' ' GLU . 89.1 m -65.9 -54.5 25.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.4 m0 -58.86 -43.29 90.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.488 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 49' ' ' MET . 61.9 t -65.07 -46.27 91.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.404 ' HB3' ' NE2' ' A' ' 50' ' ' GLN . 17.7 p -75.27 -28.53 59.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.887 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' THR . 20.8 mm-40 -64.81 -29.79 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.03 26.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.935 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -58.26 -33.32 69.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.327 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.53 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -113.61 83.23 6.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.32 -27.21 19.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.568 2.179 . . . . 0.0 112.483 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -105.19 -7.86 18.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.38 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.09 160.76 31.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.196 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 m -137.93 164.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 82.07 7.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -75.63 144.62 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.303 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -156.75 153.99 29.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.028 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -91.14 131.58 36.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.4 mt -66.12 -67.78 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.696 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -122.54 136.59 26.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.55 148.15 79.88 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.174 -0.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.33 102.73 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.555 2.17 . . . . 0.0 112.26 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.11 39.92 0.21 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.706 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -133.58 156.87 22.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.469 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -114.11 70.37 0.73 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 10.0 m-85 56.48 166.71 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.137 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.683 ' HB3' HD11 ' A' ' 80' ' ' ILE . 5.2 m-85 -174.05 114.97 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.621 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -59.92 124.52 20.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.788 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -51.21 -34.1 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.255 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -72.64 -8.17 53.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.299 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 7.11 14.1 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 75' ' ' TYR . 40.4 mt -105.05 153.75 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.918 0.389 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 80' ' ' ILE . 10.4 t0 -101.82 114.89 29.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.785 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' ' OE1' ' A' ' 50' ' ' GLN . 96.4 m-85 -96.69 29.84 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.085 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.85 ' O ' HD23 ' A' ' 84' ' ' LEU . 32.0 m-20 -130.07 23.61 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -144.88 30.05 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.1 -52.96 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 86' ' ' THR . 5.2 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.818 0.342 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.47 97.36 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.252 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.568 ' CB ' HD12 ' A' ' 67' ' ' LEU . 8.6 mtp -81.44 148.45 29.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.657 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.83 ' O ' HD21 ' A' ' 67' ' ' LEU . 56.0 m95 -129.12 -174.16 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -152.43 156.6 39.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.654 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.1 p90 -143.62 146.74 33.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 111.788 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.758 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 38.5 ttpt -134.5 123.34 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.149 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 58.2 m95 -67.45 -59.99 2.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.318 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -85.4 134.65 34.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -90.46 51.46 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -113.83 176.11 5.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.994 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.59 86.03 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.994 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -116.42 -30.74 5.8 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.564 0.221 . . . . 0.0 111.02 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.758 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.61 129.33 5.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.43 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.34 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.499 HD11 ' HD3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -138.35 97.4 3.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.241 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.436 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 9.5 m-85 -111.33 -162.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.333 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.02 12.22 62.23 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 119.026 -0.874 . . . . 0.0 114.523 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 58.1 Cg_endo -71.5 54.87 1.97 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 120.21 2.005 . . . . 0.0 111.959 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -120.38 165.24 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -56.65 141.07 44.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.021 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -46.88 -30.97 2.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.179 0.514 . . . . 0.0 110.253 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.81 86.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.434 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 32.3 tp60 -66.46 -25.57 66.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.678 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.9 mmm -74.34 -43.07 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.144 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 2.9 tp-100 -59.41 -37.34 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.996 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.3 m -62.19 -59.28 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m0 -55.53 -51.76 65.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 49' ' ' MET . 84.0 t -55.83 -50.51 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 t -75.27 -25.61 58.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.67 -26.02 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.71 2.79 37.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.766 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.52 -33.56 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -112.08 80.02 3.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.756 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.65 -28.65 37.33 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.462 2.108 . . . . 0.0 112.184 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.09 3.68 30.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.263 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.36 163.52 34.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.244 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.7 m -139.3 164.81 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.58 89.32 7.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.273 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -80.42 151.54 29.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.636 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.499 ' HD3' HD11 ' A' ' 40' ' ' LEU . 8.5 ptm180 -165.43 146.33 7.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.505 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -84.44 139.86 31.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 28' ' ' TRP . 5.2 mt -71.26 -19.85 62.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 6.8 t70 -120.99 104.35 41.62 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.918 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 57.7 Cg_endo -71.01 160.53 91.59 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 123.512 -1.453 . . . . 0.0 112.355 0.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.07 113.77 3.69 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.613 2.209 . . . . 0.0 112.382 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.07 81.75 0.7 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.617 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.72 176.78 44.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.553 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 46.83 64.26 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.424 0.63 . . . . 0.0 110.862 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CE1' ' HD2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -74.95 142.03 43.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.899 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -167.64 137.11 2.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -63.36 127.14 29.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 62' ' ' VAL . 12.2 p -51.96 -27.52 13.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -79.14 -1.72 37.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.544 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.89 8.11 7.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-O 120.553 0.216 . . . . 0.0 111.461 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 81' ' ' ASP . 57.0 mt -105.09 154.58 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.882 0.373 . . . . 0.0 111.192 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' N ' HG22 ' A' ' 80' ' ' ILE . 32.7 t0 -108.25 116.26 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.542 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CB ' ' HB2' ' A' ' 50' ' ' GLN . 73.8 m-85 -95.92 28.07 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.648 ' O ' HD23 ' A' ' 84' ' ' LEU . 7.9 t70 -124.08 30.47 6.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -144.92 29.27 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -140.54 -46.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.96 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.72 0.295 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 t -55.06 123.61 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.251 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.581 ' CB ' HD12 ' A' ' 67' ' ' LEU . 70.1 mmm -89.88 136.99 32.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.713 ' O ' HD21 ' A' ' 67' ' ' LEU . 35.3 m95 -127.29 -173.49 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.27 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 mt-10 -146.2 161.04 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.752 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.5 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 5.1 p90 -145.03 146.83 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.599 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.727 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -135.71 119.92 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -56.47 -51.51 68.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.25 176.95 6.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -120.98 38.82 3.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.57 160.25 15.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.28 -5.07 80.84 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.309 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -110.85 -23.91 10.73 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.573 0.225 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.71 149.96 0.27 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 75.2 mm-40 -55.23 152.6 7.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -123.92 89.93 3.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.317 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 15.8 m-85 -113.36 -164.39 0.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.287 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.04 8.89 64.34 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 119.003 -0.887 . . . . 0.0 114.731 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.5 Cg_endo -70.97 55.08 1.73 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.255 2.027 . . . . 0.0 112.096 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.7 m-85 -121.0 165.39 15.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.131 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -56.16 143.82 31.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.961 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.64 -30.49 2.35 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.24 -43.35 86.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.476 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 30.1 tp60 -65.98 -25.89 67.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.733 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.644 ' O ' HG23 ' A' ' 53' ' ' VAL . 34.7 mmm -74.18 -51.22 16.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.527 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.12 -33.02 64.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 55' ' ' GLU . 33.0 m -64.54 -59.06 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.715 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.0 m0 -56.18 -43.7 78.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.881 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 49' ' ' MET . 58.5 t -61.88 -51.01 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.029 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -75.4 -26.35 58.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.6 mm-40 -64.74 -29.46 70.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.21 0.3 23.8 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.856 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.439 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 1.5 m-85 -59.96 -31.75 70.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 110.826 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.589 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -117.27 75.81 8.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.1 -30.21 47.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.468 2.112 . . . . 0.0 112.262 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -105.28 5.03 31.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.24 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.18 160.55 29.53 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.145 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.1 m -135.15 164.57 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 0.0 111.241 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.18 88.43 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.036 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -85.11 150.12 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 111.629 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.24 151.6 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -84.38 139.78 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.8 mt -72.29 -65.67 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.751 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -118.45 131.52 24.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.868 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 71.9 Cg_endo -74.44 133.9 33.25 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.224 0.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 69' ' ' PRO . 49.4 Cg_exo -55.62 124.22 15.75 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.396 2.064 . . . . 0.0 112.297 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.27 42.93 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.777 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.72 137.23 15.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.314 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -112.22 65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.188 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 48.61 104.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.623 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.765 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -128.47 104.93 7.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -57.25 122.36 12.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.423 ' HB3' HG23 ' A' ' 62' ' ' VAL . 8.3 p -53.19 -28.76 28.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.46 49.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.301 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 7.13 11.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 75' ' ' TYR . 58.5 mt -101.97 153.27 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 17.0 t0 -103.47 114.83 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.25 22.38 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.053 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.783 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -119.35 27.22 8.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.712 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.0 mt -145.82 29.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.65 -56.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.846 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.423 ' OXT' HG23 ' A' ' 86' ' ' THR . 1.9 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.872 0.368 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 t -65.18 104.86 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.252 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.529 ' CB ' HD12 ' A' ' 67' ' ' LEU . 26.3 mtp -83.22 144.02 30.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.726 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.806 ' O ' HD21 ' A' ' 67' ' ' LEU . 51.3 m95 -126.86 -174.05 3.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' CD ' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -152.07 155.79 38.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.722 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -140.97 143.38 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.041 0.448 . . . . 0.0 111.606 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.671 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 7.5 ttpt -130.86 119.48 22.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.145 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -54.29 -46.89 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.95 173.42 7.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 63' ' ' TYR . 2.8 p30 -120.79 39.24 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.688 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -108.13 176.25 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.49 -4.95 76.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.14 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.28 -24.1 10.43 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.558 0.218 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.33 159.2 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -57.22 -177.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.13 84.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.168 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 16.5 m-85 -114.81 -162.57 0.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.227 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.687 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.27 11.58 60.95 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.519 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -71.39 55.15 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.183 1.991 . . . . 0.0 111.997 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 4.0 m-85 -120.11 165.3 14.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -54.96 141.96 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 86.9 p -47.67 -30.31 3.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.18 0.514 . . . . 0.0 110.21 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.3 83.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.483 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 32.1 tp60 -68.97 -25.85 64.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.585 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 40.6 mmm -76.0 -45.1 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.869 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.96 -33.04 71.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.681 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -64.03 -56.04 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.466 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 5.5 m0 -58.04 -47.39 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.594 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 58' ' ' PHE . 79.8 t -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.886 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -75.28 -33.74 61.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.679 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 51' ' ' THR . 11.3 mt-10 -64.93 -37.3 87.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.26 4.19 14.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.784 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -53.47 -32.24 49.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.34 . . . . 0.0 110.933 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -114.0 78.73 4.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.733 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 -28.52 51.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.49 2.127 . . . . 0.0 112.201 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.18 5.24 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.246 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.16 162.92 27.11 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.154 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 m -138.49 164.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 111.281 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.473 ' CE2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -79.25 84.45 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.357 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -77.59 144.6 37.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.019 0.438 . . . . 0.0 111.449 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -157.52 142.32 16.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 11.0 mtmt -83.91 139.0 32.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.999 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.806 HD21 ' O ' ' A' ' 28' ' ' TRP . 2.6 mt -70.75 -68.51 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -122.48 130.48 24.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.08 138.56 51.91 Favored 'Cis proline' 0 C--N 1.348 0.5 0 C-N-CA 123.507 -1.455 . . . . 0.0 112.35 -0.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.68 104.96 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.51 2.14 . . . . 0.0 112.337 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.43 77.85 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.601 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.42 159.17 32.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.446 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -109.29 71.19 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.049 0.452 . . . . 0.0 111.065 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.473 ' CG ' ' CE2' ' A' ' 63' ' ' TYR . 9.7 m-85 59.22 155.16 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.989 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.82 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -161.37 107.62 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.897 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -59.43 124.74 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.2 p -52.45 -34.22 47.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -64.0 -15.6 59.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.203 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.1 7.83 18.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.387 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 75' ' ' TYR . 54.3 mt -105.04 153.6 6.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.535 ' OD2' HD11 ' A' ' 84' ' ' LEU . 8.3 t0 -104.51 127.63 52.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.611 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -108.82 26.47 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.313 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.803 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -139.94 31.34 2.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.88 0.371 . . . . 0.0 110.892 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.803 HD23 ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -145.28 30.51 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.774 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -133.34 -49.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.954 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.926 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.847 0.356 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG12 ' NE1' ' A' ' 28' ' ' TRP . 32.7 t -60.12 117.14 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.472 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.0 139.9 38.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.673 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.811 ' O ' HD21 ' A' ' 67' ' ' LEU . 58.2 m95 -123.42 -174.14 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.57 ' CD ' HD22 ' A' ' 67' ' ' LEU . 1.5 mt-10 -154.84 137.51 15.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.752 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 41' ' ' TYR . 15.6 p90 -122.32 148.91 44.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.216 0.531 . . . . 0.0 111.923 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.523 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 6.1 ttmm -136.07 120.41 17.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.978 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 110.882 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -178.12 5.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.811 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -124.74 39.48 3.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.765 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -101.95 -166.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.91 -5.87 40.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.341 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.8 -19.26 8.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.525 0.202 . . . . 0.0 111.411 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -44.14 154.81 0.1 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.775 0.322 . . . . 0.0 111.526 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 3.5 pm0 -51.06 135.95 24.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.075 0.464 . . . . 0.0 111.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -121.99 78.64 1.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.043 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' TYR . 3.3 m-85 -106.66 -159.55 0.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.683 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.42 14.22 58.9 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 119.157 -0.802 . . . . 0.0 114.4 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 55.4 Cg_endo -71.19 55.13 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.041 1.921 . . . . 0.0 111.96 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CD1' ' CZ3' ' A' ' 52' ' ' TRP . 3.1 m-85 -123.0 165.62 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -62.35 149.62 41.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.99 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 t -45.86 -31.23 2.02 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.158 0.504 . . . . 0.0 110.165 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.42 72.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.28 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 22.4 tp60 -63.7 -25.74 68.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.613 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.661 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.04 -45.97 62.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.284 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -33.81 72.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.124 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' GLU . 74.2 m -60.99 -62.41 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.432 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 3.1 m-90 -54.88 -44.13 73.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.921 0.391 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.706 HG22 ' HD2' ' A' ' 58' ' ' PHE . 62.1 t -65.06 -49.29 80.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 t -75.24 -28.35 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' THR . 14.6 tp10 -65.0 -43.78 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.31 -6.0 4.97 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.94 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -53.85 -35.89 62.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.706 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -114.11 78.31 4.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.72 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -35.17 16.68 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.589 2.193 . . . . 0.0 112.39 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -104.9 4.95 32.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.275 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.71 160.25 36.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.333 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.93 164.87 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -78.84 86.9 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.306 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.525 ' CB ' HD12 ' A' ' 80' ' ' ILE . 6.8 m -82.83 146.24 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.64 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -161.73 144.49 11.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.047 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 1.5 mtmp? -84.0 133.19 34.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.893 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.811 HD21 ' O ' ' A' ' 28' ' ' TRP . 3.1 mt -64.19 -63.8 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -115.84 133.27 22.87 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.865 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.65 142.35 63.93 Favored 'Cis proline' 0 C--N 1.348 0.516 0 C-N-CA 123.425 -1.49 . . . . 0.0 112.285 0.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.11 150.23 42.49 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.445 2.096 . . . . 0.0 112.236 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.81 69.77 0.24 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.616 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.99 178.85 28.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.325 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -118.45 64.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.176 0.512 . . . . 0.0 111.085 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 49.49 -178.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.392 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.487 ' HB3' HD11 ' A' ' 80' ' ' ILE . 2.5 m-85 -174.62 108.28 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.471 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -54.52 126.59 24.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.181 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -52.45 -34.96 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -8.63 56.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.032 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -112.46 5.93 18.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.27 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' A' ' 64' ' ' CYS . 69.0 mt -105.11 154.29 6.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.867 0.365 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 80' ' ' ILE . 6.9 t0 -107.0 117.06 33.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -96.68 27.94 3.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.028 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.677 ' O ' HD23 ' A' ' 84' ' ' LEU . 15.4 t70 -133.41 31.04 3.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.767 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.9 mt -146.56 30.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -137.89 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.876 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.913 0.387 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t -62.66 100.86 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.492 ' HB2' HD12 ' A' ' 67' ' ' LEU . 35.2 mmm -84.0 140.45 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.768 ' O ' HD21 ' A' ' 67' ' ' LEU . 46.0 m95 -123.1 -175.67 3.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.012 0.434 . . . . 0.0 111.249 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HG2' HD23 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -150.47 161.03 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.941 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.96 139.1 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.179 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.695 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 25.9 ttmt -128.58 123.89 34.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -55.82 -47.77 76.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB3' HG23 ' A' ' 35' ' ' THR . 4.7 mt-10 -98.49 176.59 5.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.86 39.54 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.838 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.6 p -106.2 176.53 5.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.48 -2.86 72.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.219 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.59 -25.57 9.07 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.561 0.22 . . . . 0.0 111.016 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.23 157.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.849 0.357 . . . . 0.0 111.435 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -55.24 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 86.44 1.15 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.492 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 10.1 m-85 -115.36 -174.16 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 102.68 -5.89 51.66 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.146 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 88.3 Cg_exo -41.53 -25.3 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.329 2.065 . . . . 0.0 113.139 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.425 ' CD2' ' CZ3' ' A' ' 52' ' ' TRP . 1.2 m-85 -42.53 165.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.308 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 p -64.32 147.06 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 36.5 p -47.31 -30.16 2.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.225 0.536 . . . . 0.0 110.204 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.96 80.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.644 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.6 tp60 -68.32 -26.41 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . 26.5 mmm -69.57 -52.3 27.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -60.77 -29.42 69.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.205 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' GLU . 52.9 m -59.92 -57.43 12.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.215 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.434 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m-90 -56.2 -43.0 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.767 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG22 ' CD2' ' A' ' 58' ' ' PHE . 47.8 t -65.36 -48.51 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -29.59 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' THR . 1.0 OUTLIER -64.98 -45.17 86.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.037 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.64 -24.32 0.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.14 162.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 60.08 65.59 2.29 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.93 -34.21 91.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.495 2.13 . . . . 0.0 112.138 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -105.32 -6.21 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.93 159.37 27.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.141 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.407 HG11 ' CD1' ' A' ' 58' ' ' PHE . 12.0 m -133.48 164.63 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.993 0.425 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.19 86.99 4.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.519 ' CB ' HD12 ' A' ' 80' ' ' ILE . 2.7 m -83.47 153.57 24.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.421 . . . . 0.0 111.255 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.461 ' CG ' ' HA ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -175.71 152.88 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.796 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.52 126.72 33.55 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.538 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.768 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.8 mt -50.67 -34.26 25.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.251 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 6.4 t0 -125.29 109.07 26.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.029 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 73.6 Cg_endo -75.61 143.72 78.0 Favored 'Cis proline' 0 C--N 1.349 0.588 0 C-N-CA 123.677 -1.384 . . . . 0.0 112.254 0.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.69 111.51 2.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.488 2.125 . . . . 0.0 112.483 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.1 100.3 1.23 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.451 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' CD2' ' A' ' 74' ' ' PHE . . . -166.88 -131.52 1.28 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.981 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -63.73 76.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.014 0.435 . . . . 0.0 111.173 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.461 ' HA ' ' CG ' ' A' ' 65' ' ' ARG . 83.3 m-85 -54.28 146.5 15.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.754 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -152.75 134.85 14.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.993 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -61.58 137.3 58.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 62' ' ' VAL . 54.7 p -54.56 -26.61 33.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -81.95 -0.12 42.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.9 5.83 9.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.588 0.232 . . . . 0.0 111.484 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 64' ' ' CYS . 46.6 mt -104.77 152.68 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.451 ' OD2' HD11 ' A' ' 84' ' ' LEU . 33.6 t0 -109.41 120.34 42.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 50' ' ' GLN . 37.0 m-85 -101.35 30.59 4.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.809 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.6 t0 -132.43 28.27 4.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -145.29 31.23 1.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.95 -49.74 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.892 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.836 0.351 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.1 104.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.619 ' CB ' HD12 ' A' ' 67' ' ' LEU . 11.8 mtp -84.28 147.66 27.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.821 ' O ' HD21 ' A' ' 67' ' ' LEU . 47.0 m95 -132.72 -173.81 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 pt-20 -149.87 162.06 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.74 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -146.7 141.29 26.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 111.682 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.625 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 4.0 ttmt -131.39 122.86 27.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.25 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -58.41 -51.9 67.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 0.0 110.945 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HB3' HG23 ' A' ' 35' ' ' THR . 5.0 mt-10 -78.58 161.57 26.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -112.1 38.68 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.4 p -104.91 -166.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.71 0.19 26.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.113 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.91 -29.78 7.52 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.525 0.202 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -39.69 157.26 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.874 0.368 . . . . 0.0 111.709 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 1.6 mm-40 -59.79 -176.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -146.65 107.09 4.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -124.27 -162.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.223 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.677 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.49 12.5 69.63 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 118.992 -0.893 . . . . 0.0 114.686 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.7 Cg_endo -70.22 54.91 1.41 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 120.27 2.035 . . . . 0.0 112.056 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.447 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -121.28 165.43 15.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.024 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.8 p -57.41 142.58 43.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -46.82 -30.44 2.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.081 0.467 . . . . 0.0 110.284 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.48 89.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.629 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.438 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 36.1 tp60 -68.56 -25.84 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.846 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.3 mmm -75.96 -44.37 40.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.603 HE21 ' CB ' ' A' ' 82' ' ' PHE . 6.0 tp-100 -58.99 -38.85 80.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.314 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' GLU . 92.6 m -62.4 -57.31 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.582 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.8 m0 -53.89 -42.71 68.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.003 0.43 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.595 HG22 ' HD2' ' A' ' 58' ' ' PHE . 73.7 t -65.34 -50.48 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -28.98 60.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.1 tt0 -64.72 -26.52 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.055 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.76 2.83 28.72 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.927 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.419 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.8 -27.45 66.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.816 0.341 . . . . 0.0 111.027 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.595 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 -121.73 78.68 39.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.22 -36.81 99.11 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.551 2.167 . . . . 0.0 112.378 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.52 5.1 31.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.335 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 86.24 -173.61 46.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.141 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 61' ' ' GLY . 6.4 m -158.85 164.7 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 0.0 111.215 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 84.9 2.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.188 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.4 m -84.19 147.79 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.78 153.55 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.034 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CE ' ' CZ2' ' A' ' 28' ' ' TRP . 10.2 mttt -85.95 138.79 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.3 mt -68.8 -69.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.633 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -124.85 134.25 25.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.797 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.14 144.75 73.78 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.507 -1.455 . . . . 0.0 112.265 0.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.87 135.46 19.36 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.482 2.122 . . . . 0.0 112.268 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.49 -32.25 0.15 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.74 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.78 135.4 48.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.55 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -95.12 69.46 3.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.981 0.419 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 59.83 154.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.117 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.542 ' HB3' HD11 ' A' ' 80' ' ' ILE . 3.0 m-85 -168.27 118.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.873 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.37 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.6 p -51.55 -31.51 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -7.48 52.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.388 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -117.61 7.79 12.7 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 75' ' ' TYR . 53.6 mt -105.0 152.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.87 0.367 . . . . 0.0 111.063 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' HG22 ' A' ' 80' ' ' ILE . 27.4 t0 -104.82 116.9 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CB ' HE21 ' A' ' 50' ' ' GLN . 68.1 m-85 -96.88 30.86 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.784 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.3 m-20 -132.4 26.86 4.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.784 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.3 mt -147.0 30.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -137.58 -52.07 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.904 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.906 0.384 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.82 126.07 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.104 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.622 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.71 143.51 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.872 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.816 ' O ' HD21 ' A' ' 67' ' ' LEU . 57.2 m95 -135.95 -174.17 3.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.644 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HG2' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.65 147.54 18.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.57 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.44 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 27.4 p90 -131.37 140.54 49.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.397 . . . . 0.0 111.544 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.705 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 16.0 ttpt -123.76 123.13 39.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.2 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -58.11 -52.48 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.66 172.54 9.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.116 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.406 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 62.8 t-20 -118.02 40.33 3.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.73 -177.78 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.978 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.53 -9.55 61.39 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.154 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -112.87 -17.3 12.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.481 0.182 . . . . 0.0 111.347 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.705 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.06 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.833 0.349 . . . . 0.0 111.501 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -55.44 -177.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.86 85.86 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.36 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 6.6 m-85 -118.72 -159.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.39 14.77 61.37 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.303 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.97 54.5 1.65 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 119.933 1.866 . . . . 0.0 112.011 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.452 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.9 m-85 -123.21 165.29 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.085 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -56.92 145.15 30.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.028 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 p -47.76 -30.16 3.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.168 0.509 . . . . 0.0 110.081 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.68 -41.51 92.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.374 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.461 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 5.3 tp60 -68.72 -26.07 65.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.775 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.431 ' O ' HG23 ' A' ' 53' ' ' VAL . 15.1 mmm -76.35 -51.01 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.314 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -55.79 -32.03 63.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.027 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.8 m -65.38 -64.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.514 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.461 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.6 m0 -49.02 -42.74 39.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.494 HG22 ' HD2' ' A' ' 58' ' ' PHE . 81.5 t -62.64 -58.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.507 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.7 p -75.23 -24.75 57.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.756 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -64.66 -46.38 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 111.185 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.33 -31.18 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.416 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -57.59 156.83 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 110.82 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.494 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 63.19 61.74 1.84 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 50.8 Cg_exo -53.78 -38.59 85.32 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.466 2.11 . . . . 0.0 112.297 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.37 5.13 31.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.35 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.65 160.75 36.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.288 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.08 164.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 111.242 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -77.93 82.0 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.471 ' CB ' HD12 ' A' ' 80' ' ' ILE . 1.7 m -73.81 146.6 44.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 29' ' ' GLU . 5.3 ttm180 -162.49 159.29 24.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -94.03 137.13 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 28' ' ' TRP . 9.1 mt -72.09 -64.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -109.95 127.59 26.83 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.779 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.13 172.05 59.49 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.214 0.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.92 162.13 41.1 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.573 2.182 . . . . 0.0 112.278 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.02 43.9 94.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.471 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.02 156.39 41.08 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.626 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -67.27 75.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.408 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 33.0 p90 -54.54 151.88 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.055 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 74' ' ' PHE . 5.2 m-85 -173.11 152.57 2.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.629 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -55.31 131.56 45.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.458 ' OG ' HG21 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -52.74 -26.44 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.194 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 3.13 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.377 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -126.92 4.95 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.576 0.227 . . . . 0.0 111.376 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 64' ' ' CYS . 43.0 mt -105.0 153.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 13.2 t0 -107.29 114.84 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.78 10.02 40.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.76 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -108.9 32.27 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -147.42 31.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.763 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -134.68 -47.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.908 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.9 t0 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.787 0.327 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 27' ' ' MET . 23.7 t -63.67 158.67 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.089 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.559 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.19 140.99 24.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.811 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.748 ' O ' HD21 ' A' ' 67' ' ' LEU . 31.1 m95 -131.17 -173.9 3.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.575 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.728 ' OE2' HD23 ' A' ' 67' ' ' LEU . 1.2 pt-20 -153.55 141.9 20.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.597 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' TYR . 12.8 p90 -123.39 141.75 51.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 111.783 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.645 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 16.1 ttpt -130.07 121.73 26.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.96 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -54.55 -48.99 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -97.76 -174.82 2.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -129.68 38.48 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.667 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.24 173.55 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.989 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 -2.37 89.3 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.225 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -112.5 -26.99 8.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.552 0.215 . . . . 0.0 110.94 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.645 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -44.55 153.1 0.17 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.401 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' OE2' ' CE2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -56.26 -177.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 0.0 110.787 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.63 81.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.047 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 30' ' ' TYR . 1.9 m-85 -110.61 -157.07 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.07 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.26 14.81 61.54 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-O 119.098 -0.834 . . . . 0.0 114.392 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 54.6 Cg_endo -70.48 54.75 1.49 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-N 120.083 1.941 . . . . 0.0 111.955 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.6 m-85 -121.73 165.37 15.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 p -60.79 145.3 50.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.872 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.23 -30.36 1.97 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.135 0.493 . . . . 0.0 110.207 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.91 -44.17 90.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.526 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 34.3 tp60 -66.27 -25.64 66.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.782 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 mmm -73.37 -42.85 61.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 1.1 mm-40 -60.75 -34.36 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.884 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 55' ' ' GLU . 44.3 m -61.95 -56.97 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.9 m0 -57.53 -49.16 77.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.763 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.683 HG22 ' HD2' ' A' ' 58' ' ' PHE . 94.7 t -63.56 -45.22 98.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.133 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.6 p -75.46 -29.19 59.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.9 mm-40 -64.71 -28.08 69.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.047 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.22 -24.21 3.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.461 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -56.59 159.68 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.683 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.5 OUTLIER 62.9 61.48 1.99 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.484 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.431 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 51.3 Cg_exo -55.2 -38.46 93.62 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.57 2.18 . . . . 0.0 112.509 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -105.19 5.12 31.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.74 159.02 35.24 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.026 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.92 164.72 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CE2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -76.92 85.44 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.8 m -84.86 146.71 27.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.233 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -163.87 147.05 9.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.084 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.3 mtmp? -84.05 126.44 33.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.748 HD21 ' O ' ' A' ' 28' ' ' TRP . 7.2 mt -57.51 -61.37 2.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.705 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -119.94 136.53 24.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.81 148.82 83.8 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.511 -1.454 . . . . 0.0 112.306 0.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.92 133.17 13.54 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.521 2.148 . . . . 0.0 112.33 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.1 67.88 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.634 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.87 174.19 33.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.421 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -119.99 66.78 0.82 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.125 0.488 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CG ' ' CE2' ' A' ' 63' ' ' TYR . 34.5 m-85 52.78 175.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.36 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.548 ' HB3' HD11 ' A' ' 80' ' ' ILE . 14.1 m-85 -169.06 110.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.657 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -56.34 122.96 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 t -51.7 -29.2 17.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -1.18 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.405 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.59 7.36 8.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.464 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 75' ' ' TYR . 51.2 mt -101.77 152.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 80' ' ' ILE . 32.5 t0 -100.84 114.8 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 52.3 m-85 -97.1 31.78 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.005 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.724 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -136.19 35.09 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.977 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.8 mt -147.85 31.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CE1' ' HE2' ' A' ' 66' ' ' LYS . 94.6 m-85 -137.61 -49.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.897 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 85' ' ' TYR . 20.1 t -57.79 114.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.2 mtp -88.9 135.1 33.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.719 ' O ' HD21 ' A' ' 67' ' ' LEU . 45.0 m95 -123.03 -174.64 2.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.492 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.566 ' CD ' HD22 ' A' ' 67' ' ' LEU . 2.8 mt-10 -155.94 144.39 20.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.815 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 41' ' ' TYR . 47.1 p90 -128.52 135.96 50.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 111.695 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.823 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 4.1 ttpm? -118.16 116.77 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.055 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -56.57 -53.14 61.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.0 110.892 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.67 -174.0 4.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 66.4 t30 -134.2 38.69 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.732 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -107.59 162.38 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.27 -9.35 80.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.17 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -105.31 -25.27 12.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.604 0.24 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.823 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.58 132.98 4.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 111.415 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.6 tt0 -55.81 -177.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.478 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -151.61 120.81 6.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.065 0.46 . . . . 0.0 111.573 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.573 ' O ' ' N ' ' A' ' 30' ' ' TYR . 8.2 m-85 -128.16 -173.03 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.907 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.692 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 98.48 2.22 57.7 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.338 -0.934 . . . . 0.0 115.158 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.844 ' HA ' HD11 ' A' ' 67' ' ' LEU . 83.7 Cg_exo -42.52 -25.68 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.284 2.042 . . . . 0.0 112.886 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' CD2' ' HA2' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -43.28 165.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.365 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -61.89 146.94 48.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.087 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.0 p -47.83 -30.47 4.07 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.148 0.499 . . . . 0.0 110.22 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.64 -48.89 73.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.2 tp60 -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.395 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.516 ' O ' HG23 ' A' ' 53' ' ' VAL . 37.8 mmm -75.46 -43.52 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.939 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.482 ' NE2' ' HB2' ' A' ' 82' ' ' PHE . 3.4 tp-100 -59.25 -28.56 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.09 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' GLU . 86.2 m -71.38 -58.07 3.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.541 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 3.8 m-90 -56.85 -43.2 80.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 49' ' ' MET . 96.8 t -64.76 -47.24 89.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.7 m -75.39 -29.57 59.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.02 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' THR . 3.3 tm-20 -64.74 -34.57 78.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.47 3.05 21.02 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.926 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -54.98 -30.32 58.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.993 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -113.8 81.63 5.96 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 -29.45 43.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -105.15 5.08 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.352 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.92 162.98 29.19 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.173 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.6 m -138.8 164.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.329 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -83.44 90.8 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.231 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -78.19 144.81 36.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.71 138.74 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.566 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -84.02 121.79 27.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' A' ' 43' ' ' PRO . 2.8 mt -53.21 -31.02 41.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.071 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 23.8 t0 -124.4 108.8 29.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 74.3 Cg_endo -75.09 151.0 96.22 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.656 -1.393 . . . . 0.0 112.31 -0.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.15 112.91 3.54 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.602 2.201 . . . . 0.0 112.514 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.46 94.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.84 -136.38 2.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.081 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.52 74.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 111.27 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -54.64 166.56 0.45 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.69 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -168.16 141.15 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.136 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.17 131.36 45.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.656 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.44 ' HB3' HG23 ' A' ' 62' ' ' VAL . 10.9 p -51.61 -26.91 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -78.95 -3.13 43.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.522 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.02 7.01 7.26 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 64' ' ' CYS . 43.5 mt -104.69 152.97 6.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 80' ' ' ILE . 28.8 t0 -111.29 117.59 33.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' HB2' ' NE2' ' A' ' 50' ' ' GLN . 70.9 m-85 -96.67 30.54 2.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.78 ' O ' HD23 ' A' ' 84' ' ' LEU . 8.0 t70 -128.44 30.21 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.778 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.78 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.5 mt -147.05 30.17 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.478 ' HB3' HG21 ' A' ' 26' ' ' VAL . 63.6 m-85 -137.64 -55.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.872 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.863 0.363 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 t -64.5 113.77 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.613 ' CB ' HD12 ' A' ' 67' ' ' LEU . 12.1 mmm -92.55 150.02 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.797 ' O ' HD21 ' A' ' 67' ' ' LEU . 39.7 m95 -133.84 -173.96 3.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' CD ' HD11 ' A' ' 40' ' ' LEU . 13.2 pt-20 -151.76 156.77 40.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.558 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.8 p90 -139.48 146.56 40.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.21 0.528 . . . . 0.0 111.745 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -133.17 120.26 20.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.075 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -59.72 -55.49 33.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 110.999 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.51 160.38 21.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -107.43 39.28 1.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -103.45 161.89 13.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.004 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.75 0.15 88.6 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.111 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -112.39 -26.86 8.52 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 111.115 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.518 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -43.35 146.88 0.43 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.487 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 3.0 mp0 -56.52 -177.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.5 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -145.96 96.66 2.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.239 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-85 -113.65 -161.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.249 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.688 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.61 12.74 68.81 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 118.981 -0.899 . . . . 0.0 114.436 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.8 Cg_endo -70.61 54.63 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 120.136 1.968 . . . . 0.0 112.195 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.3 m-85 -121.46 165.23 15.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 p -57.74 144.44 38.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.995 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -30.47 2.54 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.134 0.493 . . . . 0.0 110.231 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.42 -43.27 86.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.433 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.8 tp60 -66.61 -25.91 66.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.4 mmm -76.12 -47.31 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.086 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -57.59 -31.9 66.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.143 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 55' ' ' GLU . 41.2 m -67.93 -57.31 6.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.607 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.8 m0 -57.72 -46.86 83.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 49' ' ' MET . 98.3 t -61.04 -47.85 91.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.767 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.1 t -75.19 -27.95 59.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.041 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 51' ' ' THR . 7.0 mm-40 -64.75 -38.5 91.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.3 4.0 11.32 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.855 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.85 -30.03 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -116.27 87.59 20.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.733 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.77 -33.73 33.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.4 2.066 . . . . 0.0 112.203 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -105.51 5.23 31.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 88.43 -176.21 44.78 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.102 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 61' ' ' GLY . 5.5 m -156.34 164.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.36 . . . . 0.0 111.262 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -82.02 86.46 6.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.259 179.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.1 m -79.08 155.23 28.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.107 0.48 . . . . 0.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -166.5 155.56 11.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.515 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HE3' ' CH2' ' A' ' 28' ' ' TRP . 4.6 mtmp? -93.72 132.99 37.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.3 mt -65.87 -68.17 0.39 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.787 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -122.76 131.47 24.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.772 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.58 153.81 79.82 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.366 -0.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.83 163.31 31.47 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.597 2.198 . . . . 0.0 112.358 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.58 49.26 0.29 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.637 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -129.99 136.77 9.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.324 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.496 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 64.1 mt-30 -93.0 66.99 4.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.496 ' CG ' ' O ' ' A' ' 73' ' ' GLN . 10.3 p90 51.83 160.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.836 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -165.0 111.7 0.98 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.756 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -58.63 125.38 23.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.2 t -51.96 -32.7 34.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -3.47 36.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.48 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.94 6.29 10.87 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 81' ' ' ASP . 41.1 mt -100.43 154.8 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 111.004 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 80' ' ' ILE . 14.3 t0 -105.42 114.99 29.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -96.59 33.27 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.649 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.2 t0 -134.64 30.9 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.973 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -146.09 30.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -138.44 -56.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.976 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 85' ' ' TYR . 16.2 t -64.44 115.32 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.18 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.604 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -86.83 142.29 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.801 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.825 ' O ' HD21 ' A' ' 67' ' ' LEU . 58.5 m95 -132.89 -174.03 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.823 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.651 ' OE1' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -153.75 157.96 40.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.432 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 16.6 p90 -145.83 134.61 22.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 111.81 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.663 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -119.86 123.65 44.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.997 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -57.03 -50.05 73.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 110.922 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' HG23 ' A' ' 35' ' ' THR . 13.2 mt-10 -86.81 176.64 7.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.67 39.29 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.64 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 33' ' ' GLU . 2.0 p -106.27 165.8 10.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.025 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.58 -2.55 89.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.296 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.85 -26.7 8.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.75 146.0 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.583 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -55.53 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.651 HD23 ' OE1' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -154.6 122.13 5.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' TYR . 2.0 m-85 -132.63 -160.07 1.02 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.014 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.685 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.38 15.12 64.81 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.434 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.2 Cg_endo -70.65 54.61 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 120.112 1.956 . . . . 0.0 111.959 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.09 165.46 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.158 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.2 p -56.11 145.66 25.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.8 t -48.65 -29.97 4.94 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.16 0.505 . . . . 0.0 110.07 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.526 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 37.7 tp60 -73.8 -26.02 60.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.768 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmm -75.02 -47.23 30.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.059 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.418 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 33.8 tp60 -61.16 -34.54 75.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.039 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.5 m -61.38 -53.29 58.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.268 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.429 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 3.5 m0 -58.13 -45.2 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.535 HG22 ' CD2' ' A' ' 58' ' ' PHE . 95.4 t -65.46 -45.76 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.88 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -28.36 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 51' ' ' THR . 5.2 mm-40 -64.89 -37.58 88.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.16 -23.23 1.74 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.643 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -57.84 160.73 4.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 53' ' ' VAL . 1.9 m-85 61.99 74.92 0.46 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.42 -38.92 7.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.231 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -105.22 5.18 31.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.156 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.77 159.02 34.78 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.019 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 58' ' ' PHE . 5.3 m -130.95 164.3 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -79.32 88.56 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.097 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -85.25 150.12 25.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.091 0.472 . . . . 0.0 111.805 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.5 147.64 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.271 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -84.31 140.7 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 111.25 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.825 HD21 ' O ' ' A' ' 28' ' ' TRP . 3.8 mt -74.42 -67.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -119.99 125.41 27.36 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.798 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.05 142.1 73.75 Favored 'Cis proline' 0 C--N 1.348 0.516 0 C-N-CA 123.56 -1.433 . . . . 0.0 112.255 -0.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.32 169.34 21.01 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.487 2.125 . . . . 0.0 112.354 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.2 27.95 2.53 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.747 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.56 134.96 21.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.357 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -111.14 66.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.006 0.432 . . . . 0.0 111.01 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 51.44 103.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.313 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.759 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -125.6 99.17 5.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.73 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.83 123.07 14.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.423 ' HA ' HD12 ' A' ' 80' ' ' ILE . 83.9 p -53.58 -31.05 45.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.072 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -11.23 60.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 10.18 15.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.368 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.759 HD11 ' HB3' ' A' ' 75' ' ' TYR . 93.9 mt -105.0 153.58 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.04 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' N ' HG22 ' A' ' 80' ' ' ILE . 16.2 t0 -109.57 116.23 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 53.8 m-85 -94.25 46.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.757 ' O ' HD23 ' A' ' 84' ' ' LEU . 4.3 t0 -152.06 28.94 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.0 mt -147.6 30.79 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.557 ' HB3' HG21 ' A' ' 26' ' ' VAL . 62.7 m-85 -134.47 -51.02 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 86' ' ' THR . 8.3 t . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.725 0.298 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.68 113.52 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.644 ' CB ' HD12 ' A' ' 67' ' ' LEU . 5.8 mtp -91.02 149.14 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.785 ' O ' HD21 ' A' ' 67' ' ' LEU . 44.3 m95 -133.75 -173.82 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 11.1 pt-20 -151.99 154.41 35.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.234 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.3 p90 -138.94 143.91 38.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.15 0.5 . . . . 0.0 111.98 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 34.2 ttpt -131.2 114.64 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.907 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.444 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 92.0 m95 -56.35 -53.01 62.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.899 0.38 . . . . 0.0 111.026 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.6 OUTLIER -84.86 159.51 20.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.912 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -109.03 38.98 2.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.625 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.6 p -106.65 162.78 13.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.02 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.57 -4.64 85.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -111.03 -22.88 11.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.526 0.203 . . . . 0.0 111.084 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.767 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 111.452 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 23.1 mm-40 -56.3 -175.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -156.45 90.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.97 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 5.0 m-85 -119.92 -160.26 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.302 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 89.37 12.63 62.79 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.645 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.4 Cg_endo -71.01 55.56 1.81 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 120.195 1.998 . . . . 0.0 111.92 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 6.0 m-85 -121.02 165.23 15.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.4 p -59.94 147.68 37.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.4 p -47.32 -32.11 4.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.168 0.509 . . . . 0.0 110.04 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.23 99.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.388 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.467 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 12.0 tp60 -70.01 -25.93 63.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.451 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.676 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -76.11 -46.51 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.983 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -60.45 -33.59 72.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.216 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.9 m -65.21 -57.7 7.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 2.8 m0 -57.73 -45.4 85.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 49' ' ' MET . 59.3 t -65.0 -44.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.786 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.1 t -75.28 -30.29 60.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.967 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.6 mm-40 -64.82 -32.36 74.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.51 3.09 22.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.887 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -57.25 -33.22 67.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.777 0.322 . . . . 0.0 110.854 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -112.32 77.55 2.25 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.682 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.62 -29.21 30.36 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.61 2.206 . . . . 0.0 112.3 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -105.07 -0.6 26.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 161.65 37.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.333 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.54 164.89 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 0.0 111.262 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.64 84.07 5.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.067 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -82.9 145.56 29.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.414 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.4 153.69 29.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.044 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -90.21 135.75 33.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 28' ' ' TRP . 5.3 mt -71.3 -67.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.545 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -121.1 134.14 24.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.715 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.98 149.39 92.02 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.497 -1.46 . . . . 0.0 112.361 0.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.51 138.36 35.28 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.473 2.116 . . . . 0.0 112.371 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.18 78.7 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.582 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.42 136.22 4.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.324 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -97.25 67.76 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.105 0.478 . . . . 0.0 111.113 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 59.27 154.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.093 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HB3' HD11 ' A' ' 80' ' ' ILE . 9.7 m-85 -160.93 105.33 1.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -57.27 127.26 31.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.3 p -52.62 -33.94 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 -7.36 51.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.349 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -113.79 6.26 16.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.651 0.262 . . . . 0.0 111.429 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.625 HD13 ' CZ3' ' A' ' 28' ' ' TRP . 45.8 mt -105.09 153.92 6.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.353 . . . . 0.0 110.996 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 80' ' ' ILE . 17.2 t0 -104.8 115.7 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.82 33.69 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.604 ' O ' HD23 ' A' ' 84' ' ' LEU . 9.4 t70 -139.4 33.07 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 83' ' ' ASP . 7.4 mt -145.91 30.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.7 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.83 -57.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.999 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.842 0.353 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.561 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.5 146.96 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.828 ' O ' HD21 ' A' ' 67' ' ' LEU . 53.0 m95 -132.52 -174.43 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.517 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.624 ' OE1' HD13 ' A' ' 40' ' ' LEU . 11.7 pt-20 -156.93 160.65 39.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.499 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.432 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 36.5 p90 -144.92 133.4 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.674 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 20.3 ttpp -114.58 123.5 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.082 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -55.23 -48.15 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 110.949 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.47 -177.39 3.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -124.65 38.64 4.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 p -105.14 165.23 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.58 -4.05 87.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.274 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.35 -23.7 9.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.598 0.237 . . . . 0.0 111.156 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.46 137.16 2.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.746 0.308 . . . . 0.0 111.523 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -64.42 137.09 57.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.1 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.624 HD13 ' OE1' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -114.27 136.1 53.34 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.626 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' H ' HD23 ' A' ' 40' ' ' LEU . 11.4 m-85 -141.8 -156.5 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.914 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.61 16.32 64.15 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.11 -0.828 . . . . 0.0 114.316 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.1 Cg_endo -70.4 54.6 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 119.976 1.888 . . . . 0.0 111.84 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.494 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m-85 -123.32 166.18 15.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 p -55.37 144.16 26.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.7 p -46.71 -30.28 2.3 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.221 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.67 83.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.536 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.464 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 6.6 tp60 -62.72 -26.22 68.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.66 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.645 ' O ' HG23 ' A' ' 53' ' ' VAL . 36.8 mmm -72.29 -43.19 64.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.281 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.424 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -61.33 -33.86 74.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.258 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -62.88 -58.71 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.3 m-90 -57.66 -46.31 84.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 49' ' ' MET . 60.0 t -64.25 -44.64 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.0 m -75.35 -32.39 60.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 51' ' ' THR . 10.3 tm-20 -64.8 -39.57 93.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.13 2.11 9.27 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.92 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.428 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -55.68 -25.96 42.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.538 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.2 m-85 -121.95 78.67 41.28 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.07 -30.77 46.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.633 2.222 . . . . 0.0 112.355 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -105.18 4.87 31.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.6 162.33 33.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.248 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.45 164.83 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.267 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.95 83.47 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.317 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.484 ' CB ' HD12 ' A' ' 80' ' ' ILE . 1.5 m -76.03 144.93 40.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.77 159.33 35.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.604 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HE2' ' CZ2' ' A' ' 28' ' ' TRP . 15.4 mtmt -95.69 133.3 39.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.719 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.828 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.2 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.797 0.332 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.27 135.13 57.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.0 p -52.82 -28.35 22.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -1.44 43.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -120.48 4.96 10.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.549 0.214 . . . . 0.0 111.489 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.484 HD12 ' CB ' ' A' ' 64' ' ' CYS . 34.6 mt -103.34 151.82 6.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.965 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -98.55 115.54 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 92.3 m-85 -98.59 30.39 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.751 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -134.3 29.05 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.0 mt -147.02 30.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.54 -52.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.878 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.761 0.315 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.584 ' CG ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -100.33 140.49 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.917 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.785 ' O ' HD21 ' A' ' 67' ' ' LEU . 50.0 m95 -134.11 -174.03 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 111.49 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.769 ' CD ' HD11 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -150.4 164.62 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.741 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 6.5 p90 -149.18 140.11 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.48 . . . . 0.0 111.653 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.727 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 5.2 ttmt -130.66 118.48 21.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.001 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -54.3 -49.3 69.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.425 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -94.66 176.31 6.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.822 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -131.21 38.93 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -105.47 -174.56 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.02 68.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.871 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -122.46 -35.51 3.09 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.543 0.211 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.38 134.99 3.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.833 0.349 . . . . 0.0 111.473 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -58.56 -174.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.769 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -141.59 98.63 3.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.085 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 11.2 m-85 -114.05 -162.55 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.684 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.95 10.88 66.03 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 118.959 -0.912 . . . . 0.0 114.71 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.45 55.52 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 120.272 2.036 . . . . 0.0 111.964 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.8 m-85 -122.64 165.59 16.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -58.05 144.61 39.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.7 p -46.7 -31.42 2.92 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.174 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.79 96.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.447 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 2.7 tp60 -66.06 -25.94 67.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.595 ' O ' HG23 ' A' ' 53' ' ' VAL . 34.2 mmm -74.53 -44.69 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.413 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.88 -34.99 73.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.174 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 55' ' ' GLU . 99.3 m -63.13 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.5 m0 -54.96 -45.57 74.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG22 ' HD2' ' A' ' 58' ' ' PHE . 83.9 t -65.36 -47.0 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.218 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m -75.32 -31.84 60.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 tp10 -64.81 -29.45 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.1 3.22 23.15 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.949 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -58.93 -28.21 66.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.644 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 -120.91 80.26 33.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -27.81 17.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.658 2.239 . . . . 0.0 112.448 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 -7.73 19.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.294 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.13 160.09 31.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.387 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.32 164.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 111.181 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.12 84.9 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.284 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.7 m -84.51 148.21 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -165.03 148.42 8.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.788 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.7 mtmp? -84.29 130.1 34.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 28' ' ' TRP . 9.9 mt . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.865 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.779 0.323 . . . . 0.0 110.788 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.88 127.28 31.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 p -52.52 -30.71 31.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -7.37 53.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 6.86 12.95 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.574 0.226 . . . . 0.0 111.399 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 75' ' ' TYR . 52.3 mt -104.38 153.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 0.0 111.053 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -102.12 115.67 31.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.754 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HE2' HG11 ' A' ' 53' ' ' VAL . 22.3 m-85 -96.7 35.53 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.7 m-20 -137.35 28.05 2.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.2 mt -146.51 30.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -133.53 -53.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.927 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 t . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.756 0.313 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.543 ' CB ' HD12 ' A' ' 67' ' ' LEU . 14.1 mtp -83.71 140.41 32.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.723 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.827 ' O ' HD21 ' A' ' 67' ' ' LEU . 51.8 m95 -124.55 -174.26 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 1.3 tt0 -153.04 145.23 23.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.425 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' TYR . 16.0 p90 -133.76 135.06 43.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.089 0.471 . . . . 0.0 111.983 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.791 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 5.8 ttpm? -119.8 129.31 54.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.941 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -59.53 -50.69 72.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.458 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -125.47 135.85 52.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.251 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -76.74 61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -111.85 168.28 9.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.14 -2.15 86.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.498 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.33 -28.1 6.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.653 0.264 . . . . 0.0 111.172 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -46.97 125.61 7.75 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 111.396 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 2.6 mm-40 -60.46 -177.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.94 125.78 17.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.209 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -135.93 -160.37 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.215 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.686 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.81 15.2 65.94 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-O 119.069 -0.851 . . . . 0.0 114.304 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.3 Cg_endo -70.63 54.6 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 119.996 1.898 . . . . 0.0 111.925 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.3 m-85 -125.43 165.46 18.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.025 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.7 p -55.11 144.36 24.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.984 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -46.38 -30.86 2.3 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.166 0.508 . . . . 0.0 110.257 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.65 88.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.475 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 19.1 tp60 -65.36 -26.3 67.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.627 ' O ' HG23 ' A' ' 53' ' ' VAL . 27.1 mmm -76.06 -45.86 32.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.037 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -58.95 -30.37 67.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.919 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.4 m -67.8 -58.68 4.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.435 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.448 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 4.1 m0 -55.72 -43.44 76.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.693 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 49' ' ' MET . 72.0 t -63.91 -48.23 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.858 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -75.3 -28.47 59.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.028 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.9 mt-10 -64.74 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.15 -1.09 19.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.845 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -29.86 61.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.48 78.39 28.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.635 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.84 -28.8 42.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -105.09 5.18 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.66 159.82 24.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.213 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.46 164.85 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.849 0.357 . . . . 0.0 111.209 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.22 83.45 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.585 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -74.93 144.81 43.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.243 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -159.39 143.52 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.015 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.438 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 9.7 mtmt -84.09 130.47 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.98 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 28' ' ' TRP . 7.0 mt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.801 0.334 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -59.77 126.45 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 t -52.04 -31.05 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -7.6 53.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.07 7.03 12.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.449 HD12 ' CB ' ' A' ' 64' ' ' CYS . 41.6 mt -104.36 153.33 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.014 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 12.4 t0 -99.43 114.9 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.47 38.44 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.756 ' O ' HD23 ' A' ' 84' ' ' LEU . 5.5 t70 -143.6 30.73 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -147.5 30.95 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.33 -49.98 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.883 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 t . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.783 0.325 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.672 ' CB ' HD12 ' A' ' 67' ' ' LEU . 4.4 mtp -88.32 144.56 26.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.796 ' O ' HD21 ' A' ' 67' ' ' LEU . 40.3 m95 -134.39 -173.68 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 13.4 pt-20 -156.6 146.76 21.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.641 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 41' ' ' TYR . 34.0 p90 -128.94 144.23 51.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.139 0.495 . . . . 0.0 111.854 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 28.0 ttpt -125.84 115.58 20.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -54.37 -51.25 65.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.978 0.418 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.98 177.76 7.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.7 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -132.49 42.74 3.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.69 178.26 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.893 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.81 9.86 75.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.196 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.17 -28.1 3.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.549 0.214 . . . . 0.0 111.163 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -42.71 137.97 2.06 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.751 0.31 . . . . 0.0 111.612 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.96 -177.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.485 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.84 115.78 6.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.113 0.483 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -121.0 -158.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.056 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 82.75 17.61 67.61 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.293 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -70.32 54.01 1.35 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 119.91 1.855 . . . . 0.0 112.035 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.449 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.2 165.59 16.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -57.45 144.99 34.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.904 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t -47.03 -30.14 2.49 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.145 0.498 . . . . 0.0 110.135 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.51 86.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 38.6 tp60 -68.85 -26.35 65.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.66 ' O ' HG23 ' A' ' 53' ' ' VAL . 26.8 mmm -75.86 -47.88 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.411 ' OE1' ' CG ' ' A' ' 82' ' ' PHE . 36.4 tp60 -58.81 -31.83 68.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.166 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 55' ' ' GLU . 89.1 m -65.9 -54.5 25.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.4 m0 -58.86 -43.29 90.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.488 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 49' ' ' MET . 61.9 t -65.07 -46.27 91.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.404 ' HB3' ' NE2' ' A' ' 50' ' ' GLN . 17.7 p -75.27 -28.53 59.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.887 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' THR . 20.8 mm-40 -64.81 -29.79 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.03 26.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.935 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -58.26 -33.32 69.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.327 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.53 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -113.61 83.23 6.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.32 -27.21 19.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.568 2.179 . . . . 0.0 112.483 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -105.19 -7.86 18.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.38 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.09 160.76 31.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.196 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 m -137.93 164.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 82.07 7.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -75.63 144.62 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.303 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -156.75 153.99 29.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.028 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -91.14 131.58 36.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.796 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.4 mt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.696 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.683 ' HB3' HD11 ' A' ' 80' ' ' ILE . 5.2 m-85 . . . . . 0 N--CA 1.46 0.054 0 CA-C-O 120.75 0.31 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.92 124.52 20.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.788 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -51.21 -34.1 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.255 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -72.64 -8.17 53.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.299 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 7.11 14.1 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 75' ' ' TYR . 40.4 mt -105.05 153.75 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.918 0.389 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 80' ' ' ILE . 10.4 t0 -101.82 114.89 29.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.785 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' ' OE1' ' A' ' 50' ' ' GLN . 96.4 m-85 -96.69 29.84 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.085 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.85 ' O ' HD23 ' A' ' 84' ' ' LEU . 32.0 m-20 -130.07 23.61 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -144.88 30.05 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.1 -52.96 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 86' ' ' THR . 5.2 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.736 0.303 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.568 ' CB ' HD12 ' A' ' 67' ' ' LEU . 8.6 mtp -81.44 148.45 29.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.657 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.83 ' O ' HD21 ' A' ' 67' ' ' LEU . 56.0 m95 -129.12 -174.16 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -152.43 156.6 39.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.654 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.1 p90 -143.62 146.74 33.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 111.788 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.758 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 38.5 ttpt -134.5 123.34 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.149 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 58.2 m95 -67.45 -59.99 2.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.318 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -85.4 134.65 34.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.455 ' ND2' ' CE2' ' A' ' 63' ' ' TYR . 8.7 t-20 -90.46 51.46 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -113.83 176.11 5.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.994 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.59 86.03 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.994 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -116.42 -30.74 5.8 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.564 0.221 . . . . 0.0 111.02 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.758 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.61 129.33 5.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.43 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.34 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.499 HD11 ' HD3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -138.35 97.4 3.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.241 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.436 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 9.5 m-85 -111.33 -162.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.333 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.02 12.22 62.23 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 119.026 -0.874 . . . . 0.0 114.523 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 58.1 Cg_endo -71.5 54.87 1.97 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 120.21 2.005 . . . . 0.0 111.959 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -120.38 165.24 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -56.65 141.07 44.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.021 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -46.88 -30.97 2.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.179 0.514 . . . . 0.0 110.253 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.81 86.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.434 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.4 tp-100 -66.46 -25.57 66.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.678 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.9 mmm -74.34 -43.07 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.144 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 2.9 tp-100 -59.41 -37.34 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.996 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.3 m -62.19 -59.28 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m0 -55.53 -51.76 65.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 49' ' ' MET . 84.0 t -55.83 -50.51 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 t -75.27 -25.61 58.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.67 -26.02 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.71 2.79 37.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.766 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.52 -33.56 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -112.08 80.02 3.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.756 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.65 -28.65 37.33 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.462 2.108 . . . . 0.0 112.184 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.09 3.68 30.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.263 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.36 163.52 34.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.244 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.7 m -139.3 164.81 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -83.58 89.32 7.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.273 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -80.42 151.54 29.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.636 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.499 ' HD3' HD11 ' A' ' 40' ' ' LEU . 8.5 ptm180 -165.43 146.33 7.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.505 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -84.44 139.86 31.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 28' ' ' TRP . 5.2 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -63.36 127.14 29.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 62' ' ' VAL . 12.2 p -51.96 -27.52 13.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -79.14 -1.72 37.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.544 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.89 8.11 7.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-O 120.553 0.216 . . . . 0.0 111.461 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 81' ' ' ASP . 57.0 mt -105.09 154.58 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.882 0.373 . . . . 0.0 111.192 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.433 ' N ' HG22 ' A' ' 80' ' ' ILE . 32.7 t0 -108.25 116.26 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.542 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CB ' ' HB2' ' A' ' 50' ' ' GLN . 73.8 m-85 -95.92 28.07 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.648 ' O ' HD23 ' A' ' 84' ' ' LEU . 7.9 t70 -124.08 30.47 6.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -144.92 29.27 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -140.54 -46.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.96 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.829 0.347 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.581 ' CB ' HD12 ' A' ' 67' ' ' LEU . 70.1 mmm -89.88 136.99 32.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.713 ' O ' HD21 ' A' ' 67' ' ' LEU . 35.3 m95 -127.29 -173.49 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.27 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 mt-10 -146.2 161.04 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.752 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.5 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 5.1 p90 -145.03 146.83 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.599 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.727 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -135.71 119.92 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -56.47 -51.51 68.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.25 176.95 6.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -120.98 38.82 3.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.57 160.25 15.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.28 -5.07 80.84 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.309 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -110.85 -23.91 10.73 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.573 0.225 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.71 149.96 0.27 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 75.2 mm-40 -55.23 152.6 7.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -123.92 89.93 3.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.317 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 15.8 m-85 -113.36 -164.39 0.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.287 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.04 8.89 64.34 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 119.003 -0.887 . . . . 0.0 114.731 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.5 Cg_endo -70.97 55.08 1.73 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.255 2.027 . . . . 0.0 112.096 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.7 m-85 -121.0 165.39 15.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.131 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -56.16 143.82 31.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.961 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.64 -30.49 2.35 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.24 -43.35 86.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.476 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 30.1 tp60 -65.98 -25.89 67.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.733 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.644 ' O ' HG23 ' A' ' 53' ' ' VAL . 34.7 mmm -74.18 -51.22 16.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.527 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.12 -33.02 64.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 55' ' ' GLU . 33.0 m -64.54 -59.06 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.715 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.0 m0 -56.18 -43.7 78.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.881 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 49' ' ' MET . 58.5 t -61.88 -51.01 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.029 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -75.4 -26.35 58.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.6 mm-40 -64.74 -29.46 70.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.21 0.3 23.8 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.856 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.439 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 1.5 m-85 -59.96 -31.75 70.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 110.826 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.589 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -117.27 75.81 8.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.1 -30.21 47.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.468 2.112 . . . . 0.0 112.262 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -105.28 5.03 31.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.24 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.18 160.55 29.53 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.145 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.1 m -135.15 164.57 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 0.0 111.241 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.18 88.43 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.036 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -85.11 150.12 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 111.629 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.24 151.6 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -84.38 139.78 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.8 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.751 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.765 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.746 0.308 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -57.25 122.36 12.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.423 ' HB3' HG23 ' A' ' 62' ' ' VAL . 8.3 p -53.19 -28.76 28.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.46 49.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.301 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 7.13 11.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 75' ' ' TYR . 58.5 mt -101.97 153.27 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 17.0 t0 -103.47 114.83 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.25 22.38 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.053 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.783 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -119.35 27.22 8.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.712 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.0 mt -145.82 29.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.65 -56.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.846 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.423 HG23 ' OXT' ' A' ' 86' ' ' THR . 1.9 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.788 0.327 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.529 ' CB ' HD12 ' A' ' 67' ' ' LEU . 26.3 mtp -83.22 144.02 30.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.726 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.806 ' O ' HD21 ' A' ' 67' ' ' LEU . 51.3 m95 -126.86 -174.05 3.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' CD ' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -152.07 155.79 38.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.722 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -140.97 143.38 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.041 0.448 . . . . 0.0 111.606 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.671 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 7.5 ttpt -130.86 119.48 22.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.145 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -54.29 -46.89 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.95 173.42 7.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 63' ' ' TYR . 2.8 p30 -120.79 39.24 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.688 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -108.13 176.25 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.49 -4.95 76.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.14 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.28 -24.1 10.43 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.558 0.218 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.33 159.2 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -57.22 -177.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.13 84.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.168 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 16.5 m-85 -114.81 -162.57 0.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.227 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.687 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.27 11.58 60.95 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.519 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -71.39 55.15 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.183 1.991 . . . . 0.0 111.997 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 4.0 m-85 -120.11 165.3 14.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -54.96 141.96 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 86.9 p -47.67 -30.31 3.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.18 0.514 . . . . 0.0 110.21 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.3 83.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.483 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.5 tp-100 -68.97 -25.85 64.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.585 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 40.6 mmm -76.0 -45.1 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.869 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.96 -33.04 71.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.681 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -64.03 -56.04 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.466 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 5.5 m0 -58.04 -47.39 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.594 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 58' ' ' PHE . 79.8 t -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.886 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -75.28 -33.74 61.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.679 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 51' ' ' THR . 11.3 mt-10 -64.93 -37.3 87.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.26 4.19 14.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.784 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.436 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -53.47 -32.24 49.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.34 . . . . 0.0 110.933 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -114.0 78.73 4.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.733 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 -28.52 51.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.49 2.127 . . . . 0.0 112.201 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.18 5.24 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.246 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.16 162.92 27.11 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.154 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 m -138.49 164.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 111.281 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -79.25 84.45 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.357 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -77.59 144.6 37.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.019 0.438 . . . . 0.0 111.449 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -157.52 142.32 16.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 11.0 mtmt -83.91 139.0 32.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.999 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.806 HD21 ' O ' ' A' ' 28' ' ' TRP . 2.6 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.82 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.819 0.343 . . . . 0.0 110.897 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -59.43 124.74 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.2 p -52.45 -34.22 47.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -64.0 -15.6 59.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.203 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.1 7.83 18.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.387 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 75' ' ' TYR . 54.3 mt -105.04 153.6 6.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.535 ' OD2' HD11 ' A' ' 84' ' ' LEU . 8.3 t0 -104.51 127.63 52.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.611 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -108.82 26.47 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.313 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.803 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -139.94 31.34 2.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.88 0.371 . . . . 0.0 110.892 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.803 HD23 ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -145.28 30.51 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.774 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -133.34 -49.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.954 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.926 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.406 HG12 ' NE1' ' A' ' 28' ' ' TRP . 32.7 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.872 0.368 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.472 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.0 139.9 38.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.673 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.811 ' O ' HD21 ' A' ' 67' ' ' LEU . 58.2 m95 -123.42 -174.14 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.57 ' CD ' HD22 ' A' ' 67' ' ' LEU . 1.5 mt-10 -154.84 137.51 15.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.752 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 41' ' ' TYR . 15.6 p90 -122.32 148.91 44.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.216 0.531 . . . . 0.0 111.923 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.523 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 6.1 ttmm -136.07 120.41 17.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.978 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 110.882 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -178.12 5.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.811 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -124.74 39.48 3.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.765 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -101.95 -166.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.91 -5.87 40.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.341 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.8 -19.26 8.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.525 0.202 . . . . 0.0 111.411 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -44.14 154.81 0.1 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.775 0.322 . . . . 0.0 111.526 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 3.5 pm0 -51.06 135.95 24.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.075 0.464 . . . . 0.0 111.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -121.99 78.64 1.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.043 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' TYR . 3.3 m-85 -106.66 -159.55 0.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.683 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.42 14.22 58.9 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 119.157 -0.802 . . . . 0.0 114.4 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 55.4 Cg_endo -71.19 55.13 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.041 1.921 . . . . 0.0 111.96 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CD1' ' CZ3' ' A' ' 52' ' ' TRP . 3.1 m-85 -123.0 165.62 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -62.35 149.62 41.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.99 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 t -45.86 -31.23 2.02 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.158 0.504 . . . . 0.0 110.165 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.42 72.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.28 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 22.4 tp60 -63.7 -25.74 68.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.613 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.661 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.04 -45.97 62.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.284 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -33.81 72.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.124 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' GLU . 74.2 m -60.99 -62.41 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.432 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 3.1 m-90 -54.88 -44.13 73.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.921 0.391 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.706 HG22 ' HD2' ' A' ' 58' ' ' PHE . 62.1 t -65.06 -49.29 80.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 t -75.24 -28.35 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' THR . 14.6 tp10 -65.0 -43.78 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.31 -6.0 4.97 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.94 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -53.85 -35.89 62.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.706 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -114.11 78.31 4.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.72 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -35.17 16.68 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.589 2.193 . . . . 0.0 112.39 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -104.9 4.95 32.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.275 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.71 160.25 36.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.333 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.93 164.87 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -78.84 86.9 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.306 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.525 ' CB ' HD12 ' A' ' 80' ' ' ILE . 6.8 m -82.83 146.24 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.64 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -161.73 144.49 11.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.047 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 1.5 mtmp? -84.0 133.19 34.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.893 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.811 HD21 ' O ' ' A' ' 28' ' ' TRP . 3.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.487 ' HB3' HD11 ' A' ' 80' ' ' ILE . 2.5 m-85 . . . . . 0 C--O 1.228 -0.034 0 CA-C-O 120.786 0.327 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -54.52 126.59 24.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.181 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -52.45 -34.96 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -8.63 56.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.032 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -112.46 5.93 18.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.27 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' A' ' 64' ' ' CYS . 69.0 mt -105.11 154.29 6.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.867 0.365 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 80' ' ' ILE . 6.9 t0 -107.0 117.06 33.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -96.68 27.94 3.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.028 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.677 ' O ' HD23 ' A' ' 84' ' ' LEU . 15.4 t70 -133.41 31.04 3.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.767 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.9 mt -146.56 30.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -137.89 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.876 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.754 0.312 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.492 ' HB2' HD12 ' A' ' 67' ' ' LEU . 35.2 mmm -84.0 140.45 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.768 ' O ' HD21 ' A' ' 67' ' ' LEU . 46.0 m95 -123.1 -175.67 3.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.012 0.434 . . . . 0.0 111.249 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HG2' HD23 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -150.47 161.03 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.941 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.96 139.1 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.179 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.695 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 25.9 ttmt -128.58 123.89 34.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -55.82 -47.77 76.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB3' HG23 ' A' ' 35' ' ' THR . 4.7 mt-10 -98.49 176.59 5.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.86 39.54 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.838 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.6 p -106.2 176.53 5.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.48 -2.86 72.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.219 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.59 -25.57 9.07 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.561 0.22 . . . . 0.0 111.016 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.23 157.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.849 0.357 . . . . 0.0 111.435 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -55.24 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 86.44 1.15 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.492 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 10.1 m-85 -115.36 -174.16 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 102.68 -5.89 51.66 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.146 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 88.3 Cg_exo -41.53 -25.3 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.329 2.065 . . . . 0.0 113.139 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.425 ' CD2' ' CZ3' ' A' ' 52' ' ' TRP . 1.2 m-85 -42.53 165.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.308 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 p -64.32 147.06 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 36.5 p -47.31 -30.16 2.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.225 0.536 . . . . 0.0 110.204 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.96 80.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.644 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.434 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.6 tp60 -68.32 -26.41 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . 26.5 mmm -69.57 -52.3 27.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -60.77 -29.42 69.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.205 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' GLU . 52.9 m -59.92 -57.43 12.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.215 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.434 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m-90 -56.2 -43.0 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.767 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG22 ' CD2' ' A' ' 58' ' ' PHE . 47.8 t -65.36 -48.51 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -29.59 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' THR . 1.0 OUTLIER -64.98 -45.17 86.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.037 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.64 -24.32 0.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.14 162.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 60.08 65.59 2.29 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.93 -34.21 91.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.495 2.13 . . . . 0.0 112.138 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -105.32 -6.21 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.93 159.37 27.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.141 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.407 HG11 ' CD1' ' A' ' 58' ' ' PHE . 12.0 m -133.48 164.63 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.993 0.425 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.19 86.99 4.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.519 ' CB ' HD12 ' A' ' 80' ' ' ILE . 2.7 m -83.47 153.57 24.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.421 . . . . 0.0 111.255 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.71 152.88 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.796 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.52 126.72 33.55 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.538 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.768 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.8 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.251 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.867 0.365 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -61.58 137.3 58.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 62' ' ' VAL . 54.7 p -54.56 -26.61 33.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -81.95 -0.12 42.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.9 5.83 9.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.588 0.232 . . . . 0.0 111.484 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 64' ' ' CYS . 46.6 mt -104.77 152.68 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.451 ' OD2' HD11 ' A' ' 84' ' ' LEU . 33.6 t0 -109.41 120.34 42.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 50' ' ' GLN . 37.0 m-85 -101.35 30.59 4.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.809 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.6 t0 -132.43 28.27 4.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -145.29 31.23 1.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.95 -49.74 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.892 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.814 0.34 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.619 ' CB ' HD12 ' A' ' 67' ' ' LEU . 11.8 mtp -84.28 147.66 27.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.821 ' O ' HD21 ' A' ' 67' ' ' LEU . 47.0 m95 -132.72 -173.81 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 pt-20 -149.87 162.06 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.74 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -146.7 141.29 26.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 111.682 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.625 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 4.0 ttmt -131.39 122.86 27.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.25 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -58.41 -51.9 67.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 0.0 110.945 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HB3' HG23 ' A' ' 35' ' ' THR . 5.0 mt-10 -78.58 161.57 26.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.1 38.68 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.4 p -104.91 -166.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.71 0.19 26.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.113 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.91 -29.78 7.52 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.525 0.202 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -39.69 157.26 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.874 0.368 . . . . 0.0 111.709 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 1.6 mm-40 -59.79 -176.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -146.65 107.09 4.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -124.27 -162.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.223 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.677 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.49 12.5 69.63 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 118.992 -0.893 . . . . 0.0 114.686 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.7 Cg_endo -70.22 54.91 1.41 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 120.27 2.035 . . . . 0.0 112.056 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.447 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -121.28 165.43 15.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.024 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.8 p -57.41 142.58 43.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -46.82 -30.44 2.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.081 0.467 . . . . 0.0 110.284 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.48 89.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.629 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.438 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 36.1 tp60 -68.56 -25.84 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.846 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.3 mmm -75.96 -44.37 40.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 37.3 tp60 -58.99 -38.85 80.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.314 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' GLU . 92.6 m -62.4 -57.31 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.582 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.8 m0 -53.89 -42.71 68.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.003 0.43 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.595 HG22 ' HD2' ' A' ' 58' ' ' PHE . 73.7 t -65.34 -50.48 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -28.98 60.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.1 tt0 -64.72 -26.52 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.055 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.76 2.83 28.72 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.927 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.419 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.8 -27.45 66.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.816 0.341 . . . . 0.0 111.027 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.595 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 -121.73 78.68 39.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.22 -36.81 99.11 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.551 2.167 . . . . 0.0 112.378 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.52 5.1 31.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.335 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 86.24 -173.61 46.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.141 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 61' ' ' GLY . 6.4 m -158.85 164.7 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 0.0 111.215 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 84.9 2.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.188 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.4 m -84.19 147.79 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.78 153.55 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.034 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CE ' ' CZ2' ' A' ' 28' ' ' TRP . 10.2 mttt -85.95 138.79 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.3 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.633 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.542 ' HB3' HD11 ' A' ' 80' ' ' ILE . 3.0 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.751 0.31 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.37 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.6 p -51.55 -31.51 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -7.48 52.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.388 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -117.61 7.79 12.7 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 75' ' ' TYR . 53.6 mt -105.0 152.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.87 0.367 . . . . 0.0 111.063 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' HG22 ' A' ' 80' ' ' ILE . 27.4 t0 -104.82 116.9 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 68.1 m-85 -96.88 30.86 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.784 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.3 m-20 -132.4 26.86 4.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.784 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.3 mt -147.0 30.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -137.58 -52.07 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.904 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.837 0.351 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.622 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.71 143.51 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.872 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.816 ' O ' HD21 ' A' ' 67' ' ' LEU . 57.2 m95 -135.95 -174.17 3.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.644 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HG2' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.65 147.54 18.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.57 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.44 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 27.4 p90 -131.37 140.54 49.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.397 . . . . 0.0 111.544 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.705 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 16.0 ttpt -123.76 123.13 39.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.2 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -58.11 -52.48 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.66 172.54 9.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.116 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.406 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 62.8 t-20 -118.02 40.33 3.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.73 -177.78 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.978 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.53 -9.55 61.39 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.154 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -112.87 -17.3 12.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.481 0.182 . . . . 0.0 111.347 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.705 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.06 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.833 0.349 . . . . 0.0 111.501 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -55.44 -177.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.86 85.86 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.36 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 6.6 m-85 -118.72 -159.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.39 14.77 61.37 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.303 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.97 54.5 1.65 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 119.933 1.866 . . . . 0.0 112.011 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.452 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.9 m-85 -123.21 165.29 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.085 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -56.92 145.15 30.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.028 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 p -47.76 -30.16 3.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.168 0.509 . . . . 0.0 110.081 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.68 -41.51 92.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.374 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.461 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 5.3 tp60 -68.72 -26.07 65.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.775 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.431 ' O ' HG23 ' A' ' 53' ' ' VAL . 15.1 mmm -76.35 -51.01 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.314 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -55.79 -32.03 63.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.027 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.8 m -65.38 -64.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.514 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.461 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.6 m0 -49.02 -42.74 39.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.494 HG22 ' HD2' ' A' ' 58' ' ' PHE . 81.5 t -62.64 -58.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.507 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.7 p -75.23 -24.75 57.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.756 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -64.66 -46.38 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 111.185 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.33 -31.18 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.416 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -57.59 156.83 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 110.82 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.494 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 63.19 61.74 1.84 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 50.8 Cg_exo -53.78 -38.59 85.32 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.466 2.11 . . . . 0.0 112.297 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.37 5.13 31.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.35 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.65 160.75 36.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.288 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.08 164.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 111.242 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -77.93 82.0 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.471 ' CB ' HD12 ' A' ' 80' ' ' ILE . 1.7 m -73.81 146.6 44.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 29' ' ' GLU . 5.3 ttm180 -162.49 159.29 24.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -94.03 137.13 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 28' ' ' TRP . 9.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.824 0.345 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -55.31 131.56 45.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.458 ' OG ' HG21 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -52.74 -26.44 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.194 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 3.13 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.377 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -126.92 4.95 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.576 0.227 . . . . 0.0 111.376 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 64' ' ' CYS . 43.0 mt -105.0 153.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 13.2 t0 -107.29 114.84 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.78 10.02 40.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.76 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -108.9 32.27 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -147.42 31.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.763 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -134.68 -47.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.908 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 27' ' ' MET . 23.7 t . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.912 0.386 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.559 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.19 140.99 24.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.811 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.748 ' O ' HD21 ' A' ' 67' ' ' LEU . 31.1 m95 -131.17 -173.9 3.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.575 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.728 ' OE2' HD23 ' A' ' 67' ' ' LEU . 1.2 pt-20 -153.55 141.9 20.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.597 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' TYR . 12.8 p90 -123.39 141.75 51.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 111.783 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.645 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 16.1 ttpt -130.07 121.73 26.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.96 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -54.55 -48.99 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -97.76 -174.82 2.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -129.68 38.48 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.667 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.24 173.55 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.989 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 -2.37 89.3 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.225 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -112.5 -26.99 8.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.552 0.215 . . . . 0.0 110.94 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.645 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -44.55 153.1 0.17 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.401 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' OE2' ' CE2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -56.26 -177.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 0.0 110.787 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.63 81.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.047 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 30' ' ' TYR . 1.9 m-85 -110.61 -157.07 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.07 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.26 14.81 61.54 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-O 119.098 -0.834 . . . . 0.0 114.392 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 54.6 Cg_endo -70.48 54.75 1.49 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-N 120.083 1.941 . . . . 0.0 111.955 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.6 m-85 -121.73 165.37 15.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 p -60.79 145.3 50.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.872 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.23 -30.36 1.97 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.135 0.493 . . . . 0.0 110.207 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.91 -44.17 90.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.526 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.8 tp-100 -66.27 -25.64 66.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.782 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 mmm -73.37 -42.85 61.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 1.1 mm-40 -60.75 -34.36 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.884 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 55' ' ' GLU . 44.3 m -61.95 -56.97 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.9 m0 -57.53 -49.16 77.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.763 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.683 HG22 ' HD2' ' A' ' 58' ' ' PHE . 94.7 t -63.56 -45.22 98.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.133 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.6 p -75.46 -29.19 59.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.9 mm-40 -64.71 -28.08 69.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.047 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.22 -24.21 3.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.461 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -56.59 159.68 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.683 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.5 OUTLIER 62.9 61.48 1.99 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.484 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.431 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 51.3 Cg_exo -55.2 -38.46 93.62 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.57 2.18 . . . . 0.0 112.509 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -105.19 5.12 31.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.74 159.02 35.24 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.026 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.92 164.72 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.92 85.44 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.8 m -84.86 146.71 27.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.233 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -163.87 147.05 9.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.084 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.3 mtmp? -84.05 126.44 33.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.748 HD21 ' O ' ' A' ' 28' ' ' TRP . 7.2 mt . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.705 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.548 ' HB3' HD11 ' A' ' 80' ' ' ILE . 14.1 m-85 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.755 0.312 . . . . 0.0 110.657 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -56.34 122.96 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 t -51.7 -29.2 17.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -1.18 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.405 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.59 7.36 8.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.464 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 75' ' ' TYR . 51.2 mt -101.77 152.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 80' ' ' ILE . 32.5 t0 -100.84 114.8 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 52.3 m-85 -97.1 31.78 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.005 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.724 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -136.19 35.09 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.977 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.8 mt -147.85 31.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CE1' ' HE2' ' A' ' 66' ' ' LYS . 94.6 m-85 -137.61 -49.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.897 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 85' ' ' TYR . 20.1 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.814 0.34 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.2 mtp -88.9 135.1 33.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.719 ' O ' HD21 ' A' ' 67' ' ' LEU . 45.0 m95 -123.03 -174.64 2.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.492 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.566 ' CD ' HD22 ' A' ' 67' ' ' LEU . 2.8 mt-10 -155.94 144.39 20.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.815 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 41' ' ' TYR . 47.1 p90 -128.52 135.96 50.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 111.695 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.823 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 4.1 ttpm? -118.16 116.77 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.055 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -56.57 -53.14 61.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.0 110.892 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.67 -174.0 4.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 66.4 t30 -134.2 38.69 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.732 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -107.59 162.38 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.27 -9.35 80.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.17 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -105.31 -25.27 12.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.604 0.24 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.823 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.58 132.98 4.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 111.415 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.6 tt0 -55.81 -177.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.478 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -151.61 120.81 6.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.065 0.46 . . . . 0.0 111.573 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.573 ' O ' ' N ' ' A' ' 30' ' ' TYR . 8.2 m-85 -128.16 -173.03 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.907 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.692 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 98.48 2.22 57.7 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.338 -0.934 . . . . 0.0 115.158 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.844 ' HA ' HD11 ' A' ' 67' ' ' LEU . 83.7 Cg_exo -42.52 -25.68 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.284 2.042 . . . . 0.0 112.886 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' CD2' ' HA2' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -43.28 165.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.365 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -61.89 146.94 48.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.087 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.0 p -47.83 -30.47 4.07 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.148 0.499 . . . . 0.0 110.22 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.64 -48.89 73.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.2 tp60 -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.395 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.516 ' O ' HG23 ' A' ' 53' ' ' VAL . 37.8 mmm -75.46 -43.52 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.939 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -59.25 -28.56 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.09 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' GLU . 86.2 m -71.38 -58.07 3.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.541 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 3.8 m-90 -56.85 -43.2 80.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 49' ' ' MET . 96.8 t -64.76 -47.24 89.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.7 m -75.39 -29.57 59.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.02 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' THR . 3.3 tm-20 -64.74 -34.57 78.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.47 3.05 21.02 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.926 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -54.98 -30.32 58.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.993 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -113.8 81.63 5.96 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 -29.45 43.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -105.15 5.08 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.352 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.92 162.98 29.19 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.173 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.6 m -138.8 164.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.329 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -83.44 90.8 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.231 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -78.19 144.81 36.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.71 138.74 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.566 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -84.02 121.79 27.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' A' ' 43' ' ' PRO . 2.8 mt . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.071 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.898 0.38 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.17 131.36 45.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.656 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.44 ' HB3' HG23 ' A' ' 62' ' ' VAL . 10.9 p -51.61 -26.91 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -78.95 -3.13 43.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.522 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.02 7.01 7.26 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 64' ' ' CYS . 43.5 mt -104.69 152.97 6.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 80' ' ' ILE . 28.8 t0 -111.29 117.59 33.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -96.67 30.54 2.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.78 ' O ' HD23 ' A' ' 84' ' ' LEU . 8.0 t70 -128.44 30.21 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.778 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.78 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.5 mt -147.05 30.17 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.478 ' HB3' HG21 ' A' ' 26' ' ' VAL . 63.6 m-85 -137.64 -55.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.872 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.613 ' CB ' HD12 ' A' ' 67' ' ' LEU . 12.1 mmm -92.55 150.02 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.797 ' O ' HD21 ' A' ' 67' ' ' LEU . 39.7 m95 -133.84 -173.96 3.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.5 ' CD ' HD11 ' A' ' 40' ' ' LEU . 13.2 pt-20 -151.76 156.77 40.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.558 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.8 p90 -139.48 146.56 40.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.21 0.528 . . . . 0.0 111.745 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -133.17 120.26 20.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.075 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -59.72 -55.49 33.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 110.999 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.51 160.38 21.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -107.43 39.28 1.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -103.45 161.89 13.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.004 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.75 0.15 88.6 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.111 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -112.39 -26.86 8.52 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 111.115 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.518 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -43.35 146.88 0.43 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.487 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 3.0 mp0 -56.52 -177.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.5 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -145.96 96.66 2.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.239 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.454 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-85 -113.65 -161.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.249 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.688 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.61 12.74 68.81 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 118.981 -0.899 . . . . 0.0 114.436 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.8 Cg_endo -70.61 54.63 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 120.136 1.968 . . . . 0.0 112.195 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.3 m-85 -121.46 165.23 15.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 p -57.74 144.44 38.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.995 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -30.47 2.54 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.134 0.493 . . . . 0.0 110.231 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.42 -43.27 86.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.433 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.8 tp60 -66.61 -25.91 66.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.4 mmm -76.12 -47.31 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.086 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -57.59 -31.9 66.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.143 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 55' ' ' GLU . 41.2 m -67.93 -57.31 6.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.607 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.8 m0 -57.72 -46.86 83.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 49' ' ' MET . 98.3 t -61.04 -47.85 91.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.767 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.1 t -75.19 -27.95 59.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.041 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 51' ' ' THR . 7.0 mm-40 -64.75 -38.5 91.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.3 4.0 11.32 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.855 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.85 -30.03 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -116.27 87.59 20.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.733 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.77 -33.73 33.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.4 2.066 . . . . 0.0 112.203 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -105.51 5.23 31.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 88.43 -176.21 44.78 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.102 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 61' ' ' GLY . 5.5 m -156.34 164.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.36 . . . . 0.0 111.262 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.02 86.46 6.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.259 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.1 m -79.08 155.23 28.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.107 0.48 . . . . 0.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -166.5 155.56 11.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.515 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HE3' ' CH2' ' A' ' 28' ' ' TRP . 4.6 mtmp? -93.72 132.99 37.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.3 mt . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.787 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.883 0.373 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -58.63 125.38 23.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.2 t -51.96 -32.7 34.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -3.47 36.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.48 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.94 6.29 10.87 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 81' ' ' ASP . 41.1 mt -100.43 154.8 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 111.004 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 80' ' ' ILE . 14.3 t0 -105.42 114.99 29.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -96.59 33.27 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.649 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.2 t0 -134.64 30.9 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.973 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -146.09 30.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -138.44 -56.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.976 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 85' ' ' TYR . 16.2 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.788 0.328 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.604 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -86.83 142.29 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.801 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.825 ' O ' HD21 ' A' ' 67' ' ' LEU . 58.5 m95 -132.89 -174.03 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.823 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.651 ' OE1' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -153.75 157.96 40.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.432 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 16.6 p90 -145.83 134.61 22.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 111.81 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.663 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -119.86 123.65 44.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.997 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -57.03 -50.05 73.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 110.922 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' HG23 ' A' ' 35' ' ' THR . 13.2 mt-10 -86.81 176.64 7.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.67 39.29 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.64 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 33' ' ' GLU . 2.0 p -106.27 165.8 10.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.025 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.58 -2.55 89.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.296 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.85 -26.7 8.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.75 146.0 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.583 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -55.53 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.651 HD23 ' OE1' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -154.6 122.13 5.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' TYR . 2.0 m-85 -132.63 -160.07 1.02 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.014 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.685 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.38 15.12 64.81 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.434 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.2 Cg_endo -70.65 54.61 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 120.112 1.956 . . . . 0.0 111.959 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.09 165.46 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.158 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.2 p -56.11 145.66 25.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.8 t -48.65 -29.97 4.94 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.16 0.505 . . . . 0.0 110.07 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.526 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 37.7 tp60 -73.8 -26.02 60.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.768 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmm -75.02 -47.23 30.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.059 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.418 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 33.8 tp60 -61.16 -34.54 75.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.039 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.5 m -61.38 -53.29 58.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.268 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.429 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 3.5 m0 -58.13 -45.2 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.535 HG22 ' CD2' ' A' ' 58' ' ' PHE . 95.4 t -65.46 -45.76 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.88 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -28.36 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 51' ' ' THR . 5.2 mm-40 -64.89 -37.58 88.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.16 -23.23 1.74 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.643 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -57.84 160.73 4.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 53' ' ' VAL . 1.9 m-85 61.99 74.92 0.46 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.42 -38.92 7.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.231 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -105.22 5.18 31.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.156 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.77 159.02 34.78 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.019 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 58' ' ' PHE . 5.3 m -130.95 164.3 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -79.32 88.56 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.097 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -85.25 150.12 25.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.091 0.472 . . . . 0.0 111.805 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.5 147.64 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.271 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -84.31 140.7 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 111.25 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.825 HD21 ' O ' ' A' ' 28' ' ' TRP . 3.8 mt . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.759 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.763 0.316 . . . . 0.0 110.73 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.83 123.07 14.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.423 ' HA ' HD12 ' A' ' 80' ' ' ILE . 83.9 p -53.58 -31.05 45.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.072 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -11.23 60.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 10.18 15.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.368 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.759 HD11 ' HB3' ' A' ' 75' ' ' TYR . 93.9 mt -105.0 153.58 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.04 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.406 ' N ' HG22 ' A' ' 80' ' ' ILE . 16.2 t0 -109.57 116.23 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 53.8 m-85 -94.25 46.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.757 ' O ' HD23 ' A' ' 84' ' ' LEU . 4.3 t0 -152.06 28.94 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.0 mt -147.6 30.79 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.557 ' HB3' HG21 ' A' ' 26' ' ' VAL . 62.7 m-85 -134.47 -51.02 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.519 ' O ' HG23 ' A' ' 86' ' ' THR . 8.3 t . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.343 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.644 ' CB ' HD12 ' A' ' 67' ' ' LEU . 5.8 mtp -91.02 149.14 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.785 ' O ' HD21 ' A' ' 67' ' ' LEU . 44.3 m95 -133.75 -173.82 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 11.1 pt-20 -151.99 154.41 35.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.234 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.3 p90 -138.94 143.91 38.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.15 0.5 . . . . 0.0 111.98 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 34.2 ttpt -131.2 114.64 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.907 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.444 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 92.0 m95 -56.35 -53.01 62.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.899 0.38 . . . . 0.0 111.026 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.6 OUTLIER -84.86 159.51 20.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.912 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -109.03 38.98 2.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.625 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.6 p -106.65 162.78 13.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.02 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.57 -4.64 85.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -111.03 -22.88 11.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.526 0.203 . . . . 0.0 111.084 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.767 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 111.452 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 23.1 mm-40 -56.3 -175.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -156.45 90.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.97 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 5.0 m-85 -119.92 -160.26 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.302 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 89.37 12.63 62.79 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.645 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.4 Cg_endo -71.01 55.56 1.81 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 120.195 1.998 . . . . 0.0 111.92 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 6.0 m-85 -121.02 165.23 15.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.4 p -59.94 147.68 37.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.4 p -47.32 -32.11 4.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.168 0.509 . . . . 0.0 110.04 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.23 99.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.388 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.467 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 12.0 tp60 -70.01 -25.93 63.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.451 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.676 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -76.11 -46.51 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.983 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -60.45 -33.59 72.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.216 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.9 m -65.21 -57.7 7.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 2.8 m0 -57.73 -45.4 85.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 49' ' ' MET . 59.3 t -65.0 -44.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.786 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.1 t -75.28 -30.29 60.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.967 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.6 mm-40 -64.82 -32.36 74.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.51 3.09 22.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.887 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -57.25 -33.22 67.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.777 0.322 . . . . 0.0 110.854 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -112.32 77.55 2.25 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.682 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.62 -29.21 30.36 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.61 2.206 . . . . 0.0 112.3 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -105.07 -0.6 26.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 161.65 37.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.333 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.54 164.89 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 0.0 111.262 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.64 84.07 5.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.067 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -82.9 145.56 29.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.414 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.4 153.69 29.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.044 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -90.21 135.75 33.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 28' ' ' TRP . 5.3 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.545 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HB3' HD11 ' A' ' 80' ' ' ILE . 9.7 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.809 0.338 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -57.27 127.26 31.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.3 p -52.62 -33.94 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 -7.36 51.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.349 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -113.79 6.26 16.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.651 0.262 . . . . 0.0 111.429 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.625 HD13 ' CZ3' ' A' ' 28' ' ' TRP . 45.8 mt -105.09 153.92 6.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.353 . . . . 0.0 110.996 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 80' ' ' ILE . 17.2 t0 -104.8 115.7 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.82 33.69 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.604 ' O ' HD23 ' A' ' 84' ' ' LEU . 9.4 t70 -139.4 33.07 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 83' ' ' ASP . 7.4 mt -145.91 30.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.7 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.83 -57.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.999 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.2 p30 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.889 0.376 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.48 110.49 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.561 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.5 146.96 23.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.672 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.828 ' O ' HD21 ' A' ' 67' ' ' LEU . 53.0 m95 -132.52 -174.43 3.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.517 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.624 ' OE1' HD13 ' A' ' 40' ' ' LEU . 11.7 pt-20 -156.93 160.65 39.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.499 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' CD2' ' HA3' ' A' ' 42' ' ' GLY . 36.5 p90 -144.92 133.4 21.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.938 0.399 . . . . 0.0 111.829 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.674 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 20.3 ttpp -114.58 123.5 49.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.082 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -55.23 -48.15 74.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.931 0.396 . . . . 0.0 110.949 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.47 -177.39 3.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -124.65 38.64 4.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.6 p -105.14 165.23 11.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.58 -4.05 87.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.274 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -114.35 -23.7 9.26 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.598 0.237 . . . . 0.0 111.156 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.674 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.46 137.16 2.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.746 0.308 . . . . 0.0 111.523 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -64.42 137.09 57.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.1 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.624 HD13 ' OE1' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -114.27 136.1 53.34 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.626 -179.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' H ' HD23 ' A' ' 40' ' ' LEU . 11.4 m-85 -141.8 -156.5 0.68 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.914 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.61 16.32 64.15 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-O 119.11 -0.828 . . . . 0.0 114.316 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.1 Cg_endo -70.4 54.6 1.45 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 119.976 1.888 . . . . 0.0 111.84 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.494 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 2.6 m-85 -123.32 166.18 15.73 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 p -55.37 144.16 26.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.7 p -46.71 -30.28 2.3 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.129 0.49 . . . . 0.0 110.221 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.67 83.37 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.536 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.464 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 6.6 tp60 -62.72 -26.22 68.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.66 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.645 ' O ' HG23 ' A' ' 53' ' ' VAL . 36.8 mmm -72.29 -43.19 64.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.281 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.424 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -61.33 -33.86 74.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.258 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -62.88 -58.71 6.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.532 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.464 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 3.3 m-90 -57.66 -46.31 84.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 49' ' ' MET . 60.0 t -64.25 -44.64 97.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.911 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.0 m -75.35 -32.39 60.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 51' ' ' THR . 10.3 tm-20 -64.8 -39.57 93.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 123.13 2.11 9.27 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.92 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.428 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -55.68 -25.96 42.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.765 0.317 . . . . 0.0 111.027 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.538 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.2 m-85 -121.95 78.67 41.28 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.07 -30.77 46.95 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.633 2.222 . . . . 0.0 112.355 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -105.18 4.87 31.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.6 162.33 33.16 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.248 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.45 164.83 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.822 0.344 . . . . 0.0 111.267 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CD2' ' CD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -77.95 83.47 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.317 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.484 ' CB ' HD12 ' A' ' 80' ' ' ILE . 1.5 m -76.03 144.93 40.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.648 -179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -158.77 159.33 35.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.604 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HE2' ' CZ2' ' A' ' 28' ' ' TRP . 15.4 mtmt -95.69 133.3 39.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.719 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.828 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.2 mt -64.88 -66.33 0.56 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.887 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.59 126.36 26.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.806 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.43 139.13 50.43 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.531 -1.445 . . . . 0.0 112.293 0.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.28 135.59 16.97 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.478 2.119 . . . . 0.0 112.322 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -144.02 -101.76 0.37 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.657 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.38 -149.54 8.16 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.475 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 48.9 69.16 0.6 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.3 0.571 . . . . 0.0 110.783 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.455 ' CD2' ' CD2' ' A' ' 63' ' ' TYR . 19.0 m-85 -54.56 163.47 0.91 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.137 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.15 129.8 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.796 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -58.27 135.13 57.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.0 p -52.82 -28.35 22.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.02 -1.44 43.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.3 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.1 mtt-85 -120.48 4.96 10.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.549 0.214 . . . . 0.0 111.489 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.484 HD12 ' CB ' ' A' ' 64' ' ' CYS . 34.6 mt -103.34 151.82 6.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 110.965 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -98.55 115.54 28.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 92.3 m-85 -98.59 30.39 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.801 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.751 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -134.3 29.05 3.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.864 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.0 mt -147.02 30.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.779 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -138.54 -52.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.878 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.802 0.334 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.25 135.71 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.073 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.584 ' CG ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -100.33 140.49 34.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.917 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.785 ' O ' HD21 ' A' ' 67' ' ' LEU . 50.0 m95 -134.11 -174.03 3.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 111.49 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.769 ' CD ' HD11 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -150.4 164.62 35.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.741 179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.488 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 6.5 p90 -149.18 140.11 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.107 0.48 . . . . 0.0 111.653 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.727 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 5.2 ttmt -130.66 118.48 21.01 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.001 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -54.3 -49.3 69.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.425 . . . . 0.0 110.995 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -94.66 176.31 6.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.822 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -131.21 38.93 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.654 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -105.47 -174.56 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.31 13.02 68.57 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.871 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -122.46 -35.51 3.09 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.543 0.211 . . . . 0.0 111.013 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.38 134.99 3.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.833 0.349 . . . . 0.0 111.473 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -58.56 -174.58 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.769 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.3 OUTLIER -141.59 98.63 3.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.085 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 11.2 m-85 -114.05 -162.55 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.278 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.684 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.95 10.88 66.03 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 118.959 -0.912 . . . . 0.0 114.71 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.45 55.52 1.57 Allowed 'Trans proline' 0 C--N 1.353 0.773 0 CA-C-N 120.272 2.036 . . . . 0.0 111.964 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.8 m-85 -122.64 165.59 16.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.338 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.0 p -58.05 144.61 39.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.765 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.7 p -46.7 -31.42 2.92 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.196 0.522 . . . . 0.0 110.174 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.79 96.4 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.551 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.447 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 2.7 tp60 -66.06 -25.94 67.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.595 ' O ' HG23 ' A' ' 53' ' ' VAL . 34.2 mmm -74.53 -44.69 50.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.413 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -59.88 -34.99 73.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.174 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 55' ' ' GLU . 99.3 m -63.13 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.372 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.5 m0 -54.96 -45.57 74.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG22 ' HD2' ' A' ' 58' ' ' PHE . 83.9 t -65.36 -47.0 88.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.218 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.2 m -75.32 -31.84 60.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 51' ' ' THR . 29.1 tp10 -64.81 -29.45 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.059 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.1 3.22 23.15 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.949 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -58.93 -28.21 66.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 0.0 110.948 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.644 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 -120.91 80.26 33.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.804 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.78 -27.81 17.6 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.658 2.239 . . . . 0.0 112.448 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -104.99 -7.73 19.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.294 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.13 160.09 31.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.387 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.32 164.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.871 0.367 . . . . 0.0 111.181 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.12 84.9 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.284 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.7 m -84.51 148.21 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.083 0.468 . . . . 0.0 111.516 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -165.03 148.42 8.47 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.788 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.7 mtmp? -84.29 130.1 34.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.002 0.429 . . . . 0.0 110.873 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 28' ' ' TRP . 9.9 mt -58.37 -66.32 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.865 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -118.5 136.61 24.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.61 148.69 84.12 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.409 -1.496 . . . . 0.0 112.382 0.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.47 154.31 27.65 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.563 2.175 . . . . 0.0 112.433 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.96 70.0 0.31 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.652 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.407 ' HA3' ' NH2' ' A' ' 65' ' ' ARG . . . -154.36 175.56 32.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.47 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.436 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 8.9 mt-30 -115.03 66.36 0.69 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.072 0.463 . . . . 0.0 110.975 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.436 ' CG ' ' O ' ' A' ' 73' ' ' GLN . 50.0 p90 45.09 -172.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.674 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER 179.63 113.39 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.788 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.88 127.28 31.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.9 p -52.52 -30.71 31.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -7.37 53.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.35 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.07 6.86 12.95 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.574 0.226 . . . . 0.0 111.399 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 75' ' ' TYR . 52.3 mt -104.38 153.19 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 0.0 111.053 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -102.12 115.67 31.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.754 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.442 ' HE2' HG11 ' A' ' 53' ' ' VAL . 22.3 m-85 -96.7 35.53 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.914 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.782 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.7 m-20 -137.35 28.05 2.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.886 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.2 mt -146.51 30.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -133.53 -53.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.927 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.565 ' OD1' HG22 ' A' ' 45' ' ' THR . 56.3 t0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.861 0.362 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 t -64.05 105.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.195 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.543 ' CB ' HD12 ' A' ' 67' ' ' LEU . 14.1 mtp -83.71 140.41 32.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.723 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.827 ' O ' HD21 ' A' ' 67' ' ' LEU . 51.8 m95 -124.55 -174.26 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 1.3 tt0 -153.04 145.23 23.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.425 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' TYR . 16.0 p90 -133.76 135.06 43.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.089 0.471 . . . . 0.0 111.983 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.791 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 5.8 ttpm? -119.8 129.31 54.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.941 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -59.53 -50.69 72.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.458 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -125.47 135.85 52.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.251 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -76.74 61.22 1.82 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -111.85 168.28 9.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.14 -2.15 86.71 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.498 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -117.33 -28.1 6.23 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.653 0.264 . . . . 0.0 111.172 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.791 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -46.97 125.61 7.75 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 111.396 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 2.6 mm-40 -60.46 -177.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.415 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD21 ' HE2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -141.94 125.78 17.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.137 0.494 . . . . 0.0 111.209 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -135.93 -160.37 1.05 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.215 179.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.686 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 85.81 15.2 65.94 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-O 119.069 -0.851 . . . . 0.0 114.304 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.3 Cg_endo -70.63 54.6 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 119.996 1.898 . . . . 0.0 111.925 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.439 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.3 m-85 -125.43 165.46 18.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.025 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.565 HG22 ' OD1' ' A' ' 25' ' ' ASP . 14.7 p -55.11 144.36 24.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.984 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 t -46.38 -30.86 2.3 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.166 0.508 . . . . 0.0 110.257 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.78 -43.65 88.15 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.475 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 19.1 tp60 -65.36 -26.3 67.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.724 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.627 ' O ' HG23 ' A' ' 53' ' ' VAL . 27.1 mmm -76.06 -45.86 32.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.037 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -58.95 -30.37 67.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.919 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.4 m -67.8 -58.68 4.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.435 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.448 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 4.1 m0 -55.72 -43.44 76.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.693 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 49' ' ' MET . 72.0 t -63.91 -48.23 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.858 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 t -75.3 -28.47 59.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.028 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.9 mt-10 -64.74 -32.61 74.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.15 -1.09 19.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.845 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -29.86 61.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.48 78.39 28.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.635 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.84 -28.8 42.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.539 2.159 . . . . 0.0 112.359 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -105.09 5.18 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.66 159.82 24.7 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.213 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.46 164.85 31.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.849 0.357 . . . . 0.0 111.209 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.22 83.45 5.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.585 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -74.93 144.81 43.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.243 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -159.39 143.52 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.015 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.438 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 9.7 mtmt -84.09 130.47 34.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.053 0.454 . . . . 0.0 110.98 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 28' ' ' TRP . 7.0 mt -59.55 -59.22 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -120.14 132.22 24.16 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.73 141.58 67.58 Favored 'Cis proline' 0 C--N 1.347 0.499 0 C-N-CA 123.867 -1.305 . . . . 0.0 112.09 0.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.38 111.46 3.04 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.581 2.187 . . . . 0.0 112.314 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.38 23.39 2.21 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.835 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 56.16 -160.18 7.53 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.693 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 64.74 65.42 0.62 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.421 0.629 . . . . 0.0 110.895 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.696 ' HE2' HD21 ' A' ' 40' ' ' LEU . 89.1 m-85 -55.64 -178.09 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.19 -0.913 . . . . 0.0 111.084 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -157.86 129.87 7.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -59.77 126.45 27.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.2 t -52.04 -31.05 28.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.05 -7.6 53.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.07 7.03 12.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.449 HD12 ' CB ' ' A' ' 64' ' ' CYS . 41.6 mt -104.36 153.33 6.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.827 0.346 . . . . 0.0 111.014 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 12.4 t0 -99.43 114.9 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.761 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.47 38.44 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.756 ' O ' HD23 ' A' ' 84' ' ' LEU . 5.5 t70 -143.6 30.73 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.1 mt -147.5 30.95 0.9 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.857 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.33 -49.98 0.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.883 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.812 0.339 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.5 t -62.05 120.39 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.672 ' CB ' HD12 ' A' ' 67' ' ' LEU . 4.4 mtp -88.32 144.56 26.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.941 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.796 ' O ' HD21 ' A' ' 67' ' ' LEU . 40.3 m95 -134.39 -173.68 3.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 13.4 pt-20 -156.6 146.76 21.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.641 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 41' ' ' TYR . 34.0 p90 -128.94 144.23 51.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.139 0.495 . . . . 0.0 111.854 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 28.0 ttpt -125.84 115.58 20.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.811 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -54.37 -51.25 65.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.978 0.418 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -85.98 177.76 7.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.7 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -132.49 42.74 3.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.811 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.69 178.26 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.893 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.81 9.86 75.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.196 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.17 -28.1 3.17 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.549 0.214 . . . . 0.0 111.163 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -42.71 137.97 2.06 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.751 0.31 . . . . 0.0 111.612 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.96 -177.64 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.485 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.84 115.78 6.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.113 0.483 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.475 ' O ' ' N ' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -121.0 -158.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.056 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 82.75 17.61 67.61 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-O 119.114 -0.825 . . . . 0.0 114.293 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -70.32 54.01 1.35 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 119.91 1.855 . . . . 0.0 112.035 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.449 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.2 165.59 16.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -57.45 144.99 34.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.904 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 t -47.03 -30.14 2.49 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.145 0.498 . . . . 0.0 110.135 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.21 -43.51 86.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.409 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.441 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 38.6 tp60 -68.85 -26.35 65.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.66 ' O ' HG23 ' A' ' 53' ' ' VAL . 26.8 mmm -75.86 -47.88 23.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.411 ' OE1' ' CG ' ' A' ' 82' ' ' PHE . 36.4 tp60 -58.81 -31.83 68.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.166 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 55' ' ' GLU . 89.1 m -65.9 -54.5 25.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.23 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.441 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.4 m0 -58.86 -43.29 90.77 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.488 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 49' ' ' MET . 61.9 t -65.07 -46.27 91.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.669 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.404 ' HB3' ' NE2' ' A' ' 50' ' ' GLN . 17.7 p -75.27 -28.53 59.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.887 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' A' ' 51' ' ' THR . 20.8 mm-40 -64.81 -29.79 70.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.03 26.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.935 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -58.26 -33.32 69.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.327 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.53 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -113.61 83.23 6.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.768 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.32 -27.21 19.81 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.568 2.179 . . . . 0.0 112.483 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -105.19 -7.86 18.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.38 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.09 160.76 31.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.196 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 m -137.93 164.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.26 82.07 7.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.355 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -75.63 144.62 41.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.303 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -156.75 153.99 29.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.028 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -91.14 131.58 36.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.796 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.4 mt -66.12 -67.78 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.696 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -122.54 136.59 26.75 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.55 148.15 79.88 Favored 'Cis proline' 0 C--N 1.348 0.508 0 C-N-CA 123.492 -1.462 . . . . 0.0 112.174 -0.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.33 102.73 1.51 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.555 2.17 . . . . 0.0 112.26 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -169.11 39.92 0.21 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.706 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -133.58 156.87 22.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.469 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -114.11 70.37 0.73 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 111.045 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.423 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 10.0 m-85 56.48 166.71 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.137 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.683 ' HB3' HD11 ' A' ' 80' ' ' ILE . 5.2 m-85 -174.05 114.97 0.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.621 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.92 124.52 20.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.788 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 t -51.21 -34.1 30.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.255 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -72.64 -8.17 53.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.299 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.13 7.11 14.1 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 75' ' ' TYR . 40.4 mt -105.05 153.75 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.918 0.389 . . . . 0.0 111.121 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 80' ' ' ILE . 10.4 t0 -101.82 114.89 29.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.785 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CG ' ' OE1' ' A' ' 50' ' ' GLN . 96.4 m-85 -96.69 29.84 2.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.085 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.85 ' O ' HD23 ' A' ' 84' ' ' LEU . 32.0 m-20 -130.07 23.61 5.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.87 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 83' ' ' ASP . 3.4 mt -144.88 30.05 1.19 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.735 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -138.1 -52.96 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 86' ' ' THR . 5.2 t . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.818 0.342 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.47 97.36 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.252 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.568 ' CB ' HD12 ' A' ' 67' ' ' LEU . 8.6 mtp -81.44 148.45 29.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.657 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.83 ' O ' HD21 ' A' ' 67' ' ' LEU . 56.0 m95 -129.12 -174.16 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.374 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 0.7 OUTLIER -152.43 156.6 39.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.654 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.1 p90 -143.62 146.74 33.5 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.039 0.447 . . . . 0.0 111.788 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.758 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 38.5 ttpt -134.5 123.34 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.149 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 58.2 m95 -67.45 -59.99 2.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.318 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -85.4 134.65 34.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.455 ' ND2' ' CE2' ' A' ' 63' ' ' TYR . 8.7 t-20 -90.46 51.46 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.77 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -113.83 176.11 5.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.994 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.56 4.59 86.03 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.994 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -116.42 -30.74 5.8 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.564 0.221 . . . . 0.0 111.02 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.758 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.61 129.33 5.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.43 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -56.34 -177.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.499 HD11 ' HD3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -138.35 97.4 3.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.241 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.436 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 9.5 m-85 -111.33 -162.98 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.333 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.675 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.02 12.22 62.23 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 119.026 -0.874 . . . . 0.0 114.523 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 58.1 Cg_endo -71.5 54.87 1.97 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 CA-C-N 120.21 2.005 . . . . 0.0 111.959 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -120.38 165.24 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.166 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -56.65 141.07 44.91 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.021 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -46.88 -30.97 2.79 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 121.179 0.514 . . . . 0.0 110.253 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.57 -42.81 86.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.434 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.467 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.4 tp-100 -66.46 -25.57 66.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.678 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.522 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.9 mmm -74.34 -43.07 58.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.144 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 82' ' ' PHE . 2.9 tp-100 -59.41 -37.34 77.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.996 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.3 m -62.19 -59.28 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.412 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m0 -55.53 -51.76 65.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 49' ' ' MET . 84.0 t -55.83 -50.51 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.162 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.5 t -75.27 -25.61 58.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -64.67 -26.02 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.007 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.71 2.79 37.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.766 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.52 -33.56 68.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.789 0.328 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.5 OUTLIER -112.08 80.02 3.02 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.756 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.65 -28.65 37.33 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.462 2.108 . . . . 0.0 112.184 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -105.09 3.68 30.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.263 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.36 163.52 34.76 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.244 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.7 m -139.3 164.81 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.955 0.407 . . . . 0.0 111.232 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.455 ' CE2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -83.58 89.32 7.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.273 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -80.42 151.54 29.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.636 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.499 ' HD3' HD11 ' A' ' 40' ' ' LEU . 8.5 ptm180 -165.43 146.33 7.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.505 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mtmp? -84.44 139.86 31.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 0.0 111.086 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.83 HD21 ' O ' ' A' ' 28' ' ' TRP . 5.2 mt -71.26 -19.85 62.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.186 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 6.8 t70 -120.99 104.35 41.62 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.918 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 57.7 Cg_endo -71.01 160.53 91.59 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 123.512 -1.453 . . . . 0.0 112.355 0.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.07 113.77 3.69 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.613 2.209 . . . . 0.0 112.382 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.07 81.75 0.7 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.617 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.72 176.78 44.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.553 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 46.83 64.26 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.424 0.63 . . . . 0.0 110.862 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CE1' ' HD2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -74.95 142.03 43.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.899 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -167.64 137.11 2.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -63.36 127.14 29.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 62' ' ' VAL . 12.2 p -51.96 -27.52 13.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.202 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -79.14 -1.72 37.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.544 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.89 8.11 7.43 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-O 120.553 0.216 . . . . 0.0 111.461 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 81' ' ' ASP . 57.0 mt -105.09 154.58 6.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.882 0.373 . . . . 0.0 111.192 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.433 ' N ' HG22 ' A' ' 80' ' ' ILE . 32.7 t0 -108.25 116.26 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.542 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CB ' ' HB2' ' A' ' 50' ' ' GLN . 73.8 m-85 -95.92 28.07 3.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.648 ' O ' HD23 ' A' ' 84' ' ' LEU . 7.9 t70 -124.08 30.47 6.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.66 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.8 mt -144.92 29.27 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -140.54 -46.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.96 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.72 0.295 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 t -55.06 123.61 6.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.251 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.581 ' CB ' HD12 ' A' ' 67' ' ' LEU . 70.1 mmm -89.88 136.99 32.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.713 ' O ' HD21 ' A' ' 67' ' ' LEU . 35.3 m95 -127.29 -173.49 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.27 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 mt-10 -146.2 161.04 41.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.752 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.5 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 5.1 p90 -145.03 146.83 32.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.0 111.599 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.727 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -135.71 119.92 17.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.249 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -56.47 -51.51 68.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.25 176.95 6.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.871 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -120.98 38.82 3.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.676 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.57 160.25 15.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.882 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.28 -5.07 80.84 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.309 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -110.85 -23.91 10.73 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.573 0.225 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.71 149.96 0.27 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 75.2 mm-40 -55.23 152.6 7.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -123.92 89.93 3.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.317 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 15.8 m-85 -113.36 -164.39 0.92 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.287 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.04 8.89 64.34 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-O 119.003 -0.887 . . . . 0.0 114.731 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.5 Cg_endo -70.97 55.08 1.73 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.255 2.027 . . . . 0.0 112.096 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.7 m-85 -121.0 165.39 15.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.131 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.8 p -56.16 143.82 31.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.961 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.64 -30.49 2.35 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.139 0.495 . . . . 0.0 110.225 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.24 -43.35 86.84 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.476 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 30.1 tp60 -65.98 -25.89 67.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.733 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.644 ' O ' HG23 ' A' ' 53' ' ' VAL . 34.7 mmm -74.18 -51.22 16.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.527 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.12 -33.02 64.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.373 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 55' ' ' GLU . 33.0 m -64.54 -59.06 4.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.715 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.0 m0 -56.18 -43.7 78.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.881 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 49' ' ' MET . 58.5 t -61.88 -51.01 77.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.029 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -75.4 -26.35 58.33 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.038 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 51' ' ' THR . 6.6 mm-40 -64.74 -29.46 70.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.939 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.21 0.3 23.8 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.856 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.439 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 1.5 m-85 -59.96 -31.75 70.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 0.0 110.826 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.589 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -117.27 75.81 8.68 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.1 -30.21 47.31 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.468 2.112 . . . . 0.0 112.262 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -105.28 5.03 31.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.24 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.18 160.55 29.53 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.145 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.1 m -135.15 164.57 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.382 . . . . 0.0 111.241 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.18 88.43 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.036 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -85.11 150.12 25.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 111.629 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.24 151.6 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -84.38 139.78 32.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.8 mt -72.29 -65.67 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.751 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -118.45 131.52 24.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.868 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 71.9 Cg_endo -74.44 133.9 33.25 Favored 'Cis proline' 0 C--N 1.349 0.579 0 C-N-CA 123.52 -1.45 . . . . 0.0 112.224 0.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 69' ' ' PRO . 49.4 Cg_exo -55.62 124.22 15.75 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.396 2.064 . . . . 0.0 112.297 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 157.27 42.93 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.777 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.72 137.23 15.89 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.314 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -112.22 65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.076 0.465 . . . . 0.0 111.188 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 48.61 104.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.623 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.765 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -128.47 104.93 7.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.816 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -57.25 122.36 12.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.423 ' HB3' HG23 ' A' ' 62' ' ' VAL . 8.3 p -53.19 -28.76 28.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.82 -4.46 49.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.301 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.28 7.13 11.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 75' ' ' TYR . 58.5 mt -101.97 153.27 5.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 17.0 t0 -103.47 114.83 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.648 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -95.25 22.38 6.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.053 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.783 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.6 OUTLIER -119.35 27.22 8.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.712 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.0 mt -145.82 29.42 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -143.65 -56.94 0.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.846 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.423 HG23 ' OXT' ' A' ' 86' ' ' THR . 1.9 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.872 0.368 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 t -65.18 104.86 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.252 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.529 ' CB ' HD12 ' A' ' 67' ' ' LEU . 26.3 mtp -83.22 144.02 30.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.726 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.806 ' O ' HD21 ' A' ' 67' ' ' LEU . 51.3 m95 -126.86 -174.05 3.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.231 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' CD ' HD22 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -152.07 155.79 38.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.722 179.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.484 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -140.97 143.38 34.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.041 0.448 . . . . 0.0 111.606 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.671 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 7.5 ttpt -130.86 119.48 22.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.145 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -54.29 -46.89 72.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.95 173.42 7.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.901 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 63' ' ' TYR . 2.8 p30 -120.79 39.24 3.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.688 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -108.13 176.25 5.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.941 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.49 -4.95 76.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.14 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.28 -24.1 10.43 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.558 0.218 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.33 159.2 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.0 111.428 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -57.22 -177.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.13 84.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.168 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.427 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 16.5 m-85 -114.81 -162.57 0.83 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.227 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.687 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 91.27 11.58 60.95 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.519 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.4 Cg_endo -71.39 55.15 1.95 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 120.183 1.991 . . . . 0.0 111.997 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 4.0 m-85 -120.11 165.3 14.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.133 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -54.96 141.96 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.145 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 86.9 p -47.67 -30.31 3.67 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.18 0.514 . . . . 0.0 110.21 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.98 -40.3 83.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.483 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.466 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.5 tp-100 -68.97 -25.85 64.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.585 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 40.6 mmm -76.0 -45.1 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.869 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.96 -33.04 71.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.681 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' GLU . 88.0 m -64.03 -56.04 17.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.17 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.466 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 5.5 m0 -58.04 -47.39 83.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.594 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG22 ' CD2' ' A' ' 58' ' ' PHE . 79.8 t -64.94 -41.85 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.886 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.3 t -75.28 -33.74 61.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.679 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 51' ' ' THR . 11.3 mt-10 -64.93 -37.3 87.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.806 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 118.26 4.19 14.22 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.784 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.436 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -53.47 -32.24 49.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.815 0.34 . . . . 0.0 110.933 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -114.0 78.73 4.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.733 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.77 -28.52 51.44 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.49 2.127 . . . . 0.0 112.201 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -105.18 5.24 32.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.246 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.16 162.92 27.11 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.154 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 m -138.49 164.89 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 111.281 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.473 ' CE2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -79.25 84.45 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.357 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -77.59 144.6 37.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.019 0.438 . . . . 0.0 111.449 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -157.52 142.32 16.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.707 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 11.0 mtmt -83.91 139.0 32.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 110.999 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.806 HD21 ' O ' ' A' ' 28' ' ' TRP . 2.6 mt -70.75 -68.51 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -122.48 130.48 24.65 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.821 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.08 138.56 51.91 Favored 'Cis proline' 0 C--N 1.348 0.5 0 C-N-CA 123.507 -1.455 . . . . 0.0 112.35 -0.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.68 104.96 1.99 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.51 2.14 . . . . 0.0 112.337 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -170.43 77.85 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.601 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.42 159.17 32.4 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.446 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -109.29 71.19 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.049 0.452 . . . . 0.0 111.065 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.473 ' CG ' ' CE2' ' A' ' 63' ' ' TYR . 9.7 m-85 59.22 155.16 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.989 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.82 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -161.37 107.62 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.897 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -59.43 124.74 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.2 p -52.45 -34.22 47.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -64.0 -15.6 59.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.203 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.1 7.83 18.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.387 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 75' ' ' TYR . 54.3 mt -105.04 153.6 6.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.811 0.338 . . . . 0.0 111.122 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.535 ' OD2' HD11 ' A' ' 84' ' ' LEU . 8.3 t0 -104.51 127.63 52.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.611 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -108.82 26.47 10.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.313 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.803 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -139.94 31.34 2.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.88 0.371 . . . . 0.0 110.892 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.803 HD23 ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -145.28 30.51 1.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.774 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -133.34 -49.5 0.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.954 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.926 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.847 0.356 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.406 HG12 ' NE1' ' A' ' 28' ' ' TRP . 32.7 t -60.12 117.14 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.472 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -105.0 139.9 38.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.673 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.811 ' O ' HD21 ' A' ' 67' ' ' LEU . 58.2 m95 -123.42 -174.14 2.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.477 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.57 ' CD ' HD22 ' A' ' 67' ' ' LEU . 1.5 mt-10 -154.84 137.51 15.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.752 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 41' ' ' TYR . 15.6 p90 -122.32 148.91 44.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.216 0.531 . . . . 0.0 111.923 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.523 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 6.1 ttmm -136.07 120.41 17.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.978 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -55.93 -50.96 69.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.429 . . . . 0.0 110.882 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -178.12 5.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.811 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -124.74 39.48 3.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.765 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -101.95 -166.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.9 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.91 -5.87 40.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.341 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.8 -19.26 8.68 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.525 0.202 . . . . 0.0 111.411 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -44.14 154.81 0.1 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.775 0.322 . . . . 0.0 111.526 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 3.5 pm0 -51.06 135.95 24.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.075 0.464 . . . . 0.0 111.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD12 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -121.99 78.64 1.49 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.043 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' TYR . 3.3 m-85 -106.66 -159.55 0.7 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.24 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.683 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 90.42 14.22 58.9 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-O 119.157 -0.802 . . . . 0.0 114.4 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 55.4 Cg_endo -71.19 55.13 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.041 1.921 . . . . 0.0 111.96 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.44 ' CD1' ' CZ3' ' A' ' 52' ' ' TRP . 3.1 m-85 -123.0 165.62 16.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.146 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.7 p -62.35 149.62 41.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.99 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.7 t -45.86 -31.23 2.02 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.158 0.504 . . . . 0.0 110.165 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.98 -50.42 72.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.28 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 22.4 tp60 -63.7 -25.74 68.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.613 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.661 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.04 -45.97 62.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.284 179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -33.81 72.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.124 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.558 ' O ' ' N ' ' A' ' 55' ' ' GLU . 74.2 m -60.99 -62.41 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.432 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 3.1 m-90 -54.88 -44.13 73.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.921 0.391 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.706 HG22 ' HD2' ' A' ' 58' ' ' PHE . 62.1 t -65.06 -49.29 80.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.0 t -75.24 -28.35 59.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 51' ' ' THR . 14.6 tp10 -65.0 -43.78 91.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.074 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.31 -6.0 4.97 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.94 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.7 OUTLIER -53.85 -35.89 62.0 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.706 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -114.11 78.31 4.32 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.72 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.78 -35.17 16.68 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.589 2.193 . . . . 0.0 112.39 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -104.9 4.95 32.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.275 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.71 160.25 36.37 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.333 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.93 164.87 31.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -78.84 86.9 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.306 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.525 ' CB ' HD12 ' A' ' 80' ' ' ILE . 6.8 m -82.83 146.24 29.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.64 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -161.73 144.49 11.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.047 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.448 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 1.5 mtmp? -84.0 133.19 34.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.893 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.811 HD21 ' O ' ' A' ' 28' ' ' TRP . 3.1 mt -64.19 -63.8 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.834 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -115.84 133.27 22.87 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.865 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.65 142.35 63.93 Favored 'Cis proline' 0 C--N 1.348 0.516 0 C-N-CA 123.425 -1.49 . . . . 0.0 112.285 0.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.11 150.23 42.49 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.445 2.096 . . . . 0.0 112.236 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.81 69.77 0.24 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.616 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -150.99 178.85 28.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.325 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -118.45 64.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.176 0.512 . . . . 0.0 111.085 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 49.49 -178.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.392 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.487 ' HB3' HD11 ' A' ' 80' ' ' ILE . 2.5 m-85 -174.62 108.28 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.471 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -54.52 126.59 24.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.181 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -52.45 -34.96 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.045 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.83 -8.63 56.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.032 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -112.46 5.93 18.32 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.27 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' A' ' 64' ' ' CYS . 69.0 mt -105.11 154.29 6.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.867 0.365 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 80' ' ' ILE . 6.9 t0 -107.0 117.06 33.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -96.68 27.94 3.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.028 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.677 ' O ' HD23 ' A' ' 84' ' ' LEU . 15.4 t70 -133.41 31.04 3.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.767 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.9 mt -146.56 30.41 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -137.89 -47.61 0.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.876 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.913 0.387 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t -62.66 100.86 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.492 ' HB2' HD12 ' A' ' 67' ' ' LEU . 35.2 mmm -84.0 140.45 31.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.515 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.768 ' O ' HD21 ' A' ' 67' ' ' LEU . 46.0 m95 -123.1 -175.67 3.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.012 0.434 . . . . 0.0 111.249 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' HG2' HD23 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -150.47 161.03 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.941 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.96 139.1 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.179 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.695 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 25.9 ttmt -128.58 123.89 34.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.294 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 62.0 m95 -55.82 -47.77 76.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB3' HG23 ' A' ' 35' ' ' THR . 4.7 mt-10 -98.49 176.59 5.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.86 39.54 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.838 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.427 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.6 p -106.2 176.53 5.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.961 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.48 -2.86 72.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.219 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -112.59 -25.57 9.07 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.561 0.22 . . . . 0.0 111.016 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.23 157.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.849 0.357 . . . . 0.0 111.435 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -55.24 -178.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.707 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.43 86.44 1.15 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.089 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.492 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 10.1 m-85 -115.36 -174.16 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.124 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.679 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 102.68 -5.89 51.66 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.858 -0.968 . . . . 0.0 115.146 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.679 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 88.3 Cg_exo -41.53 -25.3 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.875 0 CA-C-N 120.329 2.065 . . . . 0.0 113.139 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.425 ' CD2' ' CZ3' ' A' ' 52' ' ' TRP . 1.2 m-85 -42.53 165.26 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.308 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.6 p -64.32 147.06 53.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 36.5 p -47.31 -30.16 2.96 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.225 0.536 . . . . 0.0 110.204 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.56 -46.96 80.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.644 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.434 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.6 tp60 -68.32 -26.41 65.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.923 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . 26.5 mmm -69.57 -52.3 27.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -60.77 -29.42 69.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.205 179.49 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.478 ' O ' ' N ' ' A' ' 55' ' ' GLU . 52.9 m -59.92 -57.43 12.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.215 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.434 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 2.4 m-90 -56.2 -43.0 78.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.767 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG22 ' CD2' ' A' ' 58' ' ' PHE . 47.8 t -65.36 -48.51 82.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.068 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -29.59 60.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.035 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' THR . 1.0 OUTLIER -64.98 -45.17 86.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.037 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.64 -24.32 0.57 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.782 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -56.14 162.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' CD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 60.08 65.59 2.29 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.93 -34.21 91.33 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.495 2.13 . . . . 0.0 112.138 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -105.32 -6.21 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.93 159.37 27.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.141 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.407 HG11 ' CD1' ' A' ' 58' ' ' PHE . 12.0 m -133.48 164.63 34.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.993 0.425 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.19 86.99 4.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.632 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.519 ' CB ' HD12 ' A' ' 80' ' ' ILE . 2.7 m -83.47 153.57 24.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.983 0.421 . . . . 0.0 111.255 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.461 ' CG ' ' HA ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -175.71 152.88 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.796 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -84.52 126.72 33.55 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.538 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.768 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.8 mt -50.67 -34.26 25.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.251 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 6.4 t0 -125.29 109.07 26.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.029 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 73.6 Cg_endo -75.61 143.72 78.0 Favored 'Cis proline' 0 C--N 1.349 0.588 0 C-N-CA 123.677 -1.384 . . . . 0.0 112.254 0.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.69 111.51 2.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.488 2.125 . . . . 0.0 112.483 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.1 100.3 1.23 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.451 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' O ' ' CD2' ' A' ' 74' ' ' PHE . . . -166.88 -131.52 1.28 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.981 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -63.73 76.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.014 0.435 . . . . 0.0 111.173 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.461 ' HA ' ' CG ' ' A' ' 65' ' ' ARG . 83.3 m-85 -54.28 146.5 15.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.754 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -152.75 134.85 14.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.993 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -61.58 137.3 58.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.811 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.406 ' HB3' HG23 ' A' ' 62' ' ' VAL . 54.7 p -54.56 -26.61 33.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -81.95 -0.12 42.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.335 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.9 5.83 9.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.588 0.232 . . . . 0.0 111.484 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 64' ' ' CYS . 46.6 mt -104.77 152.68 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.847 0.356 . . . . 0.0 110.961 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.451 ' OD2' HD11 ' A' ' 84' ' ' LEU . 33.6 t0 -109.41 120.34 42.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 50' ' ' GLN . 37.0 m-85 -101.35 30.59 4.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.966 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.809 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.6 t0 -132.43 28.27 4.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.809 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.8 mt -145.29 31.23 1.11 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.896 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -134.95 -49.74 0.75 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.892 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.836 0.351 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.1 104.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.146 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.619 ' CB ' HD12 ' A' ' 67' ' ' LEU . 11.8 mtp -84.28 147.66 27.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.821 ' O ' HD21 ' A' ' 67' ' ' LEU . 47.0 m95 -132.72 -173.81 3.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.177 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 2.8 pt-20 -149.87 162.06 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.74 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 7.6 p90 -146.7 141.29 26.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.0 111.682 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.625 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 4.0 ttmt -131.39 122.86 27.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.25 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -58.41 -51.9 67.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.918 0.389 . . . . 0.0 110.945 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HB3' HG23 ' A' ' 35' ' ' THR . 5.0 mt-10 -78.58 161.57 26.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -112.1 38.68 2.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.414 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.4 p -104.91 -166.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.867 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.71 0.19 26.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.113 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.91 -29.78 7.52 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.525 0.202 . . . . 0.0 111.081 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -39.69 157.26 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.874 0.368 . . . . 0.0 111.709 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 1.6 mm-40 -59.79 -176.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -146.65 107.09 4.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.278 -179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 39' ' ' GLU . 0.2 OUTLIER -124.27 -162.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.223 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.677 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.49 12.5 69.63 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-O 118.992 -0.893 . . . . 0.0 114.686 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.677 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.7 Cg_endo -70.22 54.91 1.41 Allowed 'Trans proline' 0 C--N 1.353 0.796 0 CA-C-N 120.27 2.035 . . . . 0.0 112.056 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.447 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.9 m-85 -121.28 165.43 15.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.024 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.8 p -57.41 142.58 43.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.886 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -46.82 -30.44 2.46 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.081 0.467 . . . . 0.0 110.284 179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.48 89.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.629 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.438 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 36.1 tp60 -68.56 -25.84 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.846 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.3 mmm -75.96 -44.37 40.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 37.3 tp60 -58.99 -38.85 80.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.314 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 55' ' ' GLU . 92.6 m -62.4 -57.31 11.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.582 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 4.8 m0 -53.89 -42.71 68.97 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.003 0.43 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.595 HG22 ' HD2' ' A' ' 58' ' ' PHE . 73.7 t -65.34 -50.48 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.17 -28.98 60.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 51' ' ' THR . 13.1 tt0 -64.72 -26.52 68.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.055 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.76 2.83 28.72 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.927 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.419 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -59.8 -27.45 66.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.816 0.341 . . . . 0.0 111.027 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.595 ' HD2' HG22 ' A' ' 53' ' ' VAL . 1.5 m-85 -121.73 78.68 39.3 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.837 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.22 -36.81 99.11 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.551 2.167 . . . . 0.0 112.378 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.52 5.1 31.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.335 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 86.24 -173.61 46.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.141 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 61' ' ' GLY . 6.4 m -158.85 164.7 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.363 . . . . 0.0 111.215 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.47 84.9 2.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.188 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.4 m -84.19 147.79 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.041 0.448 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -164.78 153.55 12.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.034 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CE ' ' CZ2' ' A' ' 28' ' ' TRP . 10.2 mttt -85.95 138.79 31.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.887 0.375 . . . . 0.0 111.0 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.821 HD21 ' O ' ' A' ' 28' ' ' TRP . 8.3 mt -68.8 -69.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.633 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -124.85 134.25 25.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.797 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.14 144.75 73.78 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 123.507 -1.455 . . . . 0.0 112.265 0.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.87 135.46 19.36 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.482 2.122 . . . . 0.0 112.268 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.49 -32.25 0.15 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.74 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.78 135.4 48.87 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.55 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -95.12 69.46 3.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.981 0.419 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 59.83 154.87 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.117 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.542 ' HB3' HD11 ' A' ' 80' ' ' ILE . 3.0 m-85 -168.27 118.45 0.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.873 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.37 126.58 28.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.835 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.6 p -51.55 -31.51 24.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -7.48 52.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.388 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -117.61 7.79 12.7 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.53 0.196 . . . . 0.0 111.53 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 75' ' ' TYR . 53.6 mt -105.0 152.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.87 0.367 . . . . 0.0 111.063 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.401 ' N ' HG22 ' A' ' 80' ' ' ILE . 27.4 t0 -104.82 116.9 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.747 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.414 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 68.1 m-85 -96.88 30.86 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.784 ' O ' HD23 ' A' ' 84' ' ' LEU . 3.3 m-20 -132.4 26.86 4.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.784 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.3 mt -147.0 30.84 0.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -137.58 -52.07 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.904 179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.4 p30 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.906 0.384 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.82 126.07 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.104 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.622 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -90.71 143.51 26.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.872 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.816 ' O ' HD21 ' A' ' 67' ' ' LEU . 57.2 m95 -135.95 -174.17 3.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.644 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HG2' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.65 147.54 18.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.57 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.44 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 27.4 p90 -131.37 140.54 49.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.935 0.397 . . . . 0.0 111.544 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.705 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 16.0 ttpt -123.76 123.13 39.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.2 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -58.11 -52.48 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.073 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.66 172.54 9.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.116 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.406 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 62.8 t-20 -118.02 40.33 3.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -106.73 -177.78 3.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.978 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -92.53 -9.55 61.39 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.154 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -112.87 -17.3 12.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.481 0.182 . . . . 0.0 111.347 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.705 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.06 162.94 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.833 0.349 . . . . 0.0 111.501 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -55.44 -177.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.86 85.86 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.36 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 6.6 m-85 -118.72 -159.0 0.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.69 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.39 14.77 61.37 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.303 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.6 Cg_endo -70.97 54.5 1.65 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 119.933 1.866 . . . . 0.0 112.011 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.452 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 1.9 m-85 -123.21 165.29 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.085 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -56.92 145.15 30.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.028 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.1 p -47.76 -30.16 3.7 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.168 0.509 . . . . 0.0 110.081 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.68 -41.51 92.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.374 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.461 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 5.3 tp60 -68.72 -26.07 65.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.775 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.431 ' O ' HG23 ' A' ' 53' ' ' VAL . 15.1 mmm -76.35 -51.01 12.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.314 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -55.79 -32.03 63.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.027 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' GLU . 85.8 m -65.38 -64.88 0.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.514 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.461 ' CH2' ' HG2' ' A' ' 48' ' ' GLN . 5.6 m0 -49.02 -42.74 39.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.494 HG22 ' HD2' ' A' ' 58' ' ' PHE . 81.5 t -62.64 -58.1 9.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.507 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.7 p -75.23 -24.75 57.74 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.756 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 51' ' ' THR . 0.5 OUTLIER -64.66 -46.38 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 111.185 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.33 -31.18 0.3 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.416 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -57.59 156.83 7.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 110.82 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.494 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 63.19 61.74 1.84 Allowed Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 50.8 Cg_exo -53.78 -38.59 85.32 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.466 2.11 . . . . 0.0 112.297 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -105.37 5.13 31.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.35 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.65 160.75 36.83 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.288 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.08 164.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 111.242 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.406 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -77.93 82.0 4.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.846 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.471 ' CB ' HD12 ' A' ' 80' ' ' ILE . 1.7 m -73.81 146.6 44.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 29' ' ' GLU . 5.3 ttm180 -162.49 159.29 24.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.366 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -94.03 137.13 33.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.816 HD21 ' O ' ' A' ' 28' ' ' TRP . 9.1 mt -72.09 -64.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -109.95 127.59 26.83 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.779 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.13 172.05 59.49 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.214 0.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.92 162.13 41.1 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.573 2.182 . . . . 0.0 112.278 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.02 43.9 94.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.471 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.02 156.39 41.08 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.626 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -67.27 75.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.408 ' O ' ' CG ' ' A' ' 75' ' ' TYR . 33.0 p90 -54.54 151.88 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.055 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.408 ' CG ' ' O ' ' A' ' 74' ' ' PHE . 5.2 m-85 -173.11 152.57 2.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.629 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -55.31 131.56 45.9 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.701 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.458 ' OG ' HG21 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -52.74 -26.44 14.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.194 -179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.51 3.13 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.377 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -126.92 4.95 6.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.576 0.227 . . . . 0.0 111.376 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.471 HD12 ' CB ' ' A' ' 64' ' ' CYS . 43.0 mt -105.0 153.22 6.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' N ' HG22 ' A' ' 80' ' ' ILE . 13.2 t0 -107.29 114.84 29.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -96.78 10.02 40.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.218 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.76 ' O ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -108.9 32.27 5.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.825 0.345 . . . . 0.0 110.842 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.76 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.4 mt -147.42 31.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.763 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -134.68 -47.28 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.908 179.921 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.9 t0 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.787 0.327 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 27' ' ' MET . 23.7 t -63.67 158.67 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.089 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.559 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -148.19 140.99 24.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.811 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.748 ' O ' HD21 ' A' ' 67' ' ' LEU . 31.1 m95 -131.17 -173.9 3.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.575 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.728 ' OE2' HD23 ' A' ' 67' ' ' LEU . 1.2 pt-20 -153.55 141.9 20.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.597 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.479 ' N ' ' O ' ' A' ' 41' ' ' TYR . 12.8 p90 -123.39 141.75 51.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.115 0.483 . . . . 0.0 111.783 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.645 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 16.1 ttpt -130.07 121.73 26.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.96 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -54.55 -48.99 71.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.006 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -97.76 -174.82 2.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.955 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -129.68 38.48 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.667 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -105.24 173.55 6.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.989 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.2 -2.37 89.3 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.225 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -112.5 -26.99 8.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.552 0.215 . . . . 0.0 110.94 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.645 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -44.55 153.1 0.17 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.401 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' OE2' ' CE2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -56.26 -177.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 0.0 110.787 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.63 81.03 0.66 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.047 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 30' ' ' TYR . 1.9 m-85 -110.61 -157.07 0.6 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.07 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 88.26 14.81 61.54 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-O 119.098 -0.834 . . . . 0.0 114.392 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 54.6 Cg_endo -70.48 54.75 1.49 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 CA-C-N 120.083 1.941 . . . . 0.0 111.955 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.6 m-85 -121.73 165.37 15.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.02 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 p -60.79 145.3 50.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.872 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.23 -30.36 1.97 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.135 0.493 . . . . 0.0 110.207 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.91 -44.17 90.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.526 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.472 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.8 tp-100 -66.27 -25.64 66.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.782 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 mmm -73.37 -42.85 61.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.927 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HG2' ' CG ' ' A' ' 82' ' ' PHE . 1.1 mm-40 -60.75 -34.36 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.884 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 55' ' ' GLU . 44.3 m -61.95 -56.97 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.182 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.9 m0 -57.53 -49.16 77.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.763 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.683 HG22 ' HD2' ' A' ' 58' ' ' PHE . 94.7 t -63.56 -45.22 98.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.133 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.6 p -75.46 -29.19 59.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.9 mm-40 -64.71 -28.08 69.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.047 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 134.22 -24.21 3.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.461 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -56.59 159.68 3.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.794 0.33 . . . . 0.0 110.778 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.683 ' HD2' HG22 ' A' ' 53' ' ' VAL . 0.5 OUTLIER 62.9 61.48 1.99 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.484 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.431 ' HD3' ' N ' ' A' ' 58' ' ' PHE . 51.3 Cg_exo -55.2 -38.46 93.62 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.57 2.18 . . . . 0.0 112.509 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -105.19 5.12 31.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.24 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.74 159.02 35.24 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.026 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.5 m -130.92 164.72 33.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.113 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CE2' ' CG ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -76.92 85.44 3.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.62 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.8 m -84.86 146.71 27.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.233 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -163.87 147.05 9.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.084 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 65' ' ' ARG . 2.3 mtmp? -84.05 126.44 33.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.975 0.417 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.748 HD21 ' O ' ' A' ' 28' ' ' TRP . 7.2 mt -57.51 -61.37 2.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.705 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -119.94 136.53 24.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.831 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.81 148.82 83.8 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.511 -1.454 . . . . 0.0 112.306 0.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.92 133.17 13.54 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.521 2.148 . . . . 0.0 112.33 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 145.1 67.88 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.634 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.87 174.19 33.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.421 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -119.99 66.78 0.82 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.125 0.488 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CG ' ' CE2' ' A' ' 63' ' ' TYR . 34.5 m-85 52.78 175.16 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.36 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.548 ' HB3' HD11 ' A' ' 80' ' ' ILE . 14.1 m-85 -169.06 110.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.657 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -56.34 122.96 13.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.045 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 t -51.7 -29.2 17.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.301 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -1.18 40.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.405 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.59 7.36 8.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.464 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 75' ' ' TYR . 51.2 mt -101.77 152.74 5.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.989 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' N ' HG22 ' A' ' 80' ' ' ILE . 32.5 t0 -100.84 114.8 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.588 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CG ' ' HG2' ' A' ' 50' ' ' GLN . 52.3 m-85 -97.1 31.78 2.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.005 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.724 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -136.19 35.09 2.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.977 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.724 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.8 mt -147.85 31.08 0.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.943 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' CE1' ' HE2' ' A' ' 66' ' ' LYS . 94.6 m-85 -137.61 -49.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.897 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.828 0.347 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 85' ' ' TYR . 20.1 t -57.79 114.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.207 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 17.2 mtp -88.9 135.1 33.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.663 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.719 ' O ' HD21 ' A' ' 67' ' ' LEU . 45.0 m95 -123.03 -174.64 2.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.492 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.566 ' CD ' HD22 ' A' ' 67' ' ' LEU . 2.8 mt-10 -155.94 144.39 20.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.815 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.573 ' N ' ' O ' ' A' ' 41' ' ' TYR . 47.1 p90 -128.52 135.96 50.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 111.695 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.823 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 4.1 ttpm? -118.16 116.77 27.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.055 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -56.57 -53.14 61.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.0 110.892 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -82.67 -174.0 4.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 63' ' ' TYR . 66.4 t30 -134.2 38.69 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.732 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -107.59 162.38 14.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.952 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.27 -9.35 80.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.17 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -105.31 -25.27 12.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.604 0.24 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.823 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -43.58 132.98 4.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.833 0.349 . . . . 0.0 111.415 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.6 tt0 -55.81 -177.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.478 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -151.61 120.81 6.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.065 0.46 . . . . 0.0 111.573 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.573 ' O ' ' N ' ' A' ' 30' ' ' TYR . 8.2 m-85 -128.16 -173.03 2.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.907 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.692 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 98.48 2.22 57.7 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.338 -0.934 . . . . 0.0 115.158 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.844 ' HA ' HD11 ' A' ' 67' ' ' LEU . 83.7 Cg_exo -42.52 -25.68 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.806 0 CA-C-N 120.284 2.042 . . . . 0.0 112.886 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' CD2' ' HA2' ' A' ' 42' ' ' GLY . 0.8 OUTLIER -43.28 165.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.365 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.5 p -61.89 146.94 48.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.087 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.0 p -47.83 -30.47 4.07 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.148 0.499 . . . . 0.0 110.22 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.64 -48.89 73.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.496 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 6.2 tp60 -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.395 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.516 ' O ' HG23 ' A' ' 53' ' ' VAL . 37.8 mmm -75.46 -43.52 49.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.939 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -59.25 -28.56 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.09 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' GLU . 86.2 m -71.38 -58.07 3.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.541 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 3.8 m-90 -56.85 -43.2 80.89 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.665 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 49' ' ' MET . 96.8 t -64.76 -47.24 89.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.749 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.7 m -75.39 -29.57 59.87 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.02 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 51' ' ' THR . 3.3 tm-20 -64.74 -34.57 78.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 115.47 3.05 21.02 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.926 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.452 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -54.98 -30.32 58.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.993 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 57' ' ' TYR . 0.7 OUTLIER -113.8 81.63 5.96 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.645 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.59 -29.45 43.98 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -105.15 5.08 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.352 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.92 162.98 29.19 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.173 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 77' ' ' SER . 5.6 m -138.8 164.79 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 111.329 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.401 ' CZ ' ' OD1' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -83.44 90.8 7.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.231 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.2 m -78.19 144.81 36.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.187 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.71 138.74 16.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.566 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mtmt -84.02 121.79 27.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.035 0.445 . . . . 0.0 110.621 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.844 HD11 ' HA ' ' A' ' 43' ' ' PRO . 2.8 mt -53.21 -31.02 41.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.071 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 23.8 t0 -124.4 108.8 29.14 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 68' ' ' ASP . 74.3 Cg_endo -75.09 151.0 96.22 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.656 -1.393 . . . . 0.0 112.31 -0.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.15 112.91 3.54 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.602 2.201 . . . . 0.0 112.514 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.46 94.99 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.485 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -154.84 -136.38 2.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.081 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -66.52 74.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.958 0.408 . . . . 0.0 111.27 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -54.64 166.56 0.45 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.69 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -168.16 141.15 3.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.136 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.17 131.36 45.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.656 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.44 ' HB3' HG23 ' A' ' 62' ' ' VAL . 10.9 p -51.61 -26.91 9.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -78.95 -3.13 43.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.522 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.02 7.01 7.26 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' A' ' 64' ' ' CYS . 43.5 mt -104.69 152.97 6.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 80' ' ' ILE . 28.8 t0 -111.29 117.59 33.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -96.67 30.54 2.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.78 ' O ' HD23 ' A' ' 84' ' ' LEU . 8.0 t70 -128.44 30.21 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.778 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.78 HD23 ' O ' ' A' ' 83' ' ' ASP . 4.5 mt -147.05 30.17 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.826 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.478 ' HB3' HG21 ' A' ' 26' ' ' VAL . 63.6 m-85 -137.64 -55.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.907 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.872 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.863 0.363 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.3 t -64.5 113.77 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.613 ' CB ' HD12 ' A' ' 67' ' ' LEU . 12.1 mmm -92.55 150.02 21.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.797 ' O ' HD21 ' A' ' 67' ' ' LEU . 39.7 m95 -133.84 -173.96 3.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' CD ' HD11 ' A' ' 40' ' ' LEU . 13.2 pt-20 -151.76 156.77 40.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.558 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.8 p90 -139.48 146.56 40.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.21 0.528 . . . . 0.0 111.745 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.518 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -133.17 120.26 20.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.075 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -59.72 -55.49 33.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 110.999 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -83.51 160.38 21.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -107.43 39.28 1.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -103.45 161.89 13.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.004 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.75 0.15 88.6 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.111 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -112.39 -26.86 8.52 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.572 0.225 . . . . 0.0 111.115 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.518 ' HB3' ' HE2' ' A' ' 31' ' ' LYS . . . -43.35 146.88 0.43 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.487 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 3.0 mp0 -56.52 -177.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.5 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -145.96 96.66 2.83 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.239 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' C ' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-85 -113.65 -161.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.249 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.688 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.61 12.74 68.81 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-O 118.981 -0.899 . . . . 0.0 114.436 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 57.8 Cg_endo -70.61 54.63 1.53 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 CA-C-N 120.136 1.968 . . . . 0.0 112.195 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.464 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 3.3 m-85 -121.46 165.23 15.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 p -57.74 144.44 38.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.995 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.9 -30.47 2.54 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.134 0.493 . . . . 0.0 110.231 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.42 -43.27 86.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.433 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 30.8 tp60 -66.61 -25.91 66.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.644 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.497 ' O ' HG23 ' A' ' 53' ' ' VAL . 38.4 mmm -76.12 -47.31 24.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.086 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.7 tp60 -57.59 -31.9 66.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.143 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 55' ' ' GLU . 41.2 m -67.93 -57.31 6.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.607 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 48' ' ' GLN . 4.8 m0 -57.72 -46.86 83.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.712 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 49' ' ' MET . 98.3 t -61.04 -47.85 91.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.767 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.1 t -75.19 -27.95 59.82 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.041 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 51' ' ' THR . 7.0 mm-40 -64.75 -38.5 91.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.3 4.0 11.32 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.855 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.85 -30.03 63.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -116.27 87.59 20.4 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.733 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.77 -33.73 33.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.4 2.066 . . . . 0.0 112.203 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -105.51 5.23 31.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 62' ' ' VAL . . . 88.43 -176.21 44.78 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.102 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 61' ' ' GLY . 5.5 m -156.34 164.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.36 . . . . 0.0 111.262 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -82.02 86.46 6.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.259 179.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.1 m -79.08 155.23 28.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.107 0.48 . . . . 0.0 111.544 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -166.5 155.56 11.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.515 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HE3' ' CH2' ' A' ' 28' ' ' TRP . 4.6 mtmp? -93.72 132.99 37.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.762 0.315 . . . . 0.0 110.938 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 28' ' ' TRP . 6.3 mt -65.87 -68.17 0.39 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.787 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -122.76 131.47 24.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.772 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.58 153.81 79.82 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 123.622 -1.408 . . . . 0.0 112.366 -0.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.83 163.31 31.47 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.597 2.198 . . . . 0.0 112.358 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.58 49.26 0.29 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.637 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -129.99 136.77 9.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.324 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.496 ' O ' ' CG ' ' A' ' 74' ' ' PHE . 64.1 mt-30 -93.0 66.99 4.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.496 ' CG ' ' O ' ' A' ' 73' ' ' GLN . 10.3 p90 51.83 160.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.836 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -165.0 111.7 0.98 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.756 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -58.63 125.38 23.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.2 t -51.96 -32.7 34.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -3.47 36.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.48 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.94 6.29 10.87 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 81' ' ' ASP . 41.1 mt -100.43 154.8 4.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 111.004 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 80' ' ' ILE . 14.3 t0 -105.42 114.99 29.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.768 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -96.59 33.27 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.649 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.2 t0 -134.64 30.9 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.973 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.2 mt -146.09 30.78 1.04 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.821 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -138.44 -56.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.976 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.833 0.349 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 85' ' ' TYR . 16.2 t -64.44 115.32 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.18 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.604 ' HG2' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -86.83 142.29 28.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.801 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.825 ' O ' HD21 ' A' ' 67' ' ' LEU . 58.5 m95 -132.89 -174.03 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.061 0.458 . . . . 0.0 111.823 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.651 ' OE1' HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -153.75 157.96 40.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.432 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 16.6 p90 -145.83 134.61 22.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 111.81 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.663 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -119.86 123.65 44.13 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.997 179.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -57.03 -50.05 73.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.833 0.349 . . . . 0.0 110.922 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.407 ' HB3' HG23 ' A' ' 35' ' ' THR . 13.2 mt-10 -86.81 176.64 7.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.805 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -122.67 39.29 3.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.64 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.407 HG23 ' HB3' ' A' ' 33' ' ' GLU . 2.0 p -106.27 165.8 10.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.025 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.58 -2.55 89.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.296 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.85 -26.7 8.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.625 0.25 . . . . 0.0 111.033 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 31' ' ' LYS . . . -43.75 146.0 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.583 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -55.53 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.417 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.651 HD23 ' OE1' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -154.6 122.13 5.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.106 0.479 . . . . 0.0 111.448 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' TYR . 2.0 m-85 -132.63 -160.07 1.02 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.014 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.685 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 86.38 15.12 64.81 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-O 119.008 -0.884 . . . . 0.0 114.434 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.2 Cg_endo -70.65 54.61 1.54 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 CA-C-N 120.112 1.956 . . . . 0.0 111.959 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CE1' ' HA2' ' A' ' 42' ' ' GLY . 2.2 m-85 -123.09 165.46 16.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.158 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.2 p -56.11 145.66 25.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.894 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.8 t -48.65 -29.97 4.94 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.16 0.505 . . . . 0.0 110.07 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.87 83.35 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.526 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' HG3' ' CZ3' ' A' ' 52' ' ' TRP . 37.7 tp60 -73.8 -26.02 60.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.768 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmm -75.02 -47.23 30.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.059 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.418 ' OE1' ' CD1' ' A' ' 82' ' ' PHE . 33.8 tp60 -61.16 -34.54 75.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.039 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.5 m -61.38 -53.29 58.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.268 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.429 ' HB3' ' CE2' ' A' ' 58' ' ' PHE . 3.5 m0 -58.13 -45.2 87.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.48 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.535 HG22 ' CD2' ' A' ' 58' ' ' PHE . 95.4 t -65.46 -45.76 91.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.88 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.24 -28.36 59.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 51' ' ' THR . 5.2 mm-40 -64.89 -37.58 88.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.977 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.16 -23.23 1.74 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.643 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -57.84 160.73 4.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.83 0.348 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD2' HG22 ' A' ' 53' ' ' VAL . 1.9 m-85 61.99 74.92 0.46 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.42 -38.92 7.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.458 2.106 . . . . 0.0 112.231 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -105.22 5.18 31.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.156 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.77 159.02 34.78 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.019 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.477 HG11 ' CD1' ' A' ' 58' ' ' PHE . 5.3 m -130.95 164.3 34.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CB ' ' HB3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -79.32 88.56 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.097 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 0.8 OUTLIER -85.25 150.12 25.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.091 0.472 . . . . 0.0 111.805 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.5 147.64 7.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.271 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -84.31 140.7 31.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.892 0.377 . . . . 0.0 111.25 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.825 HD21 ' O ' ' A' ' 28' ' ' TRP . 3.8 mt -74.42 -67.41 0.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -119.99 125.41 27.36 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.798 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.05 142.1 73.75 Favored 'Cis proline' 0 C--N 1.348 0.516 0 C-N-CA 123.56 -1.433 . . . . 0.0 112.255 -0.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.32 169.34 21.01 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.487 2.125 . . . . 0.0 112.354 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.2 27.95 2.53 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.747 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.56 134.96 21.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.357 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.14 66.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.006 0.432 . . . . 0.0 111.01 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 51.44 103.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.313 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.759 ' HB3' HD11 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -125.6 99.17 5.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.73 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -57.83 123.07 14.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.893 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.423 ' HA ' HD12 ' A' ' 80' ' ' ILE . 83.9 p -53.58 -31.05 45.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.072 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -11.23 60.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.151 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.59 10.18 15.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.368 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.759 HD11 ' HB3' ' A' ' 75' ' ' TYR . 93.9 mt -105.0 153.58 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.04 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' N ' HG22 ' A' ' 80' ' ' ILE . 16.2 t0 -109.57 116.23 31.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.829 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CD1' ' OE1' ' A' ' 50' ' ' GLN . 53.8 m-85 -94.25 46.0 1.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.757 ' O ' HD23 ' A' ' 84' ' ' LEU . 4.3 t0 -152.06 28.94 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 83' ' ' ASP . 5.0 mt -147.6 30.79 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.863 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.557 ' HB3' HG21 ' A' ' 26' ' ' VAL . 62.7 m-85 -134.47 -51.02 0.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.519 ' O ' HG23 ' A' ' 86' ' ' THR . 8.3 t . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.725 0.298 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.68 113.52 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.644 ' CB ' HD12 ' A' ' 67' ' ' LEU . 5.8 mtp -91.02 149.14 21.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.785 ' O ' HD21 ' A' ' 67' ' ' LEU . 44.3 m95 -133.75 -173.82 3.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.337 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 64' ' ' CYS . 11.1 pt-20 -151.99 154.41 35.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.234 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.468 ' CD2' ' CA ' ' A' ' 42' ' ' GLY . 10.3 p90 -138.94 143.91 38.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.15 0.5 . . . . 0.0 111.98 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.767 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 34.2 ttpt -131.2 114.64 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.907 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.444 ' CH2' ' CD1' ' A' ' 58' ' ' PHE . 92.0 m95 -56.35 -53.01 62.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.899 0.38 . . . . 0.0 111.026 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 35' ' ' THR . 0.6 OUTLIER -84.86 159.51 20.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.912 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -109.03 38.98 2.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.625 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 33' ' ' GLU . 1.6 p -106.65 162.78 13.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.02 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.57 -4.64 85.11 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -111.03 -22.88 11.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.526 0.203 . . . . 0.0 111.084 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.767 ' HB3' ' HD2' ' A' ' 31' ' ' LYS . . . -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.824 0.345 . . . . 0.0 111.452 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 23.1 mm-40 -56.3 -175.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD11 ' CD ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -156.45 90.8 1.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.97 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 39' ' ' GLU . 5.0 m-85 -119.92 -160.26 0.81 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.302 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.676 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . 89.37 12.63 62.79 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 119.009 -0.884 . . . . 0.0 114.645 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 56.4 Cg_endo -71.01 55.56 1.81 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 CA-C-N 120.195 1.998 . . . . 0.0 111.92 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.443 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 6.0 m-85 -121.02 165.23 15.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 34.4 p -59.94 147.68 37.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.022 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.4 p -47.32 -32.11 4.47 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.168 0.509 . . . . 0.0 110.04 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.23 99.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.388 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.467 ' CG ' ' CZ3' ' A' ' 52' ' ' TRP . 12.0 tp60 -70.01 -25.93 63.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.451 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.676 ' O ' HG23 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -76.11 -46.51 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.983 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -60.45 -33.59 72.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.216 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 55' ' ' GLU . 96.9 m -65.21 -57.7 7.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.467 ' CZ3' ' CG ' ' A' ' 48' ' ' GLN . 2.8 m0 -57.73 -45.4 85.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.528 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 49' ' ' MET . 59.3 t -65.0 -44.89 95.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.786 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.1 t -75.28 -30.29 60.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.967 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 51' ' ' THR . 4.6 mm-40 -64.82 -32.36 74.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.896 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.51 3.09 22.6 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.887 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.409 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -57.25 -33.22 67.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.777 0.322 . . . . 0.0 110.854 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD2' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -112.32 77.55 2.25 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.682 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.62 -29.21 30.36 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.61 2.206 . . . . 0.0 112.3 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -105.07 -0.6 26.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.37 161.65 37.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.333 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.54 164.89 25.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.877 0.37 . . . . 0.0 111.262 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.64 84.07 5.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.067 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 1.3 m -82.9 145.56 29.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.414 -179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.4 153.69 29.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.044 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -90.21 135.75 33.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 110.859 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 28' ' ' TRP . 5.3 mt -71.3 -67.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.545 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -121.1 134.14 24.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.715 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.98 149.39 92.02 Favored 'Cis proline' 0 C--N 1.347 0.495 0 C-N-CA 123.497 -1.46 . . . . 0.0 112.361 0.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.51 138.36 35.28 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.473 2.116 . . . . 0.0 112.371 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 138.18 78.7 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.582 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -157.42 136.22 4.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.324 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -97.25 67.76 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.105 0.478 . . . . 0.0 111.113 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 59.27 154.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.093 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.601 ' HB3' HD11 ' A' ' 80' ' ' ILE . 9.7 m-85 -160.93 105.33 1.36 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -57.27 127.26 31.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.3 p -52.62 -33.94 48.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.198 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.52 -7.36 51.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.349 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -113.79 6.26 16.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.651 0.262 . . . . 0.0 111.429 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.625 HD13 ' CZ3' ' A' ' 28' ' ' TRP . 45.8 mt -105.09 153.92 6.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.84 0.353 . . . . 0.0 110.996 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 80' ' ' ILE . 17.2 t0 -104.8 115.7 30.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -96.82 33.69 1.83 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.604 ' O ' HD23 ' A' ' 84' ' ' LEU . 9.4 t70 -139.4 33.07 2.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 83' ' ' ASP . 7.4 mt -145.91 30.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.7 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -136.83 -57.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.08 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.999 -179.857 . . . . . . . . 0 0 . 1 stop_ save_